Article Mechanosensing by the Lamina Protects against Nuclear Rupture , DNA Damage , and Cell - Cycle Arrest Graphical Abstract Highlights d Stiff ECM , high actomyosin contractility , and low lamin - A favor nuclear rupture d Nuclear rupture causes cytoplasmic mis - localization of DNA repair factors d Repair factor depletion increases DNA damage , telomere loss , and cell - cycle arrest d Lamin - A increases during development to mechano - protect the genome Authors Sangkyun Cho , Manasvita Vashisth , Amal Abbas , . . . , Roger A . Greenberg , Benjamin L . Prosser , Dennis E . Discher Correspondence discher @ seas . upenn . edu In Brief Progeroid syndromes make affected individuals appear older , and the only known causes are mutations in DNA repair factors and lamin - A . Cho et al . show that as embryonic hearts stiffen and strengthen in development , lamin - A accumulates to oppose stress - driven nuclear rupture , repair factor loss , increased DNA damage , and cell - cycle arrest . Cho et al . , 2019 , Developmental Cell 49 , 920 – 935 June 17 , 2019 ª 2019 Elsevier Inc . https : / / doi . org / 10 . 1016 / j . devcel . 2019 . 04 . 020 Author Correction : Mechanosensing by the Lamina Protects against Nuclear Rupture , DNA Damage , and Cell Cycle Arrest Sangkyun Cho 1 , Manasvita Vashisth 1 , Amal Abbas 1 , Stephanie Majkut 1 , Kenneth Vogel 1 , Yuntao Xia 1 , Irena L . Ivanovska 1 , Jerome Irianto 1 , Manorama Tewari 1 , Kuangzheng Zhu 1 , Elisia D . Tichy 2 , Foteini Mourkioti 2 , Hsin - Yao Tang 3 , Roger A . Greenberg 4 , Benjamin L . Prosser 5 , and Dennis E . Discher 1 , 2 , 4 - 6 * 1 Molecular & Cell Biophysics Lab , University of Pennsylvania , Philadelphia , PA 19104 , USA 2 Orthopaedic Surgery and Cell & Developmental Biology , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA 19104 , USA 3 Center for Systems and Computational Biology , Wistar Institute , Philadelphia , PA 19104 , USA 4 Abramson Family Cancer Research Institute , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA 19104 , USA 5 Pennsylvania Muscle Institute , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA 19104 , USA 6 Penn Institute for Regenerative Medicine , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA 19104 , USA * Lead contact : discher @ seas . upenn . edu Summary Several figures in this article have been mis - referenced per the accompanying Amendment . Amendment A number of Figures and Supplementary Figures have been mis - referenced in this article : • p . 6 : “…mis - localization persists for hours ( Figure 2E - ii ) ”  Figure S2E - ii • p . 9 : “…how LMNA adjusts to actomyosin stress ( Figures 1A - 1E , 2C , and 2E - iii ) ”  Figure 1A - 1E • p . 11 : “…spreading , and sarcomere assembly ( Figures 6C , 5D - ii , S6H ) ”  Figures 6C , 6D - ii , S6A , E • p . 11 : “…at the single - cell level ( Figure 5D - i ) ”  Figure 6D - i • p . 12 : “…distributed throughout the nucleoplasm ( Figures 3E - ii and 4D ) ”  Figures 3E - ii and 4A - i • p . 12 : “…multiple DNA repair factors in several pathways ( Figure 2E - i ) ”  Figure S2E - i • p . 12 : “…LMNA of the ‘nuclear matrix’ ( Figures 5D - i , 5A , and 5B ) ”  Figures 5D - i , 6C , and 6D ) • p . 12 : “…intermittently strain the nucleus ( Figures 3F , 5D , and S6G ) ”  Figures 3F , 6D , and S6G • p . 13 : “…hearts across species ( Cho , et al . , 2017 ) ( Figure 7A ) ”  Figure S7D • p . 13 : “…diverse chick embryo tissues at E18 ( Figure 7B ) ”  Figure S7E • p . 13 : “…stiffness of a tissue in adults ( Figure 7C ; adapted from…”  Figure S7F • Acknowledgements : Support of National Science Foundation Materials Research Science and Engineering Center at Penn is gratefully acknowledged . The findings and conclusions of the article remain unchanged . The original article has not been corrected . Developmental Cell Article Mechanosensing by the Lamina Protects against Nuclear Rupture , DNA Damage , and Cell - Cycle Arrest Sangkyun Cho , 1 Manasvita Vashisth , 1 Amal Abbas , 1 Stephanie Majkut , 1 Kenneth Vogel , 1 Yuntao Xia , 1 Irena L . Ivanovska , 1 Jerome Irianto , 1 Manorama Tewari , 1 Kuangzheng Zhu , 1 Elisia D . Tichy , 2 Foteini Mourkioti , 2 Hsin - Yao Tang , 3 Roger A . Greenberg , 4 Benjamin L . Prosser , 5 and Dennis E . Discher 1 , 2 , 4 , 5 , 6 , 7 , * 1 Molecular & Cell Biophysics Laboratory , University of Pennsylvania , Philadelphia , PA 19104 , USA 2 Orthopaedic Surgery and Cell & Developmental Biology , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA 19104 , USA 3 Center for Systems and Computational Biology , Wistar Institute , Philadelphia , PA 19104 , USA 4 Abramson Family Cancer Research Institute , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA 19104 , USA 5 Pennsylvania Muscle Institute , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA 19104 , USA 6 Penn Institute for Regenerative Medicine , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA 19104 , USA 7 Lead Contact * Correspondence : discher @ seas . upenn . edu https : / / doi . org / 10 . 1016 / j . devcel . 2019 . 04 . 020 SUMMARY Whether cell forces or extracellular matrix ( ECM ) can impact genome integrity is largely unclear . Here , acute perturbations ( (cid:2) 1 h ) to actomyosin stress or ECM elasticity cause rapid and reversible changes in lamin - A , DNA damage , and cell cycle . The ﬁndings are especially relevant to organs such as the heart because DNA damage permanently arrests cardio - myocyte proliferation shortly after birth and thereby eliminates regeneration after injury including heart attack . Embryonic hearts , cardiac - differentiated iPS cells ( induced pluripotent stem cells ) , and various nonmuscle cell types all show that actomyosin - driven nuclear rupture causes cytoplasmic mis - local - ization of DNA repair factors and excess DNA dam - age . Binucleation and micronuclei increase as telomeres shorten , which all favor cell - cycle arrest . Deﬁciencies in lamin - A and repair factors exacerbate these effects , but lamin - A - associated defects are rescued by repair factor overexpression and also by contractility modulators in clinical trials . Contrac - tile cells on stiff ECM normally exhibit low phosphor - ylation and slow degradation of lamin - A by matrix - metalloprotease - 2 ( MMP2 ) , and inhibition of this lamin - A turnover and also actomyosin contractility are seen to minimize DNA damage . Lamin - A is thus stress stabilized to mechano - protect the genome . INTRODUCTION Proliferation of many cell types slows dramatically shortly after birth and is absent in key adult tissues ( Li et al . , 1996 ) , which pre - sents a major challenge to regeneration . Cell growth in culture is modulated by the stiffness of the extracellular matrix ( ECM ) , which generally promotes actomyosin stress ( Engler et al . , 2006 ; Paszek et al . , 2005 ) and affects the conformation ( Sawada et al . , 2006 ) , post - translational modiﬁcation ( PTM ) ( Guilluy et al . , 2014 ) , localization ( Dupont et al . , 2011 ) , and degradation ( Dingal and Discher , 2014 ) of mechanosensitive proteins . Actomyosin links to ECM and to nuclei , such that rapid changes to the ECM and tissue mechanics that result from chronic or acute injury or even drug therapies ( e . g . , cardiac arrest or cardiomyop - athy treatment [ Green et al . , 2016 ] ) can in principle affect the nu - cleus ( Takaki et al . , 2017 ; Wiggan et al . , 2017 ; Kanellos et al . , 2015 ) and perhaps the DNA within . DNA damage and telomere shortening are indeed well documented in injuries that affect the heart ( Chang et al . , 2018 ; Higo et al . , 2017 ; Shariﬁ - Sanjani et al . , 2017 ; Oh et al . , 2003 ) , as well as nonmuscle tissue—but DNA damage and repair are rarely studied in developing organs , and relationships to proliferation , ECM stiffness , and actomyosin stress are understudied . DNA damage and senescence increase with many disease - linked mutations , including those in the nucleoskeletal protein lamin - A ( LMNA ) that forms a structural meshwork around chro - matin ( Turgay et al . , 2017 ; Shimi et al . , 2015 ; Gruenbaum et al . , 2005 ) . LMNA deﬁciencies associate with elevated DNA damage ( Graziano et al . , 2018 ; Liu et al . , 2005 ) and result in accelerated aging of stiff tissues similar to deﬁciencies in DNA repair factors ( e . g . , KU80 ) ( Li et al . , 2007 ) . Moreover , progeroid syndromes are caused only by mutations in LMNA and multiple DNA repair fac - tors , but LMNA’s primary function in development remains hotly debated ( Burke and Stewart , 2013 ) , with supposed roles in gene positioning and regulation ( Harr et al . , 2015 ) seeming at odds with largely normal development of human and mouse mutants until weeks after birth . Surprisingly , senescence or apoptosis of cells with LMNA defects is rescued by culturing cells on almost any ECM ( versus rigid plastic [ de La Rosa et al . , 2013 ; Hernandez et al . , 2010 ] ) and by treatment with at least one drug affecting both cytoskeleton and nucleo - cytoplasmic traf - ﬁcking ( Larrieu et al . , 2018 , 2014 ) . Relationships between lamins , 920 Developmental Cell 49 , 920 – 935 , June 17 , 2019 ª 2019 Elsevier Inc . 0 1 2 3 10 100 ' 2N ' ' 4N ' Total DNA ( A . U . ) E d U i n t en s i t y ( A . U . ) Lamin - A DNA damage Matrix stiffness Nuclear rupture Acto - myosin stress ~ 1h Cytopl . Nucleus LMNA > 3h ? Cell cycle arrest LMNA & DNA damage are mechano - sensitive to myosin - II & matrix , but DNA damage levels change more rapidly AR = L / W L W Beating E4 heart Aspect Ratio D LMNA H2AX γ Myosin - II inhibition Rescue 73 17 42 kDa A B ii i DMSOBlebb . WashoutOM Isolate Embryonic age : Day - 4 = E4 hearts 1 h 0 . 5 h γ H2AX 17 42 LMNA M YK ( 1 μ M ) 73 42 kDa M YK ( 0 . 3 μ M ) D M S O Blebb . ( 25 μ M ) MYK ( 0 . 3 μ M ) MYK ( 1 μ M ) B l ebb . 1h W a s hou t 0 . 00 0 . 02 0 . 04 20x Δ A R / A R r e f 0 1 2 3 4 5 6 7 8 0 . 0 0 . 5 1 . 0 1 . 5 * n . s . * DMSO Ctrl Washout + OM Time ( h ) γ H 2 AX ( A . U . ) no r m . t o D M S O C t r l < 0 . 5h , 6h > - - - + + + - - - + + + - - - + + + - - - + + + C NTCollagenase ( 0 . 3 mg / ml ) Collagenase ( 1 mg / ml ) TGM 2 4 6 0 Time ( h ) E F 0 1 2 3 4 Time ( h ) Blebbistatin 0 . 5 1 2 3 4 . 5 Washout DMSO OM DMSO 0 . 5 + 1 + 3 6 + 3 Time ( h ) : LMNA H2AX γ 73 17 42 kDa 0 . 75 0 . 75 1 3 0 . 5 3 + 0 . 75 Time ( h ) : Conc . ( mg / ml ) : 0 . 3 1 Col’ase NT TGM 20 / 1 Col’ase Rescue 20 20 - - TGM G2 G1 S G H 0 1 0 . 4 1 Δ no r m . t o N T Col ' ase ( mg / ml ) ii i AR / AR ref 3 sec 5 sec A R / A R r e f LMNA KD & myosin - II inhibition / washout perturb cell cycle in intact hearts Blebb ( 2h ) Wash . ( + 1h ) DMSO 10 100 4N2N * of population 0 5 10 15 20 Ionizing MYK Blebb . DMSO * * * * * * n . s . Radiation Comet centroid distance ( μ m ) + Blebb . / MYK Washout + / - OM Cardiac arrest 0 1 2 3 4 0 1 Collagenase ( 1 mg / ml ) TGM by Mass Spec . NT Ctl * * * LMNA γ H2AX Time ( h ) I mm unob l o t n o r m . t o N T ( A . U . ) LMNA MO ctrl MO LMNA MO LMNA + Blebb ( 2h ) 73 42 kDa LMNB1 H2AX γ 17 66 90 HSP90 p21 18 0 1 2 3 4 5 6 7 8 0 . 0 0 . 5 1 . 0 1 . 5 by Mass Spec . n . s . # * * # DMSO Ctrl Washout + OM La m i n - A ( A . U . ) no r m . t o D M S O C t r l < 0 . 5h , 6h > γ H2AX LMNB1 LMNA Blebb Wash . DMSO 66 73 17 kDa 3h 2h + 1h Time ( h ) : LMNA γ H2AX 0 . 0 0 . 2 0 . 4 0 . 6 * n . s . Δ a t 1h W a s hou t G1 S G2 0 20 40 60 * * nsns o f popu l a t i on MO Ctrl MO LMNA MO LMNA 0 . 0 0 . 5 1 . 0 1 . 5 2 . 0 LMNA γ H2AX * * * * n . s . * p21 + Blebb ( 2h ) * n . s . I mm unob l o t no r m . t o M O c t r l ( A . U . ) MO Ctrl MO LMNA MO LMNA 0 . 00 0 . 02 0 . 04 0 . 06 + Blebb ( 2h ) n . s . * * * Δ A R / A R r e f Figure 1 . Contractility or Collagen Perturbations Result in Rapid (cid:2) 1 h Changes in LMNA , DNA Damage , and Cell Cycle ( A ) Chick hearts from day 4 ( E4 ) beat at 1 – 2 Hz for up to 5 days . Middle : aspect ratio ( AR ) beating strain is arrested by myosin - II inhibition but recovers with drug washout ± myosin - II activator , OM . ( B ) Immunoblot of hearts inhibited for varying durations , followed by washout ± OM ( 8 hearts per lysate ) . ( legend continued on next page ) Developmental Cell 49 , 920 – 935 , June 17 , 2019 921 actomyosin stress , ECM mechanics , and DNA damage are nonetheless obscure—especially in tissues . Embryonic hearts beat spontaneously for days after isolation from early chick embryos , and beating is acutely sensitive to myosin - II inhibition ( Figure 1A ) , as well as enzymatic stiffening or softening of the ECM ( Majkut et al . , 2013 ) . The latter studies reveal an optimal stiffness for beating that is likewise evident for cardiomyocytes ( CMs ) cultured on gels ( Majkut et al . , 2013 ; Engler et al . , 2008 ; Jacot et al . , 2008 ) . DNA damage is conceiv - ably optimized in heart as it triggers a switch from proliferation to senescence in post - natal hearts ( Puente et al . , 2014 ) . DNA dam - age is also implicated in telomere attrition and binucleation of CMs that signal irreversible exit from cell cycle ( Aix et al . , 2016 ) . We postulated embryonic hearts with rapidly tunable mechanics could prove useful as a tissue model for clarifying protein - level mechanosensing mechanisms in vivo that could be studied thoroughly in vitro with many cell types . LMNA is reportedly ‘‘undetectable’’ in early embryos ( Stewart and Burke , 1987 ) , but it accumulates clearly and progressively in tissues such as heart , bone , and lung ( Solovei et al . , 2013 ; Ro¨ber et al . , 1989 ; Lehner et al . , 1987 ) and is highest in adults within these mechanically stressed , stiff tissues that are collagen rich ( Swift et al . , 2013 ) . LMNA deﬁciencies accordingly produce measurable defects weeks after birth in such tissues , including heart ( Kubben et al . , 2011 ; Worman and Bonne , 2007 ) . We there - fore hypothesized that LMNA in normal embryos mechano - senses the earliest microenvironment in the ﬁrst organ and increases not only to stiffen the nucleus ( Osmanagic - Myers et al . , 2015 ; Dahl et al . , 2008 ; Pajerowski et al . , 2007 ) but also to regulate repair factors that confer resistance to both DNA damage and cell - cycle arrest . RESULTS Contractility and Collagen Perturbations Rapidly Impact LMNA and DNA Damage in Hearts To ﬁrst assess the consequences of cytoskeletal stress on nuclei in a tissue , we arrested embryonic hearts ( embryonic day [ E ] 4 ) with reversible inhibitors of myosin - II ( Figure 1A ) . Spontaneous beating of hearts stopped in minutes with blebbistatin ( blebb ) , but the heart re - started just as quickly upon washout of drug ( Figure1A , right ) . Anactivatorofcardiacmyosin - IIomecam - tiv mecarbil ( ‘‘OM’’ ) —in clinical trials for heart failure ( National In - stitutes of Health , 2016b [ NCT02929329 ] ) —re - started the hearts reliably . Quantitative immunoblots and mass spectrometry ( MS ) measurements ( Figures 1B , 1C - i , S1A , and S1B ) revealed a rapid decrease in LMNA ( (cid:2) 45 min decay constant ) , while LMNB re - mained unchanged ( Figure 1C - i , upper right inset ; Figure 1C ) , and similar results were evident for a cardiac myosin - II - speciﬁc inhibitor mavacamten analog ( MYK ) —in clinical trials for hyper - trophic cardiomyopathy ( National Institutes of Health , 2016a [ NCT02842242 ] ) . Despite rapid recovery of beating after drug washout ( Figure 1D ) , LMNA recovered more slowly ( > 3 h ) , indi - cating slow synthesis . DNA damage in post - natal development with LMNA deﬁ - ciencies ( Liu et al . , 2005 ) led us to hypothesize acute , embryonic changes in phospho - histone g H2AX , as a primary marker of DNA damage . A rapid decrease in DNA damage was surprising with myosin - II inhibition ( Figure 1C - ii ) given the decrease LMNA , but an electrophoretic comet assay conﬁrmed the g H2AX results ( Figure1D ) . Itisusefultokeepinmindthattheheartbeatsreason - ably well with LMNA deﬁciencies and mutations . Because blebb washout recovers beating while LMNA remains low , we antici - patedalargespikeinDNAdamageshortlyafterwashout ( Figures 1C - i and 1C - ii , right inset ) . LMNA and DNA damage eventually reached control levels ( in hours ) , but the spike highlights the disruptive effects of actomyosin stress on genome integrity . Actomyosin contractility is generally downstream of ECM stiffness ( Ulrich et al . , 2009 ; Engler et al . , 2006 ) , including for immature CMs ( Engler et al . , 2008 ; Jacot et al . , 2008 ) . Acute per - turbations of collagen matrix might therefore be expected to affect DNA damage . Collagenase treatment for 45 - min indeed resulted in rapid decreases in DNA damage and LMNA ( Fig - ure 1E ) , consistent with rapid softening of E4 hearts ( (cid:2) 50 % ) and weaker beating ( Majkut et al . , 2013 ) . Treatment with tissue transglutaminase ( TGM ) , a cross - linker of ECM that stiffens heart and thereby increases basal tension ( > 2 - fold in 2 h [ Majkut et al . , 2013 ] ) , increased g H2AX and LMNA ( only after 3 h ) except when collagenase was subsequently added ( Figure 1E ) . LMNA thus decreases quickly or increases slowly in response to changes in ECM stiffness or actomyosin tension , both of which appear to also affect DNA damage . Effects are also generally reversible . DNA Damage in LMNA - Deﬁcient Hearts Perturbs Cell Cycle and Causes Aberrant Beating Excess DNA damage has been shown to impact the cell cycle in post - natal CMs ( Puente et al . , 2014 ) , and so , we next sought ( C ) ( i ) Immunoblot densitometry reveals LMNA decreases in (cid:2) 45 - min upon myosin - II inhibition , but LMNA recovery takes > 3 h upon washout . MS conﬁrms 1 - h data with 29 LMNA - speciﬁc peptides , and inset shows LMNB1 remains unchanged . ( ii ) DNA damage g H2AX also decreases but spikes upon blebb washout ( 5 . 5 h , light blue ) . Bar graph of LMNA and g H2AX changes 1 h post washout . Bottom right immunoblot shows MYK treatment for 1 . 5 h also affects LMNA and g H2AX . One - way ANOVA ( Dunnett’s test versus DMSO Ctrl avg of 0 . 5 h , 6 h ) : * p < 0 . 05 , * * < 0 . 01 ; t test ( versus plateau average of 2 , 3 , and 4 . 5 h time points ) : # p < 0 . 05 . All error bars indicate ± SEM . ( D ) Electrophoretic comet assay of DNA damage validates g H2AX quantitation , with g - irradiation control . ( E ) Immunoblot of hearts treated with collagenase and / or transglutaminase ( TGM ) ( 8 hearts per lysate ) . Matrix digestion rapidly decreases LMNA and g H2AX , consistent with low stress ; cross - linking has opposite and reversible effect by 3 h ( t test : * p < 0 . 05 ; superﬂuous blot lanes have been removed and indicated by a blank space ) . ( F ) ( i ) MorpholinoKDofLMNA ( MO LMNA ) doesnotaffectbeating versusMO Ctrl , but ( ii ) MO LMNA increasesDNAdamage ( g H2AX ) andcellcycleinhibitorp21unless rescued by myosin - II inhibition ( i and ii ) . Two immunoblots ( anti - LMNA , p21 , and b - actin ) and display proteins ( anti - LMNB1 , g H2AX , HSP90 ) of interest above loading controls . ( 8 hearts per lysate ) . One - way ANOVA : * p < 0 . 05 , * * * < 0 . 001 . ( G ) ( i ) RepresentativeplotofEdUversusDNAintensityforcellcyclephase ( G1versusSversusG2 ; or2Nversus4N ) . ( ii ) BlebbwashoutincreasesG2and4Ncells ( versus 2 N ) . n > 77 cells per condition ; t test : * * p < 0 . 01 . ( H ) Proposed mechanosensing pathway . 922 Developmental Cell 49 , 920 – 935 , June 17 , 2019 to assess the biological consequences of DNA damage in LMNA - suppressed embryonic hearts . Morpholino ( MO ) medi - ated knockdown ( KD ) of LMNA ( MO LMNA ; (cid:2) 40 % KD in 24 h ) was achieved with no signiﬁcant effect on contractile beating ( Figures 1F - i and S1E ) . LMNA is thus not primarily upstream of beating , consistent with knockout mice ( Singh et al . , 2013 ) . Although past studies also suggest LMNA is not detectable in early embryonic hearts and is therefore dispensable ( Solovei et al . , 2013 ; Stewart and Burke , 1987 ) , morpholino KD increased g H2AX in E4 hearts ( Figure 1F - ii ) . Similar effects were seen by modest repression with retinoic acid ( RA ) of LMNA ( 20 % only af - ter 3 days ) that acts transcriptionally ( Swift et al . , 2013 ) , while RA - antagonist ( AGN ) upregulated LMNA and suppressed DNA dam - age ( Figures 1F and 1G ) . blebb was sufﬁcient to rescue the DNA damage in MO LMNA KD hearts , supporting our hypothesis that high contractility coupled to low LMNA causes excess damage . Bona ﬁde DNA damage can perturb cell cycle ( Puente et al . , 2014 ) ; the cell cycle inhibitor p21 indeed trended with g H2AX in MO - treated hearts ( Figure 1F - ii ) . EdU ( 5 - ethynyl - 2 0 - deoxyuridine ) integration before and after blebbistatin addition and washout ( per Figures 1A – 1C ) further revealed an increase in cells in G2 , withfewercellsinS , andanincreasein4Ncells ( Figure1G ) . Given that acute DNA damage can inhibit cell cycle in developing heart andissomehow coupledtomatrix - myosin - lamins ( Figure1H ) , we assessed DNA damage that was directly and abruptly increased with etoposide ( 4 - fold , 1 h ) ( Figure 2A ) . This inhibitor of replication and transcription quickly caused aberrant beating that could be reversedupondrugwashout ( Figure2B ) ; manycardiaclaminopa - thies exhibit arrhythmias and broader conduction defects ( Fatkin et al . , 1999 ) . No such effects were seen with the same dose of H 2 O 2 ( for oxidative stress ) relative to DMSO control hearts unless H 2 O 2 exposure was sustained for days . DNA damage can have multiplecauses , rangingfromdrugsandoxidativestresstonucle - ases , but reversal of damagefromnatural sourcesor etoposide in hours ( Figures 1F , 1G , and 2A ) suggest an important role for DNA repair factors ( Figure 2C ) . LMNA KD in Intact Hearts and Human iPS - CMs : Nuclear Rupture and Loss of DNA Repair To address how increased mechanical stress causes DNA dam - age , the integrity of the nucleus was scrutinized in intact E5 hearts doubly transfected with DNA repair protein GFP - KU80 ( XRCC5 ) and with a cytoplasmic protein that can bind nuclear DNA , mCherry - cGAS ( cyclic GMP - AMP synthase [ Raab et al . , 2016 ] ) ( Figure 3A - i ) . Cytoplasmic mis - localization of KU80 and concomitant formation of cGAS puncta at the nuclear periphery provided evidence of nuclear rupture in transfected hearts ( Fig - ure 3A - i , yellow arrow ) , and the fraction of such double - positive A B C Figure 2 . DNA Damage in Embryonic Hearts Causes Aberrant Beating ( A ) 1 h etoposide reversibly increases DNA damage 4 - fold ( 8 hearts per group ) . All error bars indicate ± SEM . ( B ) Beating ( top ) after 1 h of treatment is only affected by etoposide . ( i and ii ) % hearts exhibiting arrhythmia . Oxidant H 2 O 2 shows distinct kinetics . ( iii and iv ) Beating decreases and arrests compared to DMSO . 8 – 16 hearts per grp ; t test * p < 0 . 05 , * * < 0 . 01 , * * * < 0 . 001 . ( C ) Schematic : the level of DNA damage that results from various sources depends also on levels of repair factors in the nucleus . Developmental Cell 49 , 920 – 935 , June 17 , 2019 923 cells increased with MO LMNA KD unless blebb was added ( Fig - ure 3A - ii ) . Myosin - II inhibition disrupted sarcomeres , which rapidly recovered upon drug washout ( Figure 3A - iii ) , consistent with beating ( Figures 1A – 1C ) ; and mis - localization of KU80 and cGAS showed the same trends ( Figure 3A - iv ) , without any apparent changes in cell viability ( Figure 2A - i ) . DNA damage again spiked upon blebb washout and remained excessively high with addition of a nuclear import inhibitor ( Imp - i ; ivermectin ) that keeps KU80 mis - localized to cytoplasm ( Figures 3B - i , 3B - ii , and S2A - ii ) . LMNA immunoﬂuorescence ( IF ) for MO LMNA and A D E B C F Figure 3 . LMNA Knockdown in Intact Hearts and in hiPS - CMs : Nuclear Envelope Rupture and Loss of DNA Repair Factors ( A ) ( i ) Images ofE4 hearts transfected withGFP - KU80 and mCherry - cGAS . Arrow : cellwithlow LMNA and rupturednucleus , withcytoplasmic mis - localization of GFP - KU80 and mCherry - cGAS puncta at nuclear envelope . ( ii ) LMNA KD increases mis - localized KU80 and cGAS but is rescued by myosin - II inhibition . ( iii ) Imagesofstriation ( a - actinin - 2 ) beforeblebb2hafteranduponwashout ( 1h ) . ( iv ) % - rupturednuclei ( double + ’s ) decreaseswithmyosin - IIinhibitionbutincreases upon washout . Mis - localized KU80 increases further with Imp - i ivermectin ( n > 111 double - transfected cells per condition ; t test : * p < 0 . 05 ) . All error bars indicate ±SEM . ( B ) ( iandii ) anti - g H2AXand ( iandiii ) anti - LMNAimmunoblotofblebb - treatedE4heartsafterwashout±Imp - i ( 8heartsperlysate ; ttest : * p < 0 . 05 ; superﬂuousblot lanes have been removed and is indicated by a blank space ) . ( C ) LMNA immunoﬂuorescence with MO LMNA ± blebb . ( n > 139 cells per cond . ) . ( D ) Human iPS - derived cardiomyocytes ( hiPS - CMs ) on stiff 40 - kPa gels for 24 h , showing cytoplasmic KU80 in cells with nuclei having LMNA - rich , LMNB - depleted blebs at high curvature sites ( arrows ) . ( E ) ( iandii ) hiPS - CMonsoft0 . 3 - kPagelsminimizes rupture . Onrigidplastic , siLMNA KD ( (cid:2) 40 % , n > 119cellspercond . ( [ iii ] ) increasesmis - localizedKU80 ( i ) and DNA damage by g H2AX foci ( right images ) . ( n > 80 cells per cond . ; Dunnett’s test versus NT , i . e . nontreated Ctrl ) ( F ) ( i ) Passive cyclic stretch of LMNA - knockdown cells expressing GFP - KU80 ( 8 % strain , 1 Hz ) increases ( ii ) % - rupture with cytoplasmic KU80 ( upper inset ) and ( iii ) g H2AX . ( n > 55 cells per cond . ; t test : # p < 0 . 05 , # # < 0 . 01 ) . ( Unless noted otherwise , one - way ANOVA : * p < 0 . 05 , * * < 0 . 01 , * * * < 0 . 001 ) 924 Developmental Cell 49 , 920 – 935 , June 17 , 2019 blebb / washout hearts ( Figures 3B - iii and 3C ) conﬁrmed immu - noblot trends ( Figures 1C - i and 1F ) and showed Imp - i kept LMNA levels low upon washout . Human induced - pluripotent - stem - cell - derived CMs ( hiPS - CMs ) cultured on soft or stiff gels with collagen - ligand constitute another model for clarifying mechanisms at the single - cell level . Nuclei in hiPS - CMs ‘‘beat’’ ( Figure 2B ) and express low LMNA relative to some well - studied human cell lines ( e . g . , lung - derived A549 cells ) and relative to mature heart , which is much stiffer than embryos ( Swift et al . , 2013 ) . Cell morphologies and sarcomere striations resemble those of embryonic or fetal CMs . On very stiff gels ( 40 kPa ) but not on gels as soft as embryos ( 0 . 3 kPa ) , hiPS - CMs exhibited cytoplasmic , mis - localized KU80 ( Figure 3D ) , consistent with envelope rupture under high nuclear stress ( Figure 1H ) . Nuclear blebs typical of ruptured nuclei formed at points of high curvature in such cells ( Xia et al . , 2018 ) , appearing rich in LMNA but depleted of LMNBs ( Figure 3D ) . Stress - induced nuclear rupture was also imaged as rapid and stable accumu - lation of mCherry - cGAS upon nuclear probing with a high cur - vature atomic force microscopy ( AFM ) tip ( < 1 m m ) , using nano - Newton forces similar to those exerted by a cell’s actomyosin ( Figure 2C ) . KD of LMNA ( siLMNA ) doubled the fraction of cells with cyto - plasmic KU80 ( Figures 3E - i and S2D - i ) and increased g H2AX foci ( Figures 3E - ii and S2D - ii ) . These observations seem consistent with iPS - CM results for LMNA defects , which show nuclear bleb - bing ( Lee et al . , 2017 ) , focal loss of nuclear membrane ( Siu et al . , 2012 ) , cytoskeletal defects ( Bollen et al . , 2017 ) , and ﬁbrosis , all of which increase with electrical stimulation of contraction . We found LMNA levels in hiPS - CMs exhibited sensitivity to substrate stiffness similar to that in embryonic hearts ( Figure 3E - iii ) , and we saw blebb - treated siLMNA cells on rigid plastic rescued nuclear rupture ( Figure 3E - i ) , as well as DNA damage ( Figure 3E - ii ) . Relaxation of rigidity - driven actomyosin stress can thus limit nu - clear rupture . Cytoplasmic mis - localization of KU80 is merely representa - tive : repair factors 53BP1 and RPA2 also simultaneously mis - localized to the cytoplasm upon LMNA KD ( Figure 2E - i ) . Time - lapse images of GFP - 53BP1 - expressing cells further revealed mis - localization persists for hours ( Figure S 2E - ii ) . However , total KU80 levels did not vary ( Figure 2F ) , suggesting that nuclear retention is key . To assess whether mis - localization of repair factors is a gen - eral consequence of increased mechanical stress , LMNA KD of both CM and U2OS osteosarcoma cells was followed by cyclic stretch at a frequency and magnitude similar to that of the intact heart ( 8 % uniaxial strain at 1 - Hz frequency ) ( Fig - ure 3F - i ) . Mis - localized GFP - KU80 increased > 2 - fold with imposed stretching of MO LMNA KD E4 CMs but not MO Ctrl ( Fig - ure 3F - ii ) , and the fold - increase was even more dramatic with the nonbeating U2OS cells because baseline mis - localization was very low . DNA damage also increased with stretching of MO LMNA CMs while LMNA levels showed an insigniﬁcant in - crease ( Figure 3F - iii ) . An acute increase in stress without a pro - portionate increase in LMNA can thus cause mis - localization of repair factors and DNA damage , which could affect tissue - level function ( Figures 2A and 2B ) . Etoposide - treated hiPS - CM orga - noids indeed show aberrant beating ( Figure 2G ) . Loss of Repair Factors or LMNA : DNA Damage , Binucleation , Micronuclei , and Cell - Cycle Arrest To assess the impact of a limited capacity for DNA repair in cells , key individual DNA repair factors were partially depleted individually and in combination ( si - Combo ) . BRCA1 is implicated in myocardial infarction and ischemia ( Shukla et al . , 2011 ) , and RPA1 appeared abundant and constant in level in our MS of drug - or enzyme - perturbed hearts ( Figures 1C and 1E ) . DNA damage increased in hiPS - CMs for all repair factor KDs , and the combination proved additive ( Fig - ure 4A - i ) . Excess DNA damage in post - natal hearts has been associated with CM binucleation ( Aix et al . , 2016 ) —a hallmark of irreversible cell cycle exit . Soft ECM suppressed binucleation of embryonic CMs relative to stiff ECM ( Figure 4A - ii ) while suppressing mis - localization of repair factors ( Figure 3E - i ) . Partial KD of DNA repair factors directly increased the fraction of binucleated hiPS - CMs , as well as those with micronuclei ( Figure 4A - iii ) , both of which correlated strongly with g H2AX . Repair factor KD further increased the fraction of ‘‘4N’’ cells ( versus ‘‘2 N’’ ; Fig - ures 4A - iv and S3A ) , in agreement with trends for blebb - treated hearts ( Figure 1G ) and with mitotic arrest . LMNA KD had all of the same effects , consistent with a role in repair factor retention in nuclei , and , consistent also with a late checkpoint , KD showed more DNA damage per DNA in 4 N cells relative to control cells ( Figure 3B ) . Importantly , with siLMNA or siCombo KD , increased g H2AX and cell cycle perturbations were evident not only at steady state but also within 1 h of damaging DNA with etoposide ( per Figure 2 ) —which partially recovered after drug washout ( Figure 4B ) . Myosin - II inhibition once again rescued the DNA damage , as well as cell cycle effects , in siLMNA KD cells ( Figure 4C - i ) , whereas siCombo cells maintained high DNA damage ( Fig - ure 3C ) . Furthermore , overexpression of relevant DNA repair factors ( with GFP - KU70 , KU80 , BRCA1 = ‘‘GFP - Combo’’ ) rescued only the excess DNA damage in nuclear - ruptured cells compared to non - ruptured ( Figure 4C - ii ) . A baseline level of damage in the latter cells was not affected , likely because repair factors become limiting only upon nuclear rupture or depletion . A combination of factors ( GFP - Combo ) rescued the excess dam - age , while one repair factor had no effect on its own ( 53BP1 ) even on the ruptured nuclei . Rescue of DNA damage again sup - pressed the fraction of 4 N cells ( Figure 4B lower ) and cells in G2 ( Figure 3D ) . Since cardiac telomere attrition has been implicated in CM bi - nucleation ( Aix et al . , 2016 ) , as well as in cardiomyopathies and heart failure ( Shariﬁ - Sanjani et al . , 2017 ) , we assessed rupture - associated telomere shortening as a more localized form of DNA damage ( Figure 4D ) . U2OS osteosarcoma cells with ruptured nuclei ( cytoplasmic anti - KU80 ) showed lower total intensity of telomeric repeat - binding factor - 1 ( TRF1 , as an mCherry fusion ; Figure 4E - i ) and smaller TRF1 foci size ( Figure 4E - ii ) , as well as higher g H2AX in these LMNA KD cells . Importantly , partial KD of either KU80 or multiple repair factors also caused telomere attrition in cells with normal LMNA levels ( Figure 4F ) . Proper retention of DNA repair factors within stressed nuclei thus re - quires sufﬁcient LMNA , but LMNA also interacts with key repair factors ( including KU70 / 80 and RPA1 ) as conﬁrmed by immuno - precipitation - MS ( IP - MS ) ( Figure S3E ) . IP - MS further indicates Developmental Cell 49 , 920 – 935 , June 17 , 2019 925 A B C D E G H I F Figure 4 . Knockdown of LMNA or DNA Repair Factors Increases DNA Damage and Perturbs Cell Cycle ( A ) KD of LMNA or repair factors ( KU80 , BRCA1 , RPA1 , or si - Combo ) in hiPS - CMs increases : ( i ) g H2AX ( ii , iii ) binucleated CMs ( suppressed on soft matrix , inset ) and micronuclei , and ( iv ) 4 N cells ( n > 77 cells per cond . ; all error bars indicate ± SEM ) ( B ) KDs increase g H2AX before , during , and after 10 m M etoposide ( n > 39 cells per cond . ) . ( C ) ( i ) Blebb rescues siLMNA - induced DNA damage and 4 N cells ( n > 400 cells per cond . ) . ( ii ) Overexpression of DNA repair factors ( GFP - KU70 + KU80 + BRCA1 = GFP - Combo ) rescues excess DNA damage ( top ) and 4 N ( bottom ) in siLMNA cells only in ruptured nuclei ( n > 296 cells per cond . ; t test : * * p < 0 . 01 , * * * < 0 . 001 ) . ( D ) Schematic : effect of repair factor mis - localization on telomeres . ( E ) U2OS expressing mCherry - TRF1 . Ruptured nuclei ( n = 7 ) with cytoplasmic KU80 exhibit ( i ) lower TRF1 and ( ii ) smaller TRF1 foci ( t test : * p < 0 . 05 ) . ( F ) siKU80 and si - Combo decrease TRF1 ( n > 89 cells per cond . ) . ( G ) CoIP - MS of WT LMNA , phosphorylated LMNA ( anti - S22 ) , and phospho - mimetic LMNA ( GFP - S22E ) . ( H ) Cartoon : LMNA - KU80 - telomere interactions at the lamina . ( I ) Telomere Q - FISH in embryonic CMs shows MO LMNA shortens telomere unless rescued by blebb ( n > 81 nuclei per cond . ) . ( Unless noted , one - way ANOVA : * p < 0 . 05 , * * * < 0 . 001 ) 926 Developmental Cell 49 , 920 – 935 , June 17 , 2019 A B C D E F G H I ( legend on next page ) Developmental Cell 49 , 920 – 935 , June 17 , 2019 927 KU80 interacts preferentially with non - phosphorylated LMNA ( GFP - wild type [ WT ] ) compared to its phospho - solubilized nucleoplasmic form ( per IP by anti - pSer22 or phosphomimetic mutant GFP - S22E ) ( Figure 4G ) , suggesting that LMNA scaf - folds the repair of DNA at the periphery—which often includes telomeres ( Figure 4H ) . Importantly , analysis of telomeres in embryonic CMs by quantitative FISH ( Q - FISH ) revealed LMNA KD causes telomere shortening unless actomyosin is inhibited ( Figure 4I ) . The ﬁndings motivate deeper mechanistic insights into how LMNA adjusts to actomyosin stress ( Figures 1A – 1E , 3 C , and 3 E - iii ) to thereby regulate DNA damage and the cell cycle . LMNA Effectively Stiffens Nuclei during Development and Increases with Collagen - I ECM To begin to assess in normal beating hearts how LMNA senses stress , nuclear deformations were imaged at E4— just 1 to 2 days after the ﬁrst heartbeat ( Figure 5A ) . Transfec - tion of a minor fraction of CMs in hearts with mCherry - histone - H2B or GFP - LMNA facilitated imaging , and each (cid:2) 1 - Hz contraction of heart tissue was seen to strain individual CM nuclei by up to (cid:2) 5 % – 8 % . Recall that 8 % stretch at 1 - Hz was sufﬁcient to rupture CM nuclei ( Figure 3F ) . While transfec - tion did not affect overall tissue - level beating , GFP - LMNA nuclei deformed much less than neighboring control nuclei ( Figure 5A - ii ) , consistent with in vitro studies showing LMNA stiffens the nucleus ( Pajerowski et al . , 2007 ; Lammerding et al . , 2006 ) . MS of lysates quantiﬁed 29 unique LMNA pep - tides at E4 ( Figure 1C ) , conﬁrming our early detection of func - tional LMNA ( Figure 1B ) despite past reports ( Solovei et al . , 2013 ; Stewart and Burke , 1987 ) , showed a rapid increase in LMNA expression by (cid:2) 3 - fold from soft E4 hearts to stiffer E10 hearts ( Figures 5B and 5C ) . B - type lamins remained rela - tively constant , in agreement with studies of diverse soft and stiff adult tissues that suggest LMNA - speciﬁc mechanosensi - tivity ( Figures 4A – 4C ) ( Swift et al . , 2013 ) . Trends are conﬁrmed by confocal IF and immunoblots of embryonic heart ( Figures 5C - i and 5C - ii , insets ; Figure S4D ) . Collagen - I ( a - 1 and a 2 ) exhibited the largest fold change in MS analyses of heart development ( Figure 5B ) , with calibrated spike - ins of puriﬁed collagen - I matching past measurements of collagen in developing chick hearts ( Woessner et al . , 1967 ) ( Figure 4E ) . Collagen - I becomes the most abundant protein in developed animals and is a major determinant of tissue stiff - ness ( Shoulders and Raines , 2009 ) ; therefore , its increase together with many other structural proteins ( Figure 4C ) is consistent with heart stiffening ( Figure 2F ) ( Majkut et al . , 2013 ) . Mechanosensitive proteins at the interface between ad - hesions and actomyosin cytoskeleton were also upregulated , including paxillin ( Zaidel - Bar et al . , 2007 ) and vinculin ( Huang et al . , 2017 ) , consistent with increased adhesion and contractile stress ( Geiger et al . , 2009 ) . Downregulation of protein synthesis and catenins suggest a transition from a rapidly growing , epithelial - like embryo to a more specialized , terminally differen - tiated state . Lamin - A : B ratio increased with collagen - I ( Figures 5C - i and S4F ) and with tissue stiffness E t ( Figure 5 - ii ) , with a power law exponent a = 0 . 3 ( versus collagen - I ) similar to that for diverse tis - sue proteomes ( Cho et al . , 2017 ) . Experiments ﬁt a ‘‘use it or lose it’’ mathematical model ( Figure 5C - i ) wherein mechanical tension on ﬁlamentous collagen - I and LMNA ( Dingal and Discher , 2014 ) suppresses protease - driven degradation ( Figure 5C - i ) . The plot versus E t yielded a (cid:2) 0 . 7 that is similar for adult tissues ( a (cid:2) 0 . 6 [ Swift et al . , 2013 ] ) , with soft E10 brain and stiff E10 liver ﬁtting well ( Figures 4F and 4G ) . Importantly , 45 min collagenase soft - ened E4 hearts by (cid:2) 50 % and decreased LMNA ( Figure 5C ) , per Figures 1A – 1E . Different combinations of drugs were used to identify mecha - nisms for how LMNA levels change in tight coordination with collagen - I and tissue stiffness . MS - derived heatmaps of drug - treated E4 hearts ( e . g . , collagenase and blebb ) reveal rapid andlarge decreasesincollagen - I , vinculin , andLMNA ( Figure5D ; conﬁrmed by immunoblot , Figure 5A ) . Little to no change was observed across most of the detected proteome including DNA repair factors ( KU70 and RPA1 [ Figure 5B - i ] ) , matrix - metal - loproteinase MMP2 ( pro - and cleaved forms ; Figures 5B - ii and Figure 5 . Early Embryonic LMNA Increases with Collagen - I and Tissue Stiffness E t ( A ) ( i ) E4 heart beating with GFP - LMNA transfection shows nuclear ‘‘beating . ’’ Right : trace of tissue strain tensor quantiﬁed using ﬁduciary transfected nuclei per ( Taber et al . , 1994 ) or nuclear strain from nuclear area and aspect ratio ( AR ) . ( ii ) Overexpression does not affect local or global tissue strain ( left ) , but GFP - LMNA nuclei deform less than mCherry - H2B nuclei ( n > 8 nuclei per cond . ; t test : * p < 0 . 05 ) . All error bars indicate ± SEM . ( B ) ProteomicheatmapofE4 , E6 , andE10hearts ( n = 8 , 2 , and1heart ( s ) perlysate , respectively ) , rankedbyfoldchangefromtime - average : collagen - IandLMNA top the list . ( C ) ( i ) Lamin - A : B ratio from MS scales with collagen - I and ﬁts ‘‘use it or lose it’’ model of tension - inhibited turnover of structural proteins , with stress sensitivity denoted as x . Inset : confocal images of LMNA and B in hearts taken at same settings suggest LMNA increases while LMNB remains constant . ( ii ) Lamin - A : B scaling versus E t from micropipette aspiration ( lower inset ) , with exponent a similar for adult tissue ( a (cid:2) 0 . 6 ) ( Swift et al . , 2013 ) . Cyan : softening by collagenase decreases LMNA . Upper immunoblot ( norm . to HSP90 ) : LMNB varies by < 20 % from E4 - E10 as LMNA increases ( n > 8 hearts per lysate ) . ( D ) MS intensity fold changes relative to DMSO for Trx - i inhibitor of translation ( cycloheximide , 1 m M ) ; MMP - i pan - MMP inhibitor ( GM6001 , 10 m M ) ; CDK - i ( RO3306 , at > 3 . 5 m Mdosestoinhibitmany CDKs ) tosuppress LMNA phosphorylation . Cyan boxes indicaterescues ( n = 8hearts per lysate ; ttest versusDMSO : * p < 0 . 05 , * * < 0 . 01 , * * * < 0 . 001 ) . ( E ) ( i ) E4heartstreatedwithblebb±MMP - i’s ( 2h ; n = 6heartsperlysate ) . pSer390bandsatintactMW ( 73kDa ) and42kDa , consistentwithfragments ( Baghirova etal . , 2016 ; Prudovaetal . , 2010 ) predicted insilico ( Songetal . , 2012 ) . ( ii ) DecreasedLMNAwithblebbisrescuedbyMMP - i’s , includingMMP2 - speciﬁcARP - 100 . ( iii ) Blebb increases pSer390 of 73 kDa band . ( iv ) Blebb does not affect pSer390 ratio of 42 kDa and 73 kDa bands , except with MMP - i . ( n = 7 hearts per lysate ; one - way ANOVA : * p < 0 . 05 , * * p < 0 . 01 ) . ( v ) Turnover schematic . ( F ) MS validation of LMNA degradation . ( G ) Neither blebb nor MMP - i affects catalytic activation of MMP2 ( n = 8 hearts per lysate ) . ( H ) IF shows nucleoplasmic MMP2 in embryonic CMs is unaffected by blebb . ( I ) MMP - i rescues blebb - induced decrease in LMNA but does not further suppress g H2AX ( n = 6 hearts per lysate ) . g H2AX is further decreased with CDK - i to inhibit LMNA phosphorylation ( n = 8 hearts per lysate ; one - way ANOVA : * p < 0 . 05 , * * < 0 . 01 ; t test : # p < 0 . 05 ) . 928 Developmental Cell 49 , 920 – 935 , June 17 , 2019 A B E C D F Figure 6 . LMNA in Isolated Embryonic CMs Is Sensitive to Substrate Stiffness and Actomyosin Stress ( A ) Airyscan images of embryonic heart . ( B ) CM cultures on PA gels of controlled stiffness ( 0 . 3 – 40 kPa ) and constant collagen - I ligand . ( C ) Well - separated E4 CMs at 24 h on gels . As with tissue ( A ) , isolated CMs spread , elongate , and striate more with stiffness . Blebb on rigid plastic causes rounded or dendritic CM , with loss of striation . MMP inhibitors have no effect . ( legend continued on next page ) Developmental Cell 49 , 920 – 935 , June 17 , 2019 929 5B - iii ) , cardiac myosin - II ( MYH7B ) , vimentin ( VIM ) , and B - type lamins . Similar results were obtained even in the presence of the translation inhibitor ( Trx - i ) cycloheximide , except for de - creases in a few cytoskeletal proteins that indicate rapid transla - tion ( e . g . , actin [ Katz et al . , 2012 ] ) . Decreased translation thus does not explain the heart’s decreases in collagen - I and LMNA with blebb and / or collagenase . To clarify how myosin - II inhibition ( intracellular ) leads to a rapid decrease in collagen - I ( ECM ) in intact hearts , a pan - inhibitor of matrix - metalloproteinases ( MMP - i ) was used with blebb . The combination surprisingly prevented collagen - I degradation . In contrast , a CDK inhibitor ( CDK - i ; likely affecting CDK4 / 6 ) that limits interphase phosphorylation of LMNA ( e . g . , pSer22 nor - malized to total LMNA : pSer22 / LMNA in Figure 5A ) rescued blebb - induced decreases in LMNA levels without affecting the collagen - I decrease . Vinculin’s decrease concurs with decreased actomyosin tension regardless of MMP - i ( Figure 5D ) , but MMP - i surprisingly rescued blebb - induced decreases in LMNA similarly to CDK - i ( Figures 5D and S5A ) . Mechano - protection of the Genome Is Limited by LMNA Phospho - solubilization We hypothesized that one or more MMPs directly degrade LMNA . Nuclear MMP2 is well documented for many cell types including CMs ( Xie et al . , 2017 ) , and LMNA ( but not B - type lam - ins ) has been speculated to be a proteolytic target ( Baghirova et al . , 2016 ) . Beating E4 hearts treated with MMP - i or an MMP2 - speciﬁc inhibitor , MMP2 - i , rescued the blebb - induced decrease in LMNA in immunoblots that were also probed with a previously untested anti - pSer390 ( Figures 5E - i and 5E - ii ) . For other phosphosites , interphase phosphorylation , solubilization ( Kochin et al . , 2014 ) , and subsequent degradation of LMNA ( Naeem et al . , 2015 ; Bertacchini et al . , 2013 ) are already known to be suppressed by actomyosin tension on nuclei ( Buxboim et al . , 2014 ; Swift et al . , 2013 ) . Intact phospho - LMNA ( 73 kDa ) increased upon blebb treatment ( Figure 5E - iii ; pSer390 intact / LMNA intact ) , but even more dramatic was the suppression by MMP2 - i and MMP - i ( regardless of blebb ) of a 42 kDa pSer390 fragment ( pSer390 fragm . / pSer390 intact ) ( Figure 5E - iv ) . Fragment size matches predictions for MMP2 digestion ( Song et al . , 2012 ) but is likely a transient intermediate that is further degraded ( Buxboim et al . , 2014 ) ( Figure 5E - v ) . MS of hearts treated with blebb or collagenase not only conﬁrmed the trend for the fragment ( > 6 LMNA peptides ) ( Figure 5F ) but also showed MMP2 levels remain constant , as supported by immunoblots for MMP2’s activation ( cleaved / pro - MMP2 ratio ; Figures 5G and S5B ) . Anti - MMP2 ( for both pro - and active forms ) was mostly nucleoplasmic in isolated CMs with localization unaffected by actomyosin inhibition ( Figure 5H ) . Nucleoplasmic MMP2 in neonatal CMs ( Baghirova et al . , 2016 ; Kwan et al . , 2004 ) sug - gests that , independent of maturation stage , active MMP2 is localized appropriately for degradation of phospho - LMNA downstream of actomyosin tension ( Figure 5E - v ) . DNA damage was assessed after acute 2 - h treatments of CDK - i or MMP - i plus blebb . Whereas MMP - i had no effect on g H2AX relative to blebb alone , CDK - i plus blebb greatly sup - pressed DNA damage ( Figure 5I ) . Since CDK - i maintains LMNA at the lamina ( unlike MMP - i ) and thereby stiffens and sta - bilizes the nucleus ( per Figure 5A and single - cell measurements [ Buxboim et al . , 2014 ] ) , the results suggest that even low levels of nuclear stress are resisted to minimize both rupture and DNA damage in the embryonic heart . Isolated CMs Elucidate Effects of ECM Elasticity and Contractility on LMNA Turnover by MMP2 Intact heart presents many complications to understanding LMNA regulation and its function . As the heart stiffens in devel - opment , for example , collagen ligand also increases greatly for adhesion ( Figures 5B and 5C ) , sarcomere assembly becomes very dense ( Figures 6A and S6A - i ) , cells and nuclei elongate ( Fig - ures 6A - ii and S6B ) with stabilization by microtubules ( Robison et al . , 2016 ) , cells align ( Figure 6C ) , and nuclear volumes decrease ( Figure 6D ) . Gels with constant collagen - I ligand and of controlled stiffness ( 0 . 3 – 40 kPa ) ( Figure 6B ) showed—after just 24 h—the same stiffness - correlated morphology and cyto - skeleton trends for isolated E4 CMs as the intact heart from E4 to (cid:2) E11 ( Figure 6C ) . Although matrix elasticity had large effects on size , shape , sarcomere assembly , and contractility of early CMs ( Figures 6A - i , 6A - ii , and S6E ) similar to later stage CMs ( Ribeiro et al . , 2015 ; Engler et al . , 2008 ; Jacot et al . , 2008 ) , blebb quickly disrupted cell spreading , striation , and elongation on stiff gels ( 10 kPa ) and on collagen - coated rigid plastic ( Figure 6C ) . Gels that mimic the stiffness of E4 heart ( 1 – 2 kPa ) were optimal for cell beating ( Figure 6F ) , consistent with past studies ( Majkut et al . , 2013 ; Engler et al . , 2008 ) , and nuclear ‘‘beating strain’’ in isolated CMs ( Figures 6F - i and S6G - i ) was similar in magnitude to that in intact heart ( 5 % – 8 % ) ( Figure 5A ) . Surprisingly , lamin - A : B intensity increased monotonically with gel stiffness rather than exhibiting an optimum ( Figures 6D - i and S6G - ii ) . LMNA’s in - crease depended on myosin - II , as did cell / nuclear aspect ratio ( AR ) , spreading , and sarcomere assembly ( Figures 6C , 6 D - ii , and S6 A , E ) . Monotonic increases with stiffness of ECM agree with elevated isometric tension as documented for other cell types ( e . g . , Engler et al . , 2006 ) . Remarkably , MMP - i or MMP2 - i rescued the blebb - induced decrease in lamin - A : B at the sin - gle - cell level ( Figure 6 D - i ) as seen for intact embryonic hearts ( Figure 5D - i ) despite no signiﬁcant effects on cell morphology or striation ( Figures 6C and 6D - ii ) . ( D ) ( i ) Lamin - A : B increaseswithgelstiffnessexceptwithblebb ( n > 50cellsper grp ) . Effectsarerescuedby MMP - i’sonrigidplastic . ( ii ) Cell andnuclearAR ( inset ) increase as CMs polarize on stiffer gels . Blebb reduces cell / nuclear AR , but MMP - i shows no affect ( n > 47 cells per cond . ; all error bars indicate ± SEM ) . ( E ) ( i ) LMNA is more nucleoplasmic in CMs on soft gels ( 0 . 3 kPa ) than stiff ( 40 kPa ) . Blebb gives higher nucleoplasmic signal . ( ii ) Histograms of phosphorylation ( pSer / LMNA ) forpSer22andpSer390 . Signalsforbothsitesarehigherforsoftgelsandstiffgels + blebb . pSer / LMNAforraremitoticCMs ( yellow ) aretypically10 - to 20 - fold higher than interphase CMs ( cyan arrows ) . ( iii ) pSer / LMNA ratios for pSer22 and 390 ( n > 11 nuclei per cond . ) . ( F ) ( i ) Phospho - mimetic mutant GFP - S22E ( ± Trx - i , 3 h ) probed with anti - LMNA shows low LMNA versus GFP - S22A cells . Stable lines were made within a stable shLMNA line to minimize both endogenous LMNA and overexpression artifacts . Low - MW fragments ( green arrows ) are not detected in GFP - S22A cells . ( iiandiii ) BasalDNAdamageand ( iv ) % 4NcellsarehighestinGFP - S22Ecells , butblebbminimizesdifferences ( n > 93nucleipercond . ; ttest * p < 0 . 05 , * * < 0 . 01 , * * * < 0 . 001 ; irrelevant blot lanes have been removed and is indicated by a blank space ) . 930 Developmental Cell 49 , 920 – 935 , June 17 , 2019 Since myosin - II - dependent increases in lamin - A : B versus gel stiffness for isolated CMs ( Figure 6D - i ) align with lamin - A : B’s in - crease with heart stiffness and contractility during development ( Figures 5B and 5C ) , LMNA phosphorylation was re - examined ( per Figures 5D and S5A ) . IF with anti - pSer22 and pSer390 proved consistent with tension - suppressed LMNA phosphoryla - tion and turnover : cells on soft gels showed high nucleoplasmic phospho - signal as did cells on stiff gels treated with blebb ( Figure 6E ) . The latter also showed cytoplasmic phospho - signal , consistent with multisite phosphorylation in interphase ( Kochin et al . , 2014 ) . Regardless , LMNA was similarly low and decreased at the nuclear envelope ( Figure 6E - i ) . Phospho - signal normalized to total LMNA ( pSer per LMNA ) was also 2 - to 3 - fold higher in CMs on soft gels than in stiff gels ( Figures 6E - ii and 6E - iii ) . blebb - treated cells on stiff gels again showed increased pSer / LMNA for both phospho - sites . Signal in interphase cells was , however , > 10 - fold lower than in rare mitotic CMs ( Fig - ure 6E - ii , inset : purple arrow ) . Studies of stable phospho - mimetic mutants ( GFP - S22A and GFP - S22E ) conformed to the model , with higher nucleoplasmic signal but lower overall levels for S22E ( Figures 6F - i and S7A ) . Inhibition of translation for 3 h ( Trx - i ) showed more degradation only for S22E ( Figures 6F - i and S7B ) , and MMP2 - i treatment increased S22E intensity ( Fig - ure 7C ) consistent with inhibition of phospho - LMNA turnover . S22E - phosphomimetic cells also exhibited higher DNA damage ( Figures 6F - ii and 6F - iii ) and more cells in late cell cycle ( 4 N ; Fig - ure 6F - iv ) that were more suppressed by acute blebb than S22A cells . Reduction of nuclear stress by soft matrix or actomyosin inhibition at the single - cell level thus favors LMNA interphase phosphorylation , nucleoplasmic solubilization , and subsequent degradation—while also suppressing DNA damage and cell - cycle arrest . DISCUSSION LMNA defects cause disease through ‘‘cell - extrinsic mecha - nisms’’ that likely include ECM and / or cytoskeletal stress . Mosaic mice in which 50 % of the cells express defective LMNA maintain a normal lifespan , whereas mice with 100 % defective cells die within weeks of birth ( de La Rosa et al . , 2013 ) . Cultures on rigid plastic of the same cells ( and similar cell types [ Hernandez et al . , 2010 ] ) exhibit premature senes - cence and apoptosis , as is common with excess DNA damage , but growth and viability are surprisingly rescued upon culture on almost any type of ECM . Soft matrix certainly reduces cytoskeletal stress and suppresses nuclear rupture and DNA damage in CMs with low LMNA ( Figure 3E ) . The ﬁndings are further consistent with the observation that laminopathies spare soft tissues such as brain , independent of lineage or developmental origin , but generally affect stiff and mechan - ically stressed adult tissues including muscle or bone ( Cho et al . , 2018 ) . Early embryos are soft , with minimal ECM , but as tissues form and sustain higher physical stresses , collagen - I accumulates , and stiffening of the developing tissue minimizes the strain on resident cells . However , increasing stiffness and stress necessi - tate an adaptive mechanism to protect against nuclear stress , and accumulation of mechanosensitive LMNA fulﬁlls this role— unless actomyosin stress is inhibited ( Figures 1A – 1C ) . LMNA thus mechano - protects DNA by retaining repair factors in the nu - cleus ( Figures 3A – 3D ) , which thereby prevents excessive DNA damage in stiff microenvironments and / or under high actomy - osin stress ( Figure 7A ) . Rapid change in LMNA protein indepen - dent of any transcription or translation ( Trx - i ) rules out many possible contributing pathways to the equally rapid DNA dam - age response . Such conclusions about causality are otherwise difﬁcult to achieve with experiments conducted over many hours or days such as with mouse models . Results with the cardiac myosin - II speciﬁc inhibitor ( MYK ) in clinical trials for some car - diomyopathies ( National Institutes of Health , 2016a [ NCT02842242 ] ) further suggest an unconventional method to attenuate DNA damage in the heart ( Figures 1C and 1D ) . Loss of DNA repair factors could compromise genome integ - rity , but enhanced entry of cytoplasmic nucleases ( Maciejowski et al . , 2015 ) would seem unlikely to generate g H2AX foci distrib - uted throughout the nucleoplasm ( Figures 3E - ii , 4 A - i ) . Indeed , cytoplasmic proteins that bind DNA strongly ( e . g . , cGAS ) are restricted to rupture sites . Rupture results in ‘‘global’’ mis - localization of multiple DNA repair factors in several path - ways ( Figure S2 E - i ) ( Xia et al . , 2018 ; Irianto et al . , 2017 ) , and repair factor depletion causes excess DNA damage before , during , and after transiently induced damage ( by 1 h etoposide ; Figure 4B ) . Remarkably , MMPs that degrade and remodel collagen - I matrix within hours or less are found here to directly regulate LMNA of the ‘‘nuclear matrix’’ ( Figures 5D - i , 6C , and 6D ) , which indicates a surprising inside - outside symmetry ( Figure 7 ) to the ‘‘use it or lose it’’ mechanism ( Figures 5C and 7B ) of stress - sta - bilizing ﬁbers . While both phospho - LMNA and MMP2 are found mostly in the nucleoplasm of CMs , the speciﬁc functions of MMP2 in the nucleus , the location of LMNA degradation , and its activation and localization mechanisms remain to be elucidated . Nuclear MMPs are not new ( Xie et al . , 2017 ) , but tension regulation of their substrates has not been described . Our studies of isolated CMs on soft or stiff gels further demon - strate steady - state LMNA levels are determined primarily by a basal tone related to average morphologies of cells and nuclei , as opposed to dynamic contractions that intermittently strain the nucleus ( Figures 3F , 6 D , and S6G ) . Basal and dynamic strain might contribute to a ‘‘tension - time integral’’ model that seems predictive for hypertrophic versus dilated cardiomy - opathy disease fates ( Davis et al . , 2016 ) . Roles for MMPs in such diseases and compensatory changes in LMNA could emerge . Reasons why cells do not simply maintain high LMNA levels at all times in all tissues could be physical as well as biochemical . An overly rigid nucleus might disrupt cytoskeletal assembly and function . Also , LMNA ﬁne tunes differentiation and matura - tion by regulating many cytoskeletal genes via the MKL1 / SRF pathway and by interacting with regulatory factors at the nuclear periphery . Nonetheless , accumulation of LMNA in stiff tissues of the embryo begins earlier than reported ( Stewart and Burke , 1987 ) and tracks nonlinearly what eventually becomes the most abundant protein in adult animals , collagen - I ( Figure 5C ) . Collagenase softens tissue and decreases LMNA consistent with scaling trends , and the scaling LMNA (cid:2) collagen - I 0 . 3 in em - bryos matches meta - analyses of all available transcriptomes analyzed for diverse normal and diseased adult and developing Developmental Cell 49 , 920 – 935 , June 17 , 2019 931 from Swift et al . , 2013 ; Ro¨ber et al . , 1989 ) . Mechano - coupled accumulation of LMNA and collagens that begin in early devel - opment could thus persist well into maturation and perhaps even to disease and aging of adult tissues ( Figure 7G ) . Thus , me - chano - protection of the genome by LMNA likely plays a critical role not only in embryonic development but also in a broad range of adult diseases . A B ‘Use it or Lose it’ model Figure 7 . LMNA Mechanosensing Based on a ‘‘Use It or Lose It’’ Mechanism for Tension - Inhibited Turnover that Also Applies to Collagen - I ( A ) Summary sketch . ( B ) ( i ) GenecircuitmodeladaptedfromDingaletal . ( DingalandDischer , 2014 ) , with ( ii ) governingequations . Squares , genes ; circles , protein . LMNAandmyosin - II protein ( l and m ) are weak regulators of the Serum Response Factor ( SRF ) pathway . LMNA upregulates its own transcription ( via RAR g ) . LMNA and collagen - I protein turnover with x and z sensitivity of degradation to myosin tension . Myosin - II protein turnover depends on matrix elasticity E , which scales with collagen - I ( Figure 4E ) . hearts across species ( Cho et al . , 2017 ) ( Fig . S7D ) . The scaling is consistent with that across proteomes of diverse chick embryo tissues at E18 ( Fig . S7E ) , as well as adult mouse tissues ( a = 0 . 4 ) ( Swift et al . , 2013 ) , and underscores a universality of normal regulation . Even the tissue - dependent timing of LMNA detection ( Solovei et al . , 2013 ; Ro¨ ber et al . , 1989 ; Lehner et al . , 1987 ) cor - relates well with stiffness of a tissue in adults ( Fig . S7F ; adapted 932 Developmental Cell 49 , 920 – 935 , June 17 , 2019 STAR + METHODS Detailed methods are provided in the online version of this paper and include the following : d KEY RESOURCES TABLE d CONTACT FOR REAGENT AND RESOURCE SHARING d EXPERIMENTAL MODEL AND SUBJECT DETAILS B Embryonic Chick Hearts and Cardiomyocytes B Induced Pluripotent Stem Cell - Derived Cardiomyo - cytes ( iPS - CMs ) B Cell Lines d METHOD DETAILS B Mass Spectrometry ( LC - MS / MS ) of Whole Heart Lysates B Immunoblotting B Ex Vivo Drug Perturbations of Embryonic Hearts B Morpholino Knockdown in Intact Hearts B Alkaline Comet Assay B Immunoﬂuorescence Imaging B siRNA Knockdown and GFP - Repair Factor Rescue B mCherry D450A FOK1 TRF1 Expression B Quantitative Fluorescence In Situ Hybridization and Telomere Analysis d QUANTIFICATION AND STATISTICAL ANALYSIS B Quantiﬁcation of Beating Strain B Statistics SUPPLEMENTAL INFORMATION Supplemental Information can be found online at https : / / doi . org / 10 . 1016 / j . devcel . 2019 . 04 . 020 . ACKNOWLEDGMENTS This work was supported by the National Institutes of Health / National Heart Lung and Blood Institute awards R01 HL124106 and R21 HL128187 , National Cancer Institute PSOC award U54 CA193417 , the US - Israel Binational Sci - ence Foundation , Charles Kaufman Foundation award KA2015 - 79197 , and National Science Foundation grant agreement CMMI 15 - 48571 . AUTHOR CONTRIBUTIONS Conceptualization , S . C . and D . E . D . ; Investigation , S . C . , M . V . , A . A . , S . M . , K . V . , I . I . , J . I . , and M . T . ; Validation , Y . X . and K . Z . ; Formal Analysis , S . C . and D . E . D . ; Resources , E . T . , F . M . , H . T . , R . G . , and B . P . ; Writing , S . C . and D . E . D . ; Supervi - sion , D . E . D . ; Funding Acquisition , D . E . D . DECLARATION OF INTERESTS The authors declare no competing interests . Received : November 20 , 2018 Revised : February 20 , 2019 Accepted : April 16 , 2019 Published : May 16 , 2019 REFERENCES Aix , E . , Gutie ´ rrez - Gutie ´ rrez , O´ . , Sa ´ nchez - Ferrer , C . , Aguado , T . , and Flores , I . ( 2016 ) . Postnatal telomere dysfunction induces cardiomyocyte cell - cycle ar - rest through p21 activation . J . Cell Biol . 213 , 571 – 583 . Baghirova , S . , Hughes , B . G . , Poirier , M . , Kondo , M . Y . , and Schulz , R . ( 2016 ) . Nuclearmatrixmetalloproteinase - 2inthecardiomyocyteandtheischemic - re - perfused heart . J . Mol . Cell . Cardiol . 94 , 153 – 161 . Bertacchini , J . , Beretti , F . , Cenni , V . , Guida , M . , Gibellini , F . , Mediani , L . , Marin , O . , Maraldi , N . M . , de Pol , A . , Lattanzi , G . , et al . ( 2013 ) . The protein kinase Akt / PKB regulates both prelamin A degradation and Lmna gene expression . FASEB J . 27 , 2145 – 2155 . Bollen , I . A . E . , Schuldt , M . , Harakalova , M . , Vink , A . , Asselbergs , F . W . , Pinto , J . R . , Kr € uger , M . , Kuster , D . W . D . , andvanderVelden , J . ( 2017 ) . Genotype - spe - ciﬁc pathogenic effects in human dilated cardiomyopathy . J . Physiol . ( Lond . ) 595 , 4677 – 4693 . Burke , B . , and Stewart , C . L . ( 2013 ) . The nuclear lamins : ﬂexibility in function . Nat . Rev . Mol . Cell Biol . 14 , 13 – 24 . Buxboim , A . , Swift , J . , Irianto , J . , Spinler , K . R . , Dingal , P . C . , Athirasala , A . , Kao , Y . R . , Cho , S . , Harada , T . , Shin , J . W . , et al . ( 2014 ) . Matrix elasticity regu - lates lamin - A , C phosphorylation and turnover with feedback to actomyosin . Curr . Biol . 24 , 1909 – 1917 . Chang , A . C . Y . , Chang , A . C . H . , Kirillova , A . , Sasagawa , K . , Su , W . , Weber , G . , Lin , J . , Termglinchan , V . , Karakikes , I . , Seeger , T . , etal . ( 2018 ) . Telomereshort - ening is a hallmark of genetic cardiomyopathies . Proc . Natl . Acad . Sci . USA 115 , 9276 – 9281 . Cho , S . , Abbas , A . , Irianto , J . , Ivanovska , I . L . , Xia , Y . , Tewari , M . , and Discher , D . E . ( 2018 ) . Progerin phosphorylation in interphase is lower and less mecha - nosensitive than lamin - A , C in iPS - derived mesenchymal stem cells . Nucleus 9 , 230 – 245 . Cho , S . , Irianto , J . , and Discher , D . E . ( 2017 ) . Mechanosensing by the nucleus : From pathways to scaling relationships . J . Cell Biol . 216 , 305 – 315 . Dahl , K . N . , Ribeiro , A . J . , and Lammerding , J . ( 2008 ) . Nuclear shape , me - chanics , and mechanotransduction . Circ . Res . 102 , 1307 – 1318 . Davis , J . , Davis , L . C . , Correll , R . N . , Makarewich , C . A . , Schwanekamp , J . A . , Moussavi - Harami , F . , Wang , D . , York , A . J . , Wu , H . , Houser , S . R . , et al . ( 2016 ) . A tension - based model distinguishes hypertrophic versus dilated car - diomyopathy . Cell 165 , 1147 – 1159 . de La Rosa , J . , Freije , J . M . , Cabanillas , R . , Osorio , F . G . , Fraga , M . F . , Ferna´ndez - Garcı´a , M . S . , Rad , R . , Fanjul , V . , Ugalde , A . P . , Liang , Q . , et al . ( 2013 ) . Prelamin A causes progeria through cell - extrinsic mechanisms and prevents cancer invasion . Nat . Commun . 4 , 2268 . Dingal , P . C . , and Discher , D . E . ( 2014 ) . Systems mechanobiology : tension - in - hibited protein turnover is sufﬁcient to physically control gene circuits . Biophys . J . 107 , 2734 – 2743 . Dupont , S . , Morsut , L . , Aragona , M . , Enzo , E . , Giulitti , S . , Cordenonsi , M . , Zanconato , F . , Le Digabel , J . , Forcato , M . , Bicciato , S . , et al . ( 2011 ) . Role of YAP / TAZ in mechanotransduction . Nature 474 , 179 – 183 . Engler , A . J . , Carag - Krieger , C . , Johnson , C . P . , Raab , M . , Tang , H . Y . , Speicher , D . W . , Sanger , J . W . , Sanger , J . M . , and Discher , D . E . ( 2008 ) . Embryonic cardi - omyocytes beat best on a matrix with heart - like elasticity : scar - like rigidity in - hibits beating . J . Cell Sci . 121 , 3794 – 3802 . Engler , A . J . , Sen , S . , Sweeney , H . L . , and Discher , D . E . ( 2006 ) . Matrix elasticity directs stem cell lineage speciﬁcation . Cell 126 , 677 – 689 . Fatkin , D . , MacRae , C . , Sasaki , T . , Wolff , M . R . , Porcu , M . , Frenneaux , M . , Atherton , J . , Vidaillet , H . J . , Jr . , Spudich , S . , De Girolami , U . , et al . ( 1999 ) . Missense mutations in the rod domain of the lamin A / C gene as causes of dilated cardiomyopathy and conduction - system disease . N . Engl . J . Med . 341 , 1715 – 1724 . Geiger , B . , Spatz , J . P . , and Bershadsky , A . D . ( 2009 ) . Environmental sensing through focal adhesions . Nat . Rev . Mol . Cell Biol . 10 , 21 – 33 . Graziano , S . , Kreienkamp , R . , Coll - Bonﬁll , N . , and Gonzalo , S . ( 2018 ) . Causes and consequences of genomic instability in laminopathies : replication stress and interferon response . Nucleus 9 , 258 – 275 . Green , E . M . , Wakimoto , H . , Anderson , R . L . , Evanchik , M . J . , Gorham , J . M . , Harrison , B . C . , Henze , M . , Kawas , R . , Oslob , J . D . , Rodriguez , H . M . , et al . ( 2016 ) . A small - molecule inhibitor of sarcomere contractility suppresses hy - pertrophic cardiomyopathy in mice . Science 351 , 617 – 621 . Developmental Cell 49 , 920 – 935 , June 17 , 2019 933 Gruenbaum , Y . , Margalit , A . , Goldman , R . D . , Shumaker , D . K . , andWilson , K . L . ( 2005 ) . The nuclear lamina comes of age . Nat . Rev . Mol . Cell Biol . 6 , 21 – 31 . Guilluy , C . , Osborne , L . D . , Van Landeghem , L . , Sharek , L . , Superﬁne , R . , Garcia - Mata , R . , and Burridge , K . ( 2014 ) . Isolated nuclei adapt to force and reveal a mechanotransduction pathway in the nucleus . Nat . Cell Biol . 16 , 376 – 381 . Harr , J . C . , Luperchio , T . R . , Wong , X . , Cohen , E . , Wheelan , S . J . , and Reddy , K . L . ( 2015 ) . Directed targeting of chromatin to the nuclear lamina is mediated by chromatin state and A - type lamins . J . Cell Biol . 208 , 33 – 52 . Hernandez , L . , Roux , K . J . , Wong , E . S . , Mounkes , L . C . , Mutalif , R . , Navasankari , R . , Rai , B . , Cool , S . , Jeong , J . W . , Wang , H . , et al . ( 2010 ) . Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria . Dev . Cell 19 , 413 – 425 . Higo , T . , Naito , A . T . , Sumida , T . , Shibamoto , M . , Okada , K . , Nomura , S . , Nakagawa , A . , Yamaguchi , T . , Sakai , T . , Hashimoto , A . , et al . ( 2017 ) . DNA sin - gle - strand break - induced DNA damage response causes heart failure . Nat . Commun . 8 , 15104 . Huang , D . L . , Bax , N . A . , Buckley , C . D . , Weis , W . I . , and Dunn , A . R . ( 2017 ) . Vinculin forms a directionally asymmetric catch bond with F - actin . Science 357 , 703 – 706 . Irianto , J . , Xia , Y . , Pfeifer , C . R . , Athirasala , A . , Ji , J . , Alvey , C . , Tewari , M . , Bennett , R . R . , Harding , S . M . , Liu , A . J . , et al . ( 2017 ) . DNA damage follows repair factor depletion and portends genome variation in cancer cells after pore migration . Curr . Biol . 27 , 210 – 223 . Jacot , J . G . , McCulloch , A . D . , and Omens , J . H . ( 2008 ) . Substrate stiffness af - fects the functional maturation of neonatal rat ventricular myocytes . Biophys . J . 95 , 3479 – 3487 . Kanellos , G . , Zhou , J . , Patel , H . , Ridgway , R . A . , Huels , D . , Gurniak , C . B . , Sandilands , E . , Carragher , N . O . , Sansom , O . J . , Witke , W . , et al . ( 2015 ) . ADF and Coﬁlin1 control actin stress ﬁbers , nuclear integrity , and cell survival . Cell Rep . 13 , 1949 – 1964 . Katz , Z . B . , Wells , A . L . , Park , H . Y . , Wu , B . , Shenoy , S . M . , and Singer , R . H . ( 2012 ) . Beta - actin mRNA compartmentalization enhances focal adhesion sta - bility and directs cell migration . Genes Dev . 26 , 1885 – 1890 . Kochin , V . , Shimi , T . , Torvaldson , E . , Adam , S . A . , Goldman , A . , Pack , C . G . , Melo - Cardenas , J . , Imanishi , S . Y . , Goldman , R . D . , and Eriksson , J . E . ( 2014 ) . Interphase phosphorylation of lamin A . J . Cell Sci . 127 , 2683 – 2696 . Kubben , N . , Voncken , J . W . , Konings , G . , van Weeghel , M . , van den Hoogenhof , M . M . , Gijbels , M . , van Erk , A . , Schoonderwoerd , K . , van den Bosch , B . , Dahlmans , V . , et al . ( 2011 ) . Post - natal myogenic and adipogenic developmental : defects andmetabolic impairmentuponlossofA - type lamins . Nucleus 2 , 195 – 207 . Kwan , J . A . , Schulze , C . J . , Wang , W . , Leon , H . , Sariahmetoglu , M . , Sung , M . , Sawicka , J . , Sims , D . E . , Sawicki , G . , and Schulz , R . ( 2004 ) . Matrix metallopro - teinase - 2 ( MMP - 2 ) is present in the nucleus of cardiac myocytes and is capable of cleaving poly ( ADP - ribose ) polymerase ( PARP ) in vitro . FASEB J . 18 , 690 – 692 . Lammerding , J . , Fong , L . G . , Ji , J . Y . , Reue , K . , Stewart , C . L . , Young , S . G . , and Lee , R . T . ( 2006 ) . LaminsAandCbutnotlaminB1regulatenuclear mechanics . J . Biol . Chem . 281 , 25768 – 25780 . Larrieu , D . , Britton , S . , Demir , M . , Rodriguez , R . , and Jackson , S . P . ( 2014 ) . Chemical inhibition of NAT10 corrects defects of laminopathic cells . Science 344 , 527 – 532 . Larrieu , D . , Vire´ , E . , Robson , S . , Breusegem , S . Y . , Kouzarides , T . , and Jackson , S . P . ( 2018 ) . InhibitionoftheacetyltransferaseNAT10normalizespro - gericandagingcellsbyrebalancingtheTransportin - 1nuclearimportpathway . Sci . Signal . 11 , eaar5401 . Lee , Y . K . , Lau , Y . M . , Cai , Z . J . , Lai , W . H . , Wong , L . Y . , Tse , H . F . , Ng , K . M . , and Siu , C . W . ( 2017 ) . Modeling treatment response for lamin A / C related dilated cardiomyopathy in human induced pluripotent stem cells . J . Am . Heart Assoc . 6 , e005677 . Lehner , C . F . , Stick , R . , Eppenberger , H . M . , and Nigg , E . A . ( 1987 ) . Differential expression of nuclear lamin proteins during chicken development . J . Cell Biol . 105 , 577 – 587 . Li , F . , Wang , X . , Capasso , J . M . , and Gerdes , A . M . ( 1996 ) . Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal develop - ment . J . Mol . Cell . Cardiol . 28 , 1737 – 1746 . Li , H . , Vogel , H . , Holcomb , V . B . , Gu , Y . , and Hasty , P . ( 2007 ) . Deletion ofKu70 , Ku80 , or both causes early aging without substantially increased cancer . Mol . Cell . Biol . 27 , 8205 – 8214 . Liu , B . , Wang , J . , Chan , K . M . , Tjia , W . M . , Deng , W . , Guan , X . , Huang , J . D . , Li , K . M . , Chau , P . Y . , Chen , D . J . , et al . ( 2005 ) . Genomic instability in laminopathy - based premature aging . Nat . Med . 11 , 780 – 785 . Maciejowski , J . , Li , Y . , Bosco , N . , Campbell , P . J . , and de Lange , T . ( 2015 ) . ChromothripsisandKataegisinducedbytelomerecrisis . Cell 163 , 1641 – 1654 . Majkut , S . , Idema , T . , Swift , J . , Krieger , C . , Liu , A . , and Discher , D . E . ( 2013 ) . Heart - speciﬁc stiffening in early embryos parallels matrix and myosin expres - sion to optimize beating . Curr . Biol . 23 , 2434 – 2439 . Naeem , A . S . , Zhu , Y . , Di , W . L . , Marmiroli , S . , and O’Shaughnessy , R . F . ( 2015 ) . AKT1 - mediated Lamin A / C degradation is required for nuclear degradation and normal epidermal terminal differentiation . Cell Death Differ . 22 , 2123 – 2132 . NationalInstitutesofHealth . ( 2016a ) . NCT02842242APhase2open - labelpilot study evaluating MYK - 461 in subjects with symptomatic hypertrophic cardio - myopathy and left ventricular outﬂow tract obstruction . https : / / ClinicalTrials . gov / show / NCT02842242 . National Institutes of Health . ( 2016b ) . NCT02929329 Registrational study with omecamtiv mecarbil / AMG 423 to treat chronic heart failure with reduced ejec - tion fraction . https : / / ClinicalTrials . gov / show / NCT02929329 . Oh , H . , Wang , S . C . , Prahash , A . , Sano , M . , Moravec , C . S . , Taffet , G . E . , Michael , L . H . , Youker , K . A . , Entman , M . L . , and Schneider , M . D . ( 2003 ) . Telomere attrition and Chk2 activation in human heart failure . Proc . Natl . Acad . Sci . USA 100 , 5378 – 5383 . Osmanagic - Myers , S . , Dechat , T . , and Foisner , R . ( 2015 ) . Lamins at thecross - roads of mechanosignaling . Genes Dev . 29 , 225 – 237 . Pajerowski , J . D . , Dahl , K . N . , Zhong , F . L . , Sammak , P . J . , and Discher , D . E . ( 2007 ) . Physical plasticity of the nucleus in stem cell differentiation . Proc . Natl . Acad . Sci . USA 104 , 15619 – 15624 . Paszek , M . J . , Zahir , N . , Johnson , K . R . , Lakins , J . N . , Rozenberg , G . I . , Gefen , A . , Reinhart - King , C . A . , Margulies , S . S . , Dembo , M . , Boettiger , D . , et al . ( 2005 ) . Tensional homeostasis and the malignant phenotype . Cancer Cell 8 , 241 – 254 . Prudova , A . , auf dem Keller , U . , Butler , G . S . , and Overall , C . M . ( 2010 ) . Multiplex N - terminome analysisof MMP - 2and MMP - 9substrate degradomes by iTRAQ - TAILS quantitative proteomics . Mol . Cell Proteomics 9 , 894 – 911 . Puente , B . N . , Kimura , W . , Muralidhar , S . A . , Moon , J . , Amatruda , J . F . , Phelps , K . L . , Grinsfelder , D . , Rothermel , B . A . , Chen , R . , Garcia , J . A . , et al . ( 2014 ) . The oxygen - rich postnatal environment induces cardiomyocyte cell - cycle arrest through DNA damage response . Cell 157 , 565 – 579 . Raab , M . , Gentili , M . , de Belly , H . , Thiam , H . R . , Vargas , P . , Jimenez , A . J . , Lautenschlaeger , F . , Voituriez , R . , Lennon - Dume ´ nil , A . M . , Manel , N . , et al . ( 2016 ) . ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death . Science 352 , 359 – 362 . Ribeiro , A . J . , Ang , Y . S . , Fu , J . D . , Rivas , R . N . , Mohamed , T . M . , Higgs , G . C . , Srivastava , D . , and Pruitt , B . L . ( 2015 ) . Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness . Proc . Natl . Acad . Sci . USA 112 , 12705 – 12710 . Ro ¨ ber , R . A . , Weber , K . , and Osborn , M . ( 1989 ) . Differential timing of nuclear lamin A / C expression in the various organs of the mouse embryo and the young animal : a developmental study . Development 105 , 365 – 378 . Robison , P . , Caporizzo , M . A . , Ahmadzadeh , H . , Bogush , A . I . , Chen , C . Y . , Margulies , K . B . , Shenoy , V . B . , and Prosser , B . L . ( 2016 ) . Detyrosinated micro - tubules buckle and bear load in contracting cardiomyocytes . Science 352 , aaf0659 . Sawada , Y . , Tamada , M . , Dubin - Thaler , B . J . , Cherniavskaya , O . , Sakai , R . , Tanaka , S . , and Sheetz , M . P . ( 2006 ) . Force sensing by mechanical extension of the Src family kinase substrate p130Cas . Cell 127 , 1015 – 1026 . 934 Developmental Cell 49 , 920 – 935 , June 17 , 2019 Shariﬁ - Sanjani , M . , Oyster , N . M . , Tichy , E . D . , Bedi , K . C . , Jr . , Harel , O . , Margulies , K . B . , and Mourkioti , F . ( 2017 ) . Cardiomyocyte - speciﬁc telomere shortening is a distinct signature of heart failure in humans . J . Am . Heart Assoc . 6 . Shimi , T . , Kittisopikul , M . , Tran , J . , Goldman , A . E . , Adam , S . A . , Zheng , Y . , Jaqaman , K . , and Goldman , R . D . ( 2015 ) . Structural organization of nuclear lamins A , C , B1 , and B2 revealed by superresolution microscopy . Mol . Biol . Cell 26 , 4075 – 4086 . Shoulders , M . D . , and Raines , R . T . ( 2009 ) . Collagen structure and stability . Annu . Rev . Biochem . 78 , 929 – 958 . Shukla , P . C . , Singh , K . K . , Quan , A . , Al - Omran , M . , Teoh , H . , Lovren , F . , Cao , L . , Rovira , I . I . , Pan , Y . , Brezden - Masley , C . , etal . ( 2011 ) . BRCA1isanessential regulator of heart function and survival following myocardial infarction . Nat . Commun . 2 , 593 . Singh , M . , Hunt , C . R . , Pandita , R . K . , Kumar , R . , Yang , C . R . , Horikoshi , N . , Bachoo , R . , Serag , S . , Story , M . D . , Shay , J . W . , et al . ( 2013 ) . Lamin A / C deple - tion enhances DNA damage - induced stalled replication fork arrest . Mol . Cell . Biol . 33 , 1210 – 1222 . Siu , C . W . , Lee , Y . K . , Ho , J . C . , Lai , W . H . , Chan , Y . C . , Ng , K . M . , Wong , L . Y . , Au , K . W . , Lau , Y . M . , Zhang , J . , et al . ( 2012 ) . Modeling of lamin A / C mutation pre - mature cardiac aging using patient - speciﬁc induced pluripotent stem cells . Aging 4 , 803 – 822 . Solovei , I . , Wang , A . S . , Thanisch , K . , Schmidt , C . S . , Krebs , S . , Zwerger , M . , Cohen , T . V . , Devys , D . , Foisner , R . , Peichl , L . , et al . ( 2013 ) . LBR and lamin A / C sequentially tether peripheral heterochromatin and inversely regulate dif - ferentiation . Cell 152 , 584 – 598 . Song , J . , Tan , H . , Perry , A . J . , Akutsu , T . , Webb , G . I . , Whisstock , J . C . , andPike , R . N . ( 2012 ) . PROSPER : an integrated feature - based tool for predicting prote - ase substrate cleavage sites . PLoS One 7 , e50300 . Stewart , C . , andBurke , B . ( 1987 ) . Teratocarcinomastemcellsandearlymouse embryos contain only a single major lamin polypeptide closely resembling lamin B . Cell 51 , 383 – 392 . Swift , J . , Ivanovska , I . L . , Buxboim , A . , Harada , T . , Dingal , P . C . , Pinter , J . , Pajerowski , J . D . , Spinler , K . R . , Shin , J . W . , Tewari , M . , et al . ( 2013 ) . Nuclear lamin - A scales with tissue stiffness and enhances matrix - directed differentia - tion . Science 341 , 1240104 . Taber , L . A . , Sun , H . , Clark , E . B . , and Keller , B . B . ( 1994 ) . Epicardial strains in embryonic chick ventricle at stages 16 through 24 . Circ . Res . 75 , 896 – 903 . Takaki , T . , Montagner , M . , Serres , M . P . , Le Berre , M . , Russell , M . , Collinson , L . , Szuhai , K . , Howell , M . , Boulton , S . J . , Sahai , E . , et al . ( 2017 ) . Actomyosin drives cancer cell nuclear dysmorphia and threatens genome stability . Nat . Commun . 8 , 16013 . Tichy , E . D . , Sidibe , D . K . , Tierney , M . T . , Stec , M . J . , Shariﬁ - Sanjani , M . , Hosalkar , H . , Mubarak , S . , Johnson , F . B . , Sacco , A . , and Mourkioti , F . ( 2017 ) . Single stem cell imaging and analysis reveals telomere length differ - ences in diseased human and mouse skeletal muscles . Stem Cell Reports 9 , 1328 – 1341 . Turgay , Y . , Eibauer , M . , Goldman , A . E . , Shimi , T . , Khayat , M . , Ben - Harush , K . , Dubrovsky - Gaupp , A . , Sapra , K . T . , Goldman , R . D . , and Medalia , O . ( 2017 ) . The molecular architecture of lamins in somatic cells . Nature 543 , 261 – 264 . Ulrich , T . A . , de Juan Pardo , E . M . , and Kumar , S . ( 2009 ) . The mechanical rigid - ity of the extracellular matrix regulates the structure , motility , and proliferation of glioma cells . Cancer Res . 69 , 4167 – 4174 . Wiggan , O . , Schroder , B . , Krapf , D . , Bamburg , J . R . , and DeLuca , J . G . ( 2017 ) . Coﬁlin regulates nuclear architecture through a myosin - II dependent mecha - notransduction module . Sci . Rep . 7 , 40953 . Woessner , J . F . , Jr . , Bashey , R . I . , and Boucek , R . J . ( 1967 ) . Collagen develop - ment in heart and skin of the chick embryo . Biochim . biophys . Acta 140 , 329 – 338 . Worman , H . J . , andBonne , G . ( 2007 ) . ‘‘Laminopathies’’ : awidespectrumofhu - man diseases . Exp . Cell Res . 313 , 2121 – 2133 . Xia , Y . , Ivanovska , I . L . , Zhu , K . , Smith , L . , Irianto , J . , Pfeifer , C . R . , Alvey , C . M . , Ji , J . , Liu , D . , Cho , S . , et al . ( 2018 ) . Nuclear rupture at sites of high curvature compromises retention of DNA repair factors . J . Cell Biol . 217 , 3796 – 3808 . Xie , Y . , Mustafa , A . , Yerzhan , A . , Merzhakupova , D . , Yerlan , P . , N Orakov , A . , Wang , X . , Huang , Y . , and Miao , L . ( 2017 ) . Nuclear matrix metalloproteinases : functions resemble the evolution from the intracellular to the extracellular compartment . Cell Death Discov . 3 , 17036 . Zaidel - Bar , R . , Milo , R . , Kam , Z . , and Geiger , B . ( 2007 ) . A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell - matrix adhe - sions . J . Cell Sci . 120 , 137 – 148 . Developmental Cell 49 , 920 – 935 , June 17 , 2019 935 STAR + METHODS KEY RESOURCES TABLE REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Mouse monoclonal anti - lamin A / C ( 4C11 ) Cell Signaling Technology Cat # 4777s ; RRID : AB _ 10545756 Mouse monoclonal antiphospho - Histone H2A . X ( Ser139 ) , clone JBW301 EMD Millipore Cat # 05 - 636 ; RRID : AB _ 2755003 Rabbit polyclonal anti - HSP90 Abcam Cat # ab13495 ; RRID : AB _ 1269122 Rabbit polyclonal anti - lamin B1 Abcam Cat # ab16048 ; RRID : AB _ 443298 Mouse monoclonal anti - b - actin ( C4 ) Santa Cruz Biotechnology Cat # sc - 47778 ; RRID : AB _ 2714189 Goat polyclonal anti - lamin - B ( M - 20 ) Santa Cruz Biotechnology Cat # sc - 6217 ; RRID : AB _ 648158 Rabbit polyclonal antiphospho - lamin A / C ( Ser22 ) Cell Signaling Technology Cat # 2026 ; RRID : AB _ 2136155 Rabbit polyclonal antiphospho - lamin A / C ( Ser390 ) EMD Millipore N / A ( custom ) Biological Samples Human induced pluripotent stem cell - derived cardiomyocytes ( iPS - CMs ) Stanford Cardiovascular Institute ( SCVI ) Biobank http : / / med . stanford . edu / scvibiobank . html Chemicals , Peptides , and Recombinant Proteins Blebbistatin EMD Millipore # 203390 Omecamtiv mecarbil Selleckchem S2623 MYK ( MYK - 581 ) MyoKardia N / A ( gift ) Collagenase Sigma - Aldrich C7657 Transglutaminase Sigma - Aldrich T5398 Ivermectin ( Imp - i’ ) Sigma - Aldrich I8898 All - trans - retinoic acid ( RA ) Fisher Scientiﬁc AC207341000 Retinoic acid receptor antagonist ( AGN193109 ) Santa Cruz Biotechnology sc - 217589 GM6001 ( pan - MMP inhibitor , ‘MMP - i’ ) EMD Millipore CC1010 ARP - 100 ( MMP2 inhibitor , ‘MMP2 - i’ ) Santa Cruz Biotechnology sc - 203522 Cycloheximide ( CHX , ‘Trx - i’ ) Sigma - Aldrich C7698 PNA Probe ( TelC - Cy5 ) PNA bio # F1003 Critical Commercial Assays Comet Assay Kit Cell Biolabs STA - 350 Experimental Models : Cell Lines A549 lung carcinoma cell line ATCC CCL - 185 U2OS osteosarcoma cell line expressing mCherry – TRF1 Laboratory of Roger Greenberg , Univ . of Pennsylvania N / A Experimental Models : Organisms / Strains White Leghorn chicken eggs : Speciﬁc Pathogen Free ( SPF ) fertilized Charles River Laboratories Premium # 10100326 Oligonucleotides Vivo - Morpholino against chick LMNA ( MO LMNA ) : 5 0 - TTGGCATTCCTGCAACGCCGC - 3 0 Gene Tools N / A 5 0 mismatch control Vivo - Morpholino ( MO Ctrl ) : 5 0 - TTCGCATTGCTGGAACGGCCC - 3 0 Gene Tools N / A Software and Algorithms MaxQuant Version 1 . 5 . 3 . 8 Max Planck Institute of Biochemistry http : / / www . coxdocs . org / doku . php ? id = maxquant : common : download _ and _ installation ImageJ NIH https : / / imagej . nih . gov / ij / Telometer Johns Hopkins School of Medicine http : / / demarzolab . pathology . jhmi . edu / telometer / index . html e1 Developmental Cell 49 , 920 – 935 . e1 – e5 , June 17 , 2019 CONTACT FOR REAGENT AND RESOURCE SHARING Further information and requests for resources and reagents should be directed to and will be fulﬁlled by the lead Contact , Dennis E . Discher ( discher @ seas . upenn . edu ) . EXPERIMENTAL MODEL AND SUBJECT DETAILS Embryonic Chick Hearts and Cardiomyocytes White Leghorn chicken eggs ( Charles River Laboratories ; speciﬁc pathogen free ( SPF ) Fertilized eggs , Premium # 10100326 ) were used to extract embryonic hearts . SPF chicken eggs from Charles River are produced using ﬁltered - air positive - pressure ( FAPP ) poultry housing and careful selection of layer ﬂocks . Every ﬂock’s SPF status is validated in compliance with USDA memorandum 800 . 65 and European Pharmacopoeia 5 . 2 . 2 guidelines . SPF eggs were incubated at 37 (cid:3) C with 5 % CO 2 and rotated once per day until the desired developmental stage ( e . g . four days for E4 ; Hamburger - Hamilton stage 23 – 24 ( HH23 - 24 ) ) . Embryos were extracted at room temperature ( RT ) by windowing eggs , carefully removing extraembryonic membranes with sterile sonicated forceps , and cutting major blood vessels to the embryonic disk tissue to free the embryo . The extracted embryo was then placed in a dish con - taining PBS on a 37 (cid:3) C - heated plate , and quickly decapitated . For early E2 - E5 embryos , whole heart tubes were extracted by severing the conotruncus and sino venosus . For more mature ( > E5 ) embryos , embryonic disks were extracted by windowing the egg , cutting out the embryo with the overlying vitelline membrane intact , lifting out the embryo adherent to the vitelline membrane and placing in a dish of prewarmed PBS . Extraembryonic tissue was carefully cut away using dissection scissors and the embryo was teased away from the vitelline membrane using forceps . Whole hearts ( > E5 ) were extracted by severing the aortic and pulmonary vessels . The pericardium was carefully sliced and teased away from the ventricle using extraﬁne forceps . E10 brain and liver tissue were collected from the presumptive midbrain and hepatic diverticulum , respectively . All tissues were incubated at 37 (cid:3) C in pre - warmed chick heart media ( a - MEM supplemented with 10 % FBS and 1 % Penn - strep , Gibco , # 12571 ) for at least 1 hrs for stabili - zation , until ready for use . To isolate primary embryonic CMs from tissue , whole hearts were diced to submillimeter size and digested with trypsin / EDTA ( Gibco , # 25200 - 072 ) . Approximately 1 ml of trypsin per E4 heart was added and incubated for 13 min at 37 (cid:3) C with gentle shaking , then placed upright for 2 min to let large pieces of tissue settle to the bottom of the dish . The supernatant was carefully removed and replaced with an equal volume of fresh trypsin for a second round of 15 - min incubation at 37 (cid:3) C . Digestion was blocked by adding an equal volume ( 1 : 1 ) of chick heart media . Isolated cells were plated onto collagen - I - coated polyacrylamide ( PA ) gels and were allowed to adhere for > 4 hrs . Spontaneously beating CMs were imaged using an Olympus I81 microscope with a 40 3 air objective conﬁgured for phase - contrast after 24 hrs in culture . As with intact embryonic hearts , cell area and AR were measured with time to quantify beating . All experiments were performed in accordance with the guidelines of the IACUC of University of Pennsylvania . Induced Pluripotent Stem Cell - Derived Cardiomyocytes ( iPS - CMs ) Normal human iPS cells ( obtained from Dr . Joseph Wu , Stanford Cardiovascular Institute ( CVI ) biobank ) were cultured following the protocol provided : Matrigel ( BD Matrigel , hESC qualiﬁed : # 354277 ) was suspended in cold 4 (cid:3) C DMEM / F12 medium 1 : 200 dilution ( DMEM / F12 medium # 10 - 092 - CM - Fisher ) , mixed gently , and 1 ml of this suspension was added to one 6 - well plate ( Corning Catalog # 353046 ) and incubated for 1 hr at RT to allow Matrigel to coat the surface . The solution was gently aspirated and small aggregates of human iPS cells were added to each well in mTesr1 medium containing 10 m M of ROCK inhibitor ( Y27632 , 2HCl – 50 mg : # 50 - 863 - 7 - Fisher ) . Culture medium was replaced daily ( no ROCK inhibitor ) until the cells reached (cid:2) 85 % conﬂuency . Human induced pluripotent stem cells ( hiPSCs ) were differentiated into cardiomyocytes ( hiPS - CMs ) using the ‘‘Cardiomyocytes differentiation and maintenance kit’’ from Stem Cell Technologies ( # 05010 & # 05020 ) . The differentiation process was followed as described by the manufacturer’s protocol . Brieﬂy , the mTesr1 medium with ROCK inhibitor ( 10 m M ) was replaced with differentiation medium A , cultured for 2 days ( Day 0 ) , then subsequently to medium B for 2 days ( Day 2 ) and again switched to medium C twice ( Day 4 & 6 ) . From Day 8 onwards , maintenance medium ( Day 8 ) was added / refreshed every 2 days until spontaneous CM beating was observed through imaging . Cell Lines A549 ( human lung adenocarcinoma ) cell lines were obtained from ATCC ( American Type Culture Collection , Manassas , VA , USA ) and U2OS cell lines were obtained from the laboratory of Roger Greenberg , University of Pennsylvania . ATCC provides cell line authentication test recommendations per Tech Bulletin number 8 ( TB - 0111 - 00 - 02 ; 2010 ) . These include : microscopy - based cell morphology check , growth curve analysis , and mycoplasma detection ( by DNA staining ) which were conducted on all cell lines used in these studies . All cell lines maintained the expected morphology and standard growth rates with no mycoplasma detected . U2OS and A549 cell lines were cultured in DMEM high - glucose media and Ham’s F - 12 nutrient mixture ( Gibco , Life Technologies ) , respectively , supplemented with 10 % fetal bovine serum ( FBS ) and 1 % penicillin and streptomycin ( Sigma - Aldrich ) . Developmental Cell 49 , 920 – 935 . e1 – e5 , June 17 , 2019 e2 METHOD DETAILS Mass Spectrometry ( LC - MS / MS ) of Whole Heart Lysates Mass spectrometry ( LC - MS / MS , or ‘MS’ ) samples were prepared using procedures outlined in Swift et al . . Brieﬂy , (cid:2) 1 mm 3 gel sec - tions were carefully excised from SDS – PAGE gels and were washed in 50 % 0 . 2 - M ammonium bicarbonate ( AB ) , 50 % acetonitrile ( ACN ) solution for 30 min at 37 (cid:3) C . The washed slices were lyophilized for > 15 min , incubated with a reducing agent ( 20 mM TCEP in 25 - mM AB solution ) , and alkylated ( 40 mM iodoacetamide ( IAM ) in 25 - mM AB solution ) . The gel sections were lyophilized again before in - gel trypsinization ( 20 mg / mL sequencing grade modiﬁed trypsin , Promega ) overnight at 37 (cid:3) C with gentle shaking . The re - sulting tryptic peptides were extracted by adding 50 % digest dilution buffer ( 60 - mM AB solution with 3 % formic acid ) and injected into a high - pressure liquid chromatography ( HPLC ) system coupled to a hybrid LTQ - Orbitrap XL mass spectrometer ( Thermo Fisher Scientiﬁc ) via a nanoelectrospray ion source . Raw data from each MS sample was processed using MaxQuant ( version 1 . 5 . 3 . 8 , Max Planck Institute of Biochemistry ) . MaxQuant’s built - in Label - Free Quantiﬁcation ( LFQ ) algorithm was employed with full tryptic digestion and up to 2 missed cleavage sites . Peptides were searched against a FASTA database compiled from UniRef100 Gallus gallus ( chicken ; downloaded from UniProt ) , plus contaminants and a reverse decoy database . The software’s decoy search mode was set as ‘revert’ and a MS / MS tolerance limit of 20 ppm was used , along with a false discovery rate ( FDR ) of 1 % . The minimum number of amino acid residues per tryptic peptide was set to 7 , and MaxQuant’s ‘match between runs’ feature was used for transfer of peak identiﬁcations across samples . All other parameters were run under default settings . The output tables from MaxQuant were fed into its bioinformatics suite , Perseus ( version 1 . 5 . 2 . 4 ) , for protein annotation and sorting . Immunoblotting Hearts isolated from chick embryos ( E4 , E6 , and E10 ; n R 8 , 4 , and 2 per sample , respectively ) were rinsed with prewarmed PBS , excised into submillimeter pieces , quickly suspended in ice - cold 1 3 NuPage LDS buffer ( Invitrogen ; diluted 1 : 4 in 1 3 RIPA buffer , plus 1 % protease inhibitor cocktail , 1 % b - mercaptoethanol ) , and lysed by probe - sonication on ice ( 10 3 3 s pulses , intermediate power setting ) . Samples were then heated to 80 (cid:3) C for 10 min and centrifuged at maximum speed for 30 min at 4 (cid:3) C . SDS - PAGE gels were loaded with 5 - 15 m L of lysate per lane ( NuPage 4 % - 12 % bis - Tris ; Invitrogen ) . Lysates were diluted with additional 1 3 NuPage LDS buffer if necessary . Gel electrophoresis was run for 10 min at 100 V and 1 hrs at 160 V . Separated samples were then transferred to a polyvinylidene ﬂuoride membrane using an iBlot Gel Transfer Device ( Invitrogen ) . The membrane was blocked with 5 % nonfat dry milk in TTBS buffer ( Tris - buffered saline , BioRad ; with 0 . 1 % Tween - 20 ) , washed 3 3 in TTBS , and incubated with primary antibodies against : LMNA ( 1 : 500 , CST , # 4777 ) , g H2AX ( 1 : 1000 , EMD Millipore , # 05 - 636 ) , HSP90 ( 1 : 1000 , Abcam , # ab13495 ) , b - actin ( 1 : 200 , Santa Cruz , # sc - 47778 ) , LMNB ( 1 : 200 , Santa Cruz , # sc - 6217 ) , LMNB1 ( 1 : 1000 , Abcam , ab16048 ) , LMNA pSer22 ( 1 : 500 , CST , # 2026 ) , and / or LMNA pSer390 ( 1 : 500 , EMD Millipore , custom - made Ab ) diluted in TBS to ﬁnal concen - trations generally on the order of (cid:2) 1 m g / ml at 4 (cid:3) C overnight . After washing 3 3 with TTBS , the membrane was incubated with 1 : 2000 diluted secondary Ab : anti - mouse HRP - conjugated IgG ( GE Healthcare , Little Chalfont , UK ) , at RT for R 1 . 5 hrs . The membrane was washed 3 3 again with TTBS and developed with ChromoSensor ( GenScript ) for (cid:2) 3 min at RT . Immunoblot images were obtained using a HP Scanjet 4850 . Densitometry was performed using ImageJ ( NIH ) . Ex Vivo Drug Perturbations of Embryonic Hearts For actomyosin perturbation experiments , intact E4 hearts were incubated in 25 m M blebbistatin ( EMD Millipore , # 203390 , stock solution 50 mg / ml in DMSO ) , 1 m M omecamtiv mecarbil ( OM , cytokinetics ) , or 0 . 3 - 1 m M MYK - 581 ( gift from MyoKardia , analog of MYK - 461 ( Green et al . , 2016 ) ) in heart medium at 37 (cid:3) C , for the desired duration . Drug solutions were kept away from light to mini - mize photodeactivation . Treated hearts were compared to a control sample treated with an equal concentration of vehicle solvent DMSO in heart culture media . Drug solutions were gently washed - out with prewarmed chick heart media 3 3 for recovery experi - ments . For collagen matrix perturbations , E4 heart tissue was incubated in 0 . 3 - 1 - mg / ml concentrations of collagenase ( Sigma , # C7657 ) for (cid:2) 45 min , or 20 - mg / mL transglutaminase ( Sigma , T5398 ) for up to 3 hrs at 37 (cid:3) C . Enzyme activity was blocked by replac - ing with chick heart media containing 5 % BSA . Nuclear import / export of KU80 was inhibited using 5 m M ivermectin ( Sigma I8898 ) , 10 m M mifepristone ( Sigma M8046 ) , or45 nM leptomycin B ( Sigma L2913 ) for 24 hrs . For transcriptional modulation of LMNA , hearts were incubated with 1 m M retinoic acid ( RA , Fisher Scientiﬁc ) or antagonist to retinoic acid ( AGN - 193109 , Santa Cruz ) , for short ( 3 hrs ) or long ( 72 hrs ) treatment times . For MMP inhibition during blebbistatin treatment , hearts were incubated with 10 m M GM6001 ( ‘MMP - i’ , EMD Millipore , # CC1010 ) or with 30 m M of ARP - 100 ( ‘MMP2 - i’ , Santa Cruz , CAS 704888 - 90 - 4 ) . 1 m M cycloheximide ( ‘Trx - I’ , Sigma , C7698 - 1G ) was added to block protein synthesis during actomyosin and / or matrix perturbations . 5 m M ivermectin ( Sigma , I8898 ) was used to inhibit nuclear import . A minimum of 8 hearts were treated and pooled per lysate / experimental condition . Morpholino Knockdown in Intact Hearts Vivo - Morpholinos ( MO ) against LMNA mRNA and the corresponding 5 0 - mispair control were designed according to the manufac - turer’s guidelines ( Gene Tools , Inc . ) : 5 0 - TTGGCATTCCTGCAACGCCGC - 3 0 ( MO LMNA ) and 5 0 - TTCGCATTGCTGGAACGGCCC - 3 0 ( MO Ctrl ) . Desired concentrations ( 1 , 2 , 5 , 10 , 30 m M ) were prepared by dilution in heart growth medium at 37 (cid:3) C , and the resulting so - lutions were added to E4 hearts for 24 hrs before analysis . e3 Developmental Cell 49 , 920 – 935 . e1 – e5 , June 17 , 2019 Alkaline Comet Assay Alkaline comet assays was performed according to manufacturer’s protocol ( Cell Biolabs ) . Brieﬂy , cells were trypsinized , mixed with liqueﬁed agarose at 37 (cid:3) C , placed drop - wise onto the supplied glass slide , and incubated for 15 min at 4 (cid:3) C for the agarose to gel . Lysis buffer from the kit was then added to the solidiﬁed gel and incubated for 45 min , followed by an additional 30 - min incubation with alkaline solution . Electrophoresis was performed at 300 mA for 30 min followed by a 70 % ethanol wash , before samples were air dried overnight . Finally , DNA dye in the kit was added to each sample for 15 minutes , followed by epiﬂuorescence imaging as described above . Immunoﬂuorescence Imaging Cells were rinsed with prewarmed PBS , ﬁxed with 4 % paraformaldehyde ( PFA , Fisher ) for 15 min , washed 3 3 with PBS and permea - bilized with 0 . 5 % Triton - X ( Fisher ) in PBS for 10 min . Permeabilized cells were then blocked with 5 % BSA in PBS for R 1 . 5 hrs . Sam - ples were incubated overnight with primary antibodies in 0 . 5 % BSA solution , with gentle agitation at 4 (cid:3) C . The primary antibodies used were : LMNA ( 1 : 500 , CST , # 4777 ) , LMNB ( 1 : 500 , Santa Cruz , # sc - 6217 ) , LMNA pSer22 ( 1 : 500 , CST , # 2026 ) , LMNA pSer390 ( 1 : 500 , EMD Millipore , new custom - made Ab ) , a - actinin - 2 ( 1 : 500 , Abcam , # ab9465 ) , g H2AX ( EMD Millipore , # 05 - 636 ) , KU80 ( 1 : 500 , Cell Signaling ) , 53BP1 ( 1 : 300 , Novus , # NB100 - 304 ) , RPA2 ( 1 : 500 , Abcam ) . Samples were washed 3 3 in 0 . 1 % BSA in PBS and incubated with the corresponding secondary antibodies at 1 : 500 dilution for 1 . 5 hrs at RT ( Alexa Fluor 488 , 546 and 647 nm ; Invitrogen ) . Cells on gels or glass coverslips were mounted with mounting media ( Invitrogen ProLong Gold Antifade Reagent ) . Images of adherent cells were taken with an Olympus IX81 . All images in a given experiment were taken under the same imaging conditions and were analyzed using ImageJ ( NIH ) . For confocal imaging of embryonic heart tissue , heart samples were rinsed with PBS , ﬁxed with 4 % paraformaldehyde ( PFA , Fisher ) for 45 min , washed 3 3 with PBS , and permeabilized with 0 . 5 % Triton - X ( Fisher ) in PBS for 3 hrs . Samples were then incubated overnight with primary antibodies in 0 . 5 % BSA solution with gentle agitation at 4 (cid:3) C ( as described above ) , and washed 3 3 in 0 . 1 % BSA and 0 . 05 % Triton - X in PBS . Corresponding secondary antibodies were added at 1 : 500 dilution for 1 . 5 hrs at RT . Immunostained hearts were then mounted between glass coverslips with mounting media ( Invitrogen ProLong Gold Antifade Reagent ) . Images were taken with Leica TCS SP8 system with either a 63 3 / 1 . 4 NA oil - immersion or 40 3 / 1 . 2 NA water - immersion objective . siRNA Knockdown and GFP - Repair Factor Rescue All siRNAs used in this study were purchased from Dharmacon ( ON - TARGETplus SmartPool ; siBRCA1 , L - 003461 - 00 ; siBRCA2 , L - 003462 - 00 ; siKu80 , L - 010491 - 00 ; siRPA1 , L - 015749 - 01 ; siLMNA , L - 004978 - 00 and nontargeting siRNA , D - 001810 - 10 ) . GFP - KU70 and GFP - KU80 were gifts from Dr . Stuart L Rulten from University of Sussex , Brighton , UK , and GFP - 53BP1 was a gift from Dr . Roger Greenberg from University of Pennsylvania . Cells were plated 24 hours before transfection . Lipofectamine / nucleic - acid complexes were prepared according to the manufacturer’s instructions ( Lipofectamine 2000 , Invitrogen ) , by mixing siRNA ( 25 nM ) or GFPs ( 0 . 2 – 0 . 5 ng / ml ) with 1 m g / ml Lipofectamine 2000 . Final solutions were added to cells and incubated for 3 days ( for siRNAs ) or 24 hours ( for GFPs ) in corresponding media containing 10 % FBS . mCherry D450A FOK1 TRF1 Expression Death domain ( DD ) – estrogen receptor ( ER ) – mCherry – TRF1 – FokI constructs were cloned and concentrated TRF1 - FokI lentivirus with Polybrene ( 8 mg / ml ) diluted in media was added to U2OS cells at a minimum titer . Doxycycline - inducible TRF1 – FokI lines were generated using the Tet - On 3G system . Doxycycline was used at a concentration of 40 ng / ml for 16 – 24 hrs to induce expression of TRF1 – D450A FokI . Shield - 1 ( Cheminpharma LLC ) and 4 - hydroxytamoxifen ( 4 - OHT ) ( Sigma ) were both used at a concentration of 1 m M for 2 hrs , to allow for TRF1 – D450A FokI stabilization and translocation into the nucleus . Quantitative Fluorescence In Situ Hybridization and Telomere Analysis Isolated cells were attached on slides , ﬁxed and stained for PNA telomeric probe as we previously described in ( Tichy et al . , 2017 ) . Images of mMuSCs were taken using a Nikon eclipse 90 i wide - ﬁeld epiﬂuorescence microscope equipped with a Prior Proscan III motorized stage , a Photometrics Coolsnap HQ2 14 - bit digital camera , and a Nikon 100 3 / 1 . 40 Plan Apo VC objective . Telomeres were analyzed with the investigators blinded to genotypes and / or conditions using open - source software Telometer , as previously described . The program generates statistics on the entire region of the nucleus . Analysis includes the intensity sum of all Cy5 telo - mere pixels for a given nucleus ( proportional to the cell’s total telomere length ) and the intensity sum of all DAPI pixels for the nucleus ( proportional to total cellular nuclear DNA content ) . QUANTIFICATION AND STATISTICAL ANALYSIS Quantiﬁcation of Beating Strain Transfected E4 chick hearts were video - imaged using an Olympus I81 at 4 3 magniﬁcation , with a CCD camera . Procedures described by Taber et al . ( Taber et al . , 1994 ) were followed to calculate 2D tissue beating strain . Brieﬂy , R 3 groups of 3 cells located within 20 m m of each other were selected as ﬁduciary markers along the outer walls of ventricular tissue . A custom MATLAB program was written to track their displacements and compute trace of the tissue strain tensor ( Taber et al . , 1994 ) . Alternatively , for higher - throughput quantitation of contractility changes ( n > 10 hearts per sample , e . g . following blebbistatin treatment ) , morphological Developmental Cell 49 , 920 – 935 . e1 – e5 , June 17 , 2019 e4 measurements ( projected 2D area , aspect ratio ( AR ) , circularity , perimeter , etc . ) of beating whole - hearts were traced with time . Morphology measurements were normalized to baseline reference values , and peak - to - valley ‘amplitudes’ were averaged over > 5 beats to quantify tissue beating strain ( e . g . D AR / AR ref ) . A similar approach was taken to quantify nuclear deformations : the pro - jected 2D area and aspect ratio ( AR ) of transfected nuclei ( e . g . expressing GFP - LMNA ) were traced with time , and the normalized amplitudes were measured and compared across experimental conditions . Statistics All statistical analyses were performed and graphs were generated using GraphPad Prism 5 . All error bars reﬂect ± SEM . Unless stated otherwise , all comparisons for groups of three or more were analyzed by one - way ANOVA followed by a Dunnett’s multiple comparison test . Pairwise sample comparisons were performed using Student’s t - test . Population distribution analyses were per - formed using the Kolmogorov - Smirnov test , with a = 0 . 05 . Information regarding statistical analyses are included in the ﬁgure leg - ends . For all ﬁgures , the p - values for statistical tests are as follows : n . s . = not signiﬁcant , * p < 0 . 05 , * * < 0 . 01 , * * * < 0 . 001 ( or # p < 0 . 05 , # # < 0 . 01 for multiple tests within the same dataset ) . e5 Developmental Cell 49 , 920 – 935 . e1 – e5 , June 17 , 2019 Developmental Cell , Volume 49 Supplemental Information Mechanosensing by the Lamina Protects against Nuclear Rupture , DNA Damage , and Cell - Cycle Arrest Sangkyun Cho , Manasvita Vashisth , Amal Abbas , Stephanie Majkut , Kenneth Vogel , Yuntao Xia , Irena L . Ivanovska , Jerome Irianto , Manorama Tewari , Kuangzheng Zhu , Elisia D . Tichy , Foteini Mourkioti , Hsin - Yao Tang , Roger A . Greenberg , Benjamin L . Prosser , and Dennis E . Discher Cho…Discher Mechanoprotecting the developing genome Feb 2019 Page 1 of 5 Supplemental Information Supplemental Figure Legends Figure S1 . Reversible inhibition of contractility and transcriptional suppression of LMNA result in increased DNA damage , Related to Figures 1 & 2 . ( A ) ( i ) Full - length Western blot ( top ) and corresponding Coomassie Brilliant Blue - stained gel ( bottom ) for data shown in Fig . 1B & C . Key time points are highlighted in colors . ( ii ) Densitometry line profiles along the electrophoresis axis ( vertical colored arrows ) shows significant changes in LMNA and γH2AX , but not β - actin ( loading control ) . ( iii ) Coomassie Brilliant Blue total intensity along each lane shows total protein content remains unchanged across conditions . All error bars indicate ±SEM . ( B ) ( i ) WB for a key time point ( 1h post - blebb treatment ) using an alternative housekeeping protein HSP90 as a loading control ( top ) . Densitometry line profiles ( bottom ) show similar ~ 35 % reduction in LMNA but not HSP90 , even in the presence of a protein synthesis inhibitor , ( C HX , or ‘Trx - i’ ) . ( ii ) Coomassie Brilliant Blue total intensity remains unchanged ( < 10 % ) across conditions ( n = 8 hearts per lysate ) . ( C ) Mass spectrometry ( MS ) of heart lysates detects 29 peptides unique to LMNA , and verifies that a broad range of housekeeping p roteins , including LMNB1 , LMNB2 , GAPDH , HSP70 , β - tubulin , and β - actin , remain unchanged with blebbistatin treatment ( ± Trx - i ) . n = 8 hearts per lysate . ( D ) ( i ) Quantification of tissue beating strain ΔAR / AR ref and ( ii ) heart rate ( beats / min ; BPM ) in blebbistatin treated hearts . Myosin - II inhibition by blebbistatin rapidly suppresses beating ( < 30 min ) , but effects are reversible such that washout of drug with culture medium ( ± OM ) results in near full recovery by 1h . ( E ) ( i ) LMNA and γH2AX immunoblots with different doses of MO . ( ii ) Low dowses ( < 5 μm ) have no significant effect on beating strain ( ΔAR / AR ref ) or rate ( BPM ) , but higher doses suppress beating , indicating potential cytotoxicity ( one - way ANOVA ; * p < 0 . 05 , * * < 0 . 01 ) . ( F ) ( i ) Retinoic acid ( RA ) and antagonist to retinoic acid ( AGN ) treatment in intact embryonic hearts have no observable effect on LMNA levels or DNA damage ( γH2AX ) at 3h . ( n = 6 hearts per cond . ) . ( ii ) Significant changes in LMNA and γH2AX are detectable only after 72h treatment , consistent with slow transcriptional modulation . A reduction in LMNA upon RA treatment ( 72h ) is accompanied by an increase in DNA damage as measured by γH2AX , while AGN treatment leads to an upregulation of LMNA coupled to suppression of DNA damage ( n = 8 hearts per lysate , t - test ; * p < 0 . 05 ) . ( G ) LMNA WB of RA / AGN treated E4 hearts , with three different loading volumes ( Low , Med , High ) . Bottom left : LMNA vs HSP90 scatter plot ( all R 2 > 0 . 99 ) ; Right : linear fits from LMNA vs HSP90 scatter plot show slopes for AGN > Untr . > RA . ( H ) RA and AGN treatment does not significantly affect contractility of hearts even after 72h of treatment . Cho…Discher Mechanoprotecting the developing genome Feb 2019 Page 2 of 5 Figure S2 . Suppression of LMNA levels in intact embryonic hearts and in beating hiPS - CMs increase rupture under high stress , causing prolonged ( > 1h ) loss of repair factors from the nucleus and accumulation of DNA damage , Related to Figure 3 . ( A ) ( i ) Blebbistatin treatment and washout have no significant effect on cell death / viability , as determined by % - transfected cells with fragmented DNA . ( ii ) As with embryonic hearts , blebbistatin washout results in an increase in rupture with cytoplasmic mis - localization of KU80 . An excess of rupture is seen with washout plus a nuclear import inhibitor ( ivermectin , ‘Imp - i ' , which inhibits Impα / β mediated import ) , but not with washout plus a specific inhibitor of integrase ( IN ) nuclear import ( mifepristone , ‘Mifepr . ’ ) that does not target KU80’s NLS . On the other hand , washout with a nuclear export inhibitor ( leptomycin B , ‘Exp - I’ ) greatly suppresses cytoplasmic mis - localization of KU80 ( t - test * p < 0 . 05 , * * < 0 . 01 ) . All error bars indicate ±SEM . ( B ) As seen with nuclei in intact embryonic hearts , ‘nuclear beating’ occurs in hiPS - CMs and can be quantified by changes in nucleus area and DNA mean intensity ( condensation / de - condensation of DNA ) , which are inversely correlated . ( C ) Time - lapse images of nuclei probed with a pointed ( < 1 μm ) Atomic Force Microscopy ( AFM ) tip ( at ~ 7 nN ) . Nuclear rupture upon stress is evident in the rapid and stable accumulation of a cytoplasmic protein that binds DNA ( GFP - cGAS ) . ( D ) ( i ) Nuclear / cytoplasmic KU80 IF intensity ratio decreases with siLMNA knockdown , and ( ii ) anti - correlates with γH2AX foci count ( one - way ANOVA ; * * * p < 0 . 001 ) . ( E ) ( i ) Cytoplasmic mis - localization is not limited to KU80 , but applicable to other DNA repair factors including 53BP1 and RPA2 ( top : IF images , bottom : intensity profiles along white dashed line ) . Scale bar = 10 μm . ( ii ) Time - lapse images of siLMNA knockdown cells transduced with GFP - 53BP1 show that nuclear rupture and cytoplasmic mis - localization occur within minutes and are maintained for at least 1h in culture indicating slow recovery . ( F ) Total ( nuclear + cytoplasmic ) KU80 abundance is unaffected by siLMNA or blebbistatin treatment . ( G ) Kymograph of beating hiPS - CM organoids generated by tracing length along yellow line with time . Blebbistatin treatment results in reversible inhibition of contractility . Cho…Discher Mechanoprotecting the developing genome Feb 2019 Page 3 of 5 Figure S3 . Repair factor loss perturbs cell cycle , but effects are rescued by myosin - II inhibition , Related to Figure 4 . ( A ) ( i ) Histograms of normalized DNA content in hiPS - CMs after knockdown of LMNA and DNA repair factors . All repair factor knockdowns results in a higher fraction of ‘4N’ cells , with effects most severe for siCombo . ( ii ) Kolmogrov - Smirnov test ( α = 0 . 05 ) for siRNA treated populations . ( iii ) γH2AX foci count inversely correlates with KU80 nuclear IF intensity at the single cell level , consistent with limited repair . All error bars indicate ±SEM . ( B ) DNA damage per total DNA is elevated in 4N cells after LMNA knockdown and decreased in 2N cells , based again on measurements of individual cells . ( C ) Left : Representative scatter plot of EdU intensity versus total DNA content used to determine cell cycle phase ( G1 , S , and G2 ) . Right : siLMNA treatment increases fraction of cells in G2 , but effects are rescued by blebbistatin ( t - test * p < 0 . 05 , * * * < 0 . 001 ) . ( D ) ( i ) Venn diagram of nuclear proteins pulled down by co - immunoprecipitation mass spectrometry ( CoIP - MS ) using anti - GFP on GFP - KU70 expressing cells . ( ii ) As expected , KU80 is a strong interaction partner of KU70 ( as components of the KU complex ) , as are lamins - A and B . Figure S4 . Parallel increases in lamin - A : B , collagen matrix , and tissue stiffness fit a ‘lose it or use it’ model of tension - stabilization of fibers , Related to Figure 5 . ( A ) LMNA MS intensity scales with heart tissue stiffness with exponent α ~ 0 . 75 similar to that for adult tissue proteomes ( Swift , et al . , 2013 ) . All error bars indicate ±SEM . ( B ) Lamins - B1 & B2 remain comparatively constant throughout development and exhibit much weaker scaling ( α < 0 . 25 ) . ( C ) Heartmap of proteins detected by LC - MS / MS in the ECM , adhesion complexes , sarcomeres , and the nuclear lamina . Proteins were ranked based on the fold - change relative to the average . ( D ) Lamin - A : B ratio quantified by ( i ) WB densitometry and ( ii ) IF ( t - test * p < 0 . 05 ) . ( E ) MS measurements of collagen - I calibrated with spike - ins of known amounts of purified collagen - I . Dividing calibrated measurements by reported myocardium volumes ( Kim , et al . , 2011 ) gives collagen - I densities far lower than those used in studies of collagen - I gels ( Yang , et al . , 2009 ) , suggesting lower densities are needed for a stiffness in the kPa range as measured for heart ( Fig . 4C - ii ) . ( F ) Heart stiffness measurements by micropipette aspiration plotted against collagen - I MS intensity yield power - law scaling comparable to that found for diverse adult tissues ( Swift , et al . , 2013 ) . ( G ) LMNA & B immunoblots for E10 brain and liver tissue . Cho…Discher Mechanoprotecting the developing genome Feb 2019 Page 4 of 5 Figure S5 . Acute drug perturbations in E4 heart rapidly impact LMNA levels and phosphorylation at multiple sites , but do not affect total abundance of repair factors or MMP2 , Related to Figure 5 . ( A ) Immunoblot validation of LMNA trends seen in MS profiling of drug perturbations ( n > 6 hearts per lysate ) . Immunoblots against phosphorylated Ser22 and Ser390 show that normalized phosphorylation ( ‘pSer22 / LMNA’ and ‘Ser390 / LMNA’ ) increases with blebbistatin - inhibition of actomyosin stress or with collagenase - softening of tissue , but decreases with CDK - i treatment ( one - way ANOVA ; * p < 0 . 05 , * * p < 0 . 01 , * * * p < 0 . 001 ) . All error bars indicate ±SEM . ( B ) ( i ) RPA1 ( DNA repair factor ) and ( ii ) pro - MMP2 levels are unaffected by drug perturbations ( per MS ) . ( iii ) Catalytic activation of MMP2 ( ‘cleaved / pro - MMP2’ fraction , as measured by immunoblot ) is not affected by drug perturbations to contractility and / or collagen matrix . ( C ) Schematic plot of fractional abundance of intact LMNA and its phosphorylated fragments , including intermediates , upon relaxation of stress . Figure S6 . Cell - on - gel morphological trends in CM size , shape , contractility , and LMNA mirror those of in vivo hearts without affecting cell cycle / proliferation , Related to Figure 6 . ( A ) ( i ) Projected area of the nucleus relative to that of the cell ( ‘Nucl . / Cyto . Area fraction’ ) decreases ( ii ) and cells elongate ( increased aspect ratio , AR ) , as the embryonic heart stiffens and cells undergo hypertrophic growth and spreading from E4 – E10 . Isolated E4 CMs cultured on gels likewise exhibit increased cell spreading and elongation on stiffer gels ( t - test * p < 0 . 05 , * * < 0 . 01 , * * * < 0 . 001 ) . All error bars indicate ±SEM . ( B ) Two of the most abundantly expressed α - and β - tubulin isoforms ( TUBA1C , TUBB7 ) increase in level from E4 to E10 and the increase is accompanied by a decrease in TTLL12 , which tyrosinates and de - stabilizes microtubules ( Robison , et al . , 2016 ) . Trends are consistent with increased stiffness as well as with polarization / elongation of CMs during development ( Fig . 4D - ii , Fig . S6A ) . ( C ) Axial alignment of cells ( anisotropy , quantified as 1 / COV of the major axes of nuclei ) increases from early ( E4 ) to late ( E11 ) hearts . Upper left inset : major axis angle distribution of E4 and E11 nuclei . ( D ) Nuclear volume ( estimated by confocal Z - stack ) decreases in development from E4 to E10 . ( E ) Varying matrix stiffness alone in E4 CM cultures is sufficient to recapitulate trends in morphology and intracellular organization seen in vivo ( from E4 to E11 ) . ( F ) Normalized cell and nuclear beating strains measured by ( i ) ‘ΔAR / AR ref ’ and ( ii ) ‘ΔArea / Area ref ’ , and ( iii ) % - beating cells all exhibit an optimum on gels mimicking the stiffness of embryonic hearts ( ~ 2 kPa ) . Blebbistatin treatment abolishes mechano - sensitivity . ( n > 10 cells / nuclei per condition ) . ( G ) ( i ) Nuclear beating strain ( ‘Nucleus ΔAR / AR ref ’ ) correlates well with cell beating strain ( ‘Cell ΔAR / AR ref ’ ) , ( ii ) but lamin - A : B ratio does not correlate with beating . Lamin - A : B instead couples to average morphology changes in spreading area and elongation that relate to basal isometric tension . Cho…Discher Mechanoprotecting the developing genome Feb 2019 Page 5 of 5 ( H ) Lamin - A : B in cells on rigid plastic decreases with MYK inhibition of cardiac myosin contractility ( as with blebbistatin treatment ) , but remains unchanged with OM treatment . Figure S7 . Phosphorylation of LMNA favors degradation by MMP2 , Related to Figure 6 & 7 . ( A ) Representative images of cells transduced with phsopho - mimetic mutants GFP - S22A and GFP - S22E , with or without protein synthesis inhibitor Trx - i . ( i , ii ) Line profiles across individual nuclei reveal ‘non - phosphorylatable’ GFP - S22A signal is far more enriched at the lamina than in the nucleoplasm , compared to ‘constitutively phosphorylated’ GFP - S22E ( n > 15 nuclei ) . Treatment with Trx - i does not alter nucleoplasm / lamina ratio in either mutant . ( iii ) Overall fluorescence intensity of GFP - S22A is ~ 50 % higher than that of GFP - S22E . Trx - i induces a minor ~ 10 % decrease in either case . All error bars indicate ±SEM . ( B ) Immunoblots with anti - lamin - A / C and anti - GFP reveal multiple low - MW degradation fragment bands ( green triangles ) in the GFP - S22E mutant which are absent in the S22A mutant . ( ii ) Line intensity profile of anti - lamin - A / C immunoblot ( i , left ) . Low - MW degradation fragments that are present in the GFP - S22E mutant but not in the GFP - S22A mutant , are shaded in blue , with green arrows indicating distinct bands . ( C ) GFP fluorescence intensity of GFP - S22E expressing cells increases upon MMP2 - I ( ARP - 100 ) treatment , consistent with inhibition of degradation . ( D ) Representative transcriptomics dataset for mouse embryonic hearts obtained from NCBI’s Gene Expression Omnibus ( GEO ) Database . Log - log plot shows normalized mRNA expression vs Col1a1 . As expected for obligate heterotrimer subunits of collagen - I , Col1a2 correlates robustly with Col1a1 , with scaling exponent ( = slope on a log - log plot ) , α Col1a2 ~ 1 . Lmna also increases with Col1a1 , although with slightly weaker scaling α Lmna ~ 0 . 3 , indicating potential feedback to gene expression . Right : bar graph of average scaling exponents ( vs Col1a1 ) for proteins of interest in the ECM , cytoskeleton , nuclear envelope , as well as several transcription factors implicated in mechanosensing and / or cardiac development . ( E ) Proteomics dataset for diverse E18 chick embryonic tissues , adapted from Uebbing et al . ( Uebbing et al . , 2015 ) . Lmna again increases with Col1a1 & 2 , with exponent α Lmna ~ 0 . 3 . Right inset : datapoints for heart samples plotted separately reveal similar scaling . ( F ) Tissue - dependent timing of initial LMNA expression in early embryos correlates well with the stiffness that a given tissue eventually achieves in adult ( adapted from ( Swift , et al . , 2013 ; Rober , et al . , 1989 ) ) . Figure S1 Myosin - II inhibition Rescue D i ii (cid:533)(cid:16)(cid:68)(cid:70)(cid:87)(cid:76)(cid:81) LMNA H2AX (cid:74) (cid:80) M : (cid:24)(cid:182)(cid:3)(cid:48)(cid:76)(cid:86)(cid:80)(cid:17) 10 2 10 30 10 ( 48h ) MO LMNA MO C(cid:87)rl LMNA (cid:56)(cid:81)(cid:87)(cid:85)(cid:17) RA AGN 73 HSP90 LMNA (cid:56)(cid:81)(cid:87)(cid:85)(cid:17) RA AGN 73 90 (cid:533)(cid:16)(cid:68)(cid:70)(cid:87)(cid:76)(cid:81)(cid:3) H2AX (cid:74) 42 17 F G (cid:533)(cid:16)(cid:68)(cid:70)(cid:87)(cid:76)(cid:81)(cid:3) H2AX (cid:74) 17 42 i ii 0 3 72 (cid:55)(cid:76)(cid:80)(cid:72)(cid:3)(cid:11)(cid:75)(cid:12) (cid:53)(cid:72)(cid:87)(cid:76)(cid:81)(cid:82)(cid:76)(cid:70)(cid:3)(cid:68)(cid:70)(cid:76)(cid:71)(cid:3)(cid:11)(cid:53)(cid:36)(cid:12)(cid:36)(cid:81)(cid:87)(cid:68)(cid:74)(cid:82)(cid:81)(cid:76)(cid:86)(cid:87)(cid:3)(cid:11)(cid:36)(cid:42)(cid:49)(cid:12) LMNA E 0(cid:17)00 0(cid:17)02 0(cid:17)04 0(cid:17)06 MO LMNA MO C(cid:87)rl (cid:81)(cid:17)(cid:86)(cid:17) * * + Bl(cid:72)bb * * * B (cid:72)(cid:68) (cid:87) (cid:76) (cid:81)(cid:74) (cid:86) (cid:87) r (cid:68) (cid:76) (cid:81) (cid:39) A R / A R r (cid:72) f 0 10 20 30 0 50 100 (cid:81)(cid:17)(cid:86)(cid:17) * * * + Bl(cid:72)bb MO (cid:70)(cid:82)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)r(cid:68)(cid:87)(cid:76)(cid:82)(cid:81) ( (cid:80) M ) b(cid:72)(cid:68) (cid:87) (cid:86) / (cid:80) (cid:76) (cid:81) ( BP M ) 0 10 20 30 0(cid:17)0 0(cid:17)5 1(cid:17)0 1(cid:17)5 2(cid:17)0 LMNA (cid:74) H2AX * * * * * MO C(cid:87)rl MO (cid:70)(cid:82)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)r(cid:68)(cid:87)(cid:76)(cid:82)(cid:81) ( (cid:80) M ) D (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) (cid:82) (cid:80) (cid:72) (cid:87) r y (cid:81)(cid:82) r (cid:80) (cid:17) (cid:87) (cid:82) 5 ' (cid:80) (cid:76) (cid:86) (cid:80) (cid:68) (cid:87) (cid:70) h M O C (cid:87) r l ( A (cid:17) U (cid:17) ) i ii (cid:37)(cid:72)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:86)(cid:3)(cid:85)(cid:68)(cid:83)(cid:76)(cid:71)(cid:79)(cid:92)(cid:3)(cid:83)(cid:72)(cid:85)(cid:87)(cid:88)(cid:85)(cid:69)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:80)(cid:92)(cid:82)(cid:16)(cid:44)(cid:44)(cid:3)(cid:80)(cid:82)(cid:71)(cid:88)(cid:79)(cid:68)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:69)(cid:88)(cid:87)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:69)(cid:92)(cid:3)(cid:79)(cid:82)(cid:90)(cid:3)(cid:71)(cid:82)(cid:86)(cid:72)(cid:86)(cid:3)(cid:11)(cid:31)(cid:24)(cid:88)(cid:48)(cid:12)(cid:3)(cid:82)(cid:73)(cid:3)(cid:48)(cid:50)(cid:3)(cid:87)(cid:85)(cid:72)(cid:68)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3) T(cid:85)(cid:68)(cid:81)(cid:86)(cid:70)r(cid:17)(cid:3)(cid:85)(cid:72)(cid:74)(cid:88)(cid:79)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:69)(cid:92)(cid:3)(cid:53)A(cid:3)(cid:82)(cid:85) (cid:36)(cid:42)(cid:49)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:81)(cid:87)(cid:76)(cid:16)(cid:70)(cid:82)(cid:85)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:47)(cid:48)(cid:49)A(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:39)(cid:49)A(cid:3)(cid:71)(cid:68)(cid:80)(cid:68)(cid:74)(cid:72)(cid:3)(cid:68)(cid:73)(cid:87)(cid:72)(cid:85)(cid:3)(cid:71)(cid:68)(cid:92)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:85)(cid:72)(cid:68)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87) A B MSTPSQRRSG RGGGPSGTPL SPTRITR LAVYIDKVR L RITESEEVVS REVSGIK KT LDSVAKERAR VRE EHKELKARNA KK R DLRAQVAK LEGALSEAKK RV DAENRLQTLK EELEFQK ETKRR HETR QQEFESK RQ HEDQIRHYRD ELEKTYGAKL ENAKQSAER QLAAKEAKLR ER EGGRRLLAEK EREMAEMRAR LALDM EINAYR KLLE GEEER LRLSP SPSSQRGARS SGLQHSGAGS AKKRRLEDGE GREGREGRTS FSHHARTSGR FVRLRNKSN EDQALGNWQV KRQNGDDPPL TYRFPPKFTL KLVRTVII NDDDEDEEDD EVSIHHR SR G YR K LQE KEDLQELNDR S LELENAGLR AAY EAELADAR LQLELSK EADLLAAQ ARLKDLEALL NSKEAALSTA LGEK NLENE VR QLQDEMLR NIY SEELR LVEIDN GR L AEALQDLR N SSMAGAAHEE LQQTHIRIDS LSAELSQLQK EVEEALSR MQQQLDEYQE LLDIK VGVEEVDLEG R AGQAVTIWA SGAGATHSPP SDVVWKAQSS WGSGDSLRTA LINSNGEEVA MR HHH SGCSGSADPA EYNLR TVL CGTCGQPADK GSAAAASSAS SASTVTVSR SSGGGIGE GLLGR SYVLG GAGPRRQAPA PQGCSIM S(cid:72)q(cid:17) (cid:70)(cid:82)v(cid:72)r(cid:68)(cid:74)(cid:72) = (cid:3)(cid:3)(cid:23)(cid:26)(cid:17)(cid:22)(cid:8) (cid:41)(cid:39)(cid:53)(cid:3)(cid:31)(cid:3)(cid:20)(cid:8) (cid:48)(cid:68)(cid:86)(cid:86)(cid:3)(cid:54)(cid:83)(cid:72)(cid:70)(cid:17)(cid:3)(cid:11)(cid:47)(cid:38)(cid:16)(cid:48)(cid:54)(cid:18)(cid:48)(cid:54)(cid:12)(cid:3)(cid:82)(cid:73)(cid:3)(cid:40)(cid:23)(cid:3)(cid:90)(cid:75)(cid:82)(cid:79)(cid:72)(cid:3)(cid:75)(cid:72)(cid:68)(cid:85)(cid:87) 51 101 151 201 251 301 351 401 451 501 551 601 651 1 (cid:21)(cid:28)(cid:3)(cid:83)(cid:72)(cid:83)(cid:87)(cid:17)(cid:3)(cid:88)(cid:81)(cid:76)(cid:84)(cid:88)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:47)(cid:48)(cid:49)(cid:36)(cid:20)(cid:3)(cid:83)(cid:72)(cid:83)(cid:87)(cid:17)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:47)(cid:48)(cid:49)(cid:37) (cid:43)(cid:72)(cid:68)(cid:71) (cid:302)(cid:16)(cid:75)(cid:72)(cid:79)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:85)(cid:82)(cid:71) T(cid:68)(cid:76)(cid:79)(cid:3)(cid:71)(cid:82)(cid:80)(cid:68)(cid:76)(cid:81) EER LRLSP SPSSQRGARS SGLQHSGAGS AKKRRLEDGE GREGREGRTS FSHHARTSGR VGVEEVDLEG FVRLRNKSN EDQALGNWQV KRQNGDDPPL TYRFPPKFTL K R AGQAVTIWA KLVRTVII SGAGATHSPP SDVVWKAQSS WGSGDSLRTA LINSNGEEVA MR NDDDEDEEDD EVSIHHR SR HHH SGCSGSADPA EYNLR TVL CGTCGQPADK G YR GSAAAASSAS SASTVTVSR SSGGGIGE GLLGR SYVLG GAGPRRQAPA PQGCSIM 0 20 40 60 80 100 73 42 17 DMSO ( 0(cid:17)5h ) Bl(cid:72)bb ( 0(cid:17)5h ) Bl(cid:72)bb ( 4(cid:17)5h ) W(cid:68)(cid:86)h(cid:82)(cid:88)(cid:87) ( + 1h ) LMNA (cid:69) (cid:16)(cid:68)(cid:70)(cid:87)(cid:76)(cid:81) (cid:74) H2AX MW r(cid:68)(cid:81)(cid:74)(cid:72) ( kD(cid:68) ) (cid:44) (cid:80)(cid:80) (cid:88)(cid:81)(cid:82)b l (cid:82) (cid:87) D (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) (cid:82) (cid:80) (cid:72) (cid:87) r y ( A (cid:17) U (cid:17) ) D M S O ( 0 (cid:17) 5h ) B l (cid:72)bb ( 0 (cid:17) 5h ) B l (cid:72)bb ( 1h ) B l (cid:72)bb ( 2h ) B l (cid:72)bb ( 3h ) B l (cid:72) bb ( 4 (cid:17) 5h ) W (cid:68) (cid:86) h (cid:82)(cid:88) (cid:87) ( + 1h ) W (cid:68) (cid:86) h (cid:82)(cid:88) (cid:87) ( + 3h ) D M S O ( 6h ) + O M ( 7 (cid:17) 5h ) 0(cid:17)0 0(cid:17)5 1(cid:17)0 1(cid:17)5 (cid:81)(cid:17)(cid:86)(cid:17) C (cid:82)(cid:82) (cid:80) (cid:68) (cid:86)(cid:86) (cid:76) (cid:72) b r (cid:76)ll(cid:76) (cid:68)(cid:81) (cid:87) b l (cid:88)(cid:72) T (cid:82) (cid:87) (cid:68) l (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) (cid:58)(cid:72)(cid:86)(cid:87)(cid:72)(cid:85)(cid:81)(cid:3)(cid:69)(cid:79)(cid:82)(cid:87) (cid:21)(cid:17)(cid:22)(cid:91) (cid:19)(cid:17)(cid:25)(cid:91) (cid:19)(cid:17)(cid:25)(cid:24)(cid:91) (cid:31)(cid:20)(cid:17)(cid:20)(cid:91) LMNA HSP90 (cid:38) (cid:82)(cid:82) (cid:80) (cid:68) (cid:86)(cid:86) (cid:76) (cid:72) (cid:3) (cid:69) (cid:85) (cid:76)(cid:79)(cid:79)(cid:76) (cid:68)(cid:81) (cid:87)(cid:3) (cid:69) (cid:79) (cid:88)(cid:72) DMSO (cid:37)(cid:79)(cid:72)(cid:69)(cid:69) (cid:37)(cid:79)(cid:72)(cid:69)(cid:69)(cid:14)(cid:55)(cid:85)(cid:91)(cid:16)(cid:76) (cid:87)(cid:3)(cid:32)(cid:3)(cid:20)(cid:75) 90 73 (cid:78)(cid:39)(cid:68) 80 60 50 40 30 20 15 110 160 L M N B 1 ( 21 ) L M N B 2 ( 28 ) G A P D H ( 15 ) H SP 70 ( 35 ) (cid:16) (cid:87) (cid:88)b (cid:88) l(cid:76) (cid:81) ( 12 ) (cid:69) (cid:16) (cid:68) (cid:70) (cid:87) (cid:76) (cid:81) ( 10 ) (cid:69) 0(cid:17)0 0(cid:17)5 1(cid:17)0 1(cid:17)5 Bl(cid:72)bb ( 1h ) Bl(cid:72)bb + Tr(cid:91)(cid:16)(cid:76) ( 1h ) Housekeeping proteins (cid:81)(cid:17)(cid:86)(cid:17) P r o t ( # pep t ) M (cid:68) (cid:86)(cid:86) S (cid:83)(cid:72) (cid:70) (cid:17) (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y N (cid:82) r (cid:80) (cid:17) (cid:87) (cid:82) D M S O (cid:48)(cid:68)(cid:86)(cid:86)(cid:3)(cid:54)(cid:83)(cid:72)(cid:70)(cid:17)(cid:3)(cid:70)(cid:82)(cid:81)(cid:73)(cid:76)(cid:85)(cid:80)(cid:86)(cid:3)(cid:58)(cid:37)(cid:3)(cid:84)(cid:88)(cid:68)(cid:81)(cid:87)(cid:76)(cid:87)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:47)(cid:48)(cid:49)A & DNA(cid:3)(cid:71)(cid:68)(cid:80)(cid:68)(cid:74)(cid:72)(cid:15) (cid:68)(cid:81)(cid:71)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:68)(cid:79)(cid:86)(cid:3)(cid:75)(cid:82)(cid:88)(cid:86)(cid:72)(cid:78)(cid:72)(cid:72)(cid:83)(cid:76)(cid:81)(cid:74)(cid:3)(cid:83)(cid:85)(cid:82)(cid:87)(cid:72)(cid:76)(cid:81)(cid:86)(cid:3)(cid:11)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:47)(cid:48)(cid:49)(cid:37)’(cid:86)(cid:12)(cid:3)(cid:85)(cid:72)(cid:80)(cid:68)(cid:76)(cid:81)(cid:3)(cid:88)(cid:81)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:68)(cid:70)(cid:87)(cid:82)(cid:80)(cid:92)(cid:82)(cid:86)(cid:76)(cid:81)(cid:3)(cid:83)(cid:72)(cid:85)(cid:87)(cid:88)(cid:85)(cid:69)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:3) U(cid:81)(cid:87)r(cid:17) RA AGN 0(cid:17)0 0(cid:17)5 1(cid:17)0 1(cid:17)5 L(cid:68)(cid:80)(cid:76)(cid:81)(cid:16)A (cid:74) H2AX(cid:81)(cid:86) (cid:81)(cid:86) (cid:81)(cid:86) (cid:81)(cid:86) (cid:44) (cid:80)(cid:80) (cid:88)(cid:81)(cid:82)b l (cid:82) (cid:87) (cid:81)(cid:82) r (cid:80) (cid:17) (cid:87) (cid:82) (cid:88)(cid:81) (cid:87) r (cid:72)(cid:68) (cid:87) (cid:72)(cid:71) ( 3h ) U(cid:81)(cid:87)r(cid:17) RA AGN 0(cid:17)0 0(cid:17)5 1(cid:17)0 1(cid:17)5 2(cid:17)0 * * (cid:44) (cid:80)(cid:80) (cid:88)(cid:81)(cid:82)b l (cid:82) (cid:87) (cid:81)(cid:82) r (cid:80) (cid:17) (cid:87) (cid:82) (cid:88)(cid:81) (cid:87) r (cid:72) (cid:68) (cid:87) (cid:72)(cid:71) ( 72h ) 0 1 2 3 4 5 6 7 8 0 20 40 60 80 100 W(cid:68)(cid:86)h(cid:82)(cid:88)(cid:87) + OM T(cid:76)(cid:80)(cid:72) ( hr ) b(cid:72)(cid:68) (cid:87) (cid:86) / (cid:80) (cid:76) (cid:81) ( BP M ) 0(cid:17)00 0(cid:17)02 0(cid:17)04 0(cid:17)06 Bl(cid:72)bb(cid:17) ( 25 (cid:80) M ) W(cid:68)(cid:86)h(cid:82)(cid:88)(cid:87) DMSO C(cid:87)rl MYK ( 1 (cid:80) M ) + OM T (cid:76) (cid:86)(cid:86) (cid:88)(cid:72) b(cid:72)(cid:68) (cid:87) (cid:76) (cid:81)(cid:74) (cid:86) (cid:87) r (cid:68) (cid:76) (cid:81) (cid:39) A R / A R r (cid:72) f C (cid:533)(cid:16)(cid:68)(cid:70)(cid:87)(cid:76)(cid:81)(cid:3) LMNA H2AX (cid:74) 80 60 50 (cid:78)(cid:39)(cid:68) 40 30 20 15 (cid:38) (cid:82)(cid:82) (cid:80) (cid:68) (cid:86)(cid:86) (cid:76) (cid:72) (cid:3) (cid:69) (cid:85) (cid:76)(cid:79)(cid:79)(cid:76) (cid:68)(cid:81) (cid:87)(cid:3) (cid:69) (cid:79) (cid:88)(cid:72) 80 60 50 40 30 20 15 110 160 D M S O ( 0 (cid:17) 5h ) B l (cid:72)bb ( 0 (cid:17) 5h ) B l (cid:72)bb ( 1h ) B l (cid:72)bb ( 2h ) B l (cid:72)bb ( 3h ) B l (cid:72)bb ( 4 (cid:17) 5h ) W (cid:68) (cid:86) h(cid:82)(cid:88) (cid:87) ( + 1h ) W (cid:68) (cid:86) h(cid:82)(cid:88) (cid:87) ( + 3h ) D M S O ( 6h ) + O M ( 7 (cid:17) 5h ) i ii iii i ii (cid:19)(cid:17)(cid:25)(cid:24)(cid:91) 0 50 100 150 90 kD(cid:68) 73 kD(cid:68) HSP90 LMNA (cid:44) (cid:80)(cid:80) (cid:88)(cid:81)(cid:82)b l (cid:82) (cid:87) D (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) (cid:82) (cid:80) (cid:72) (cid:87) r y ( A (cid:17) U (cid:17) ) D M S O ( 1h ) B l (cid:72)bb ( 1h ) B l (cid:72)bb + T r (cid:91) (cid:16) (cid:76) ( 1h ) 0(cid:17)0 0(cid:17)5 1(cid:17)0 1(cid:17)5 (cid:81)(cid:17)(cid:86)(cid:17) C (cid:82)(cid:82) (cid:80) (cid:68) (cid:86)(cid:86) (cid:76) (cid:72) b r (cid:76)ll(cid:76) (cid:68)(cid:81) (cid:87) b l (cid:88)(cid:72) T (cid:82) (cid:87) (cid:68) l (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) HSP90 LMNA (cid:56)(cid:81)(cid:87)(cid:85)(cid:17) RA AGN (cid:47)(cid:82)(cid:90) (cid:48)(cid:72)(cid:71) (cid:43)(cid:76)(cid:74)(cid:75) (cid:47)(cid:82)(cid:90) (cid:48)(cid:72)(cid:71) (cid:43)(cid:76)(cid:74)(cid:75) (cid:47)(cid:82)(cid:90) (cid:48)(cid:72)(cid:71) (cid:43)(cid:76)(cid:74)(cid:75) 73 90 10 0(cid:17)0 0(cid:17)5 1(cid:17)0 1(cid:17)5 2(cid:17)0 70 75 DMSORAAGN (cid:81)(cid:17)(cid:86)(cid:17) (cid:81)(cid:17)(cid:86)(cid:17) + Bl(cid:72)bb(cid:17) 72 T(cid:76)(cid:80)(cid:72) ( h ) (cid:39) A R / A R r (cid:72) f (cid:81)(cid:82) r (cid:80) (cid:17) D M S O H U(cid:81)(cid:87)r(cid:17) RA AGN 0(cid:17)0 0(cid:17)5 1(cid:17)0 1(cid:17)5 * S l (cid:82) (cid:83)(cid:72) ( L M N A v(cid:86) H SP 90 ) N (cid:82) r (cid:80) (cid:17) (cid:87) (cid:82) U (cid:81) (cid:87) r (cid:17) 0 1 2 3 4 1 1 2 3 4 5 0 Day 3 ( post - treatment ) Day 0 T(cid:76)(cid:80)(cid:72) ( (cid:86)(cid:72)(cid:70) ) A R / A R r (cid:72) f 0 5 (cid:117) 10 04 1 (cid:117) 10 05 2 (cid:117) 10 05 2 (cid:117) 10 05 3 (cid:117) 10 05 0 5(cid:17)0 (cid:117) 10 4 1(cid:17)0 (cid:117) 10 5 1(cid:17)5 (cid:117) 10 5 2(cid:17)0 (cid:117) 10 5 AGN RA U(cid:81)(cid:87)r(cid:17) 0(cid:17)9988 0(cid:17)9946 0(cid:17)9909 R 2 HSP90 ( A(cid:17)U(cid:17) ) L M N A ( A (cid:17) U (cid:17) ) 17 42 73 (cid:78)(cid:39)(cid:68) (cid:39)(cid:76)(cid:68)(cid:86)(cid:87)(cid:82)(cid:79)(cid:72)(cid:54)(cid:92)(cid:86)(cid:87)(cid:82)(cid:79)(cid:72) (cid:50)(cid:89)(cid:72)(cid:85)(cid:79)(cid:68)(cid:92) (cid:37)(cid:76)(cid:81)(cid:68)(cid:85)(cid:92) Figure S2 A F D (cid:19)(cid:3)(cid:80)(cid:76)(cid:81) (cid:20)(cid:19)(cid:3)(cid:80)(cid:76)(cid:81) (cid:25)(cid:19)(cid:3)(cid:80)(cid:76)(cid:81) (cid:42) (cid:41) (cid:51) (cid:16) (cid:24)(cid:22) (cid:37)(cid:51) (cid:20) NT (cid:86)(cid:76) C (cid:87) l (cid:86)(cid:76) LMNA (cid:86)(cid:76) LMNA 0 2 4 6 8 * * * (cid:81)(cid:17)(cid:86)(cid:17) (cid:81)(cid:17)(cid:86)(cid:17) + Bl (cid:72) bb (cid:17) K U 80 N (cid:88) (cid:70) l (cid:17) / C y (cid:87) (cid:82)(cid:83) l (cid:17) i ii (cid:14)(cid:37)(cid:79)(cid:72)(cid:69)(cid:69)(cid:17) (cid:58)(cid:68)(cid:86)(cid:75)(cid:82)(cid:88)(cid:87) Ex vivo (cid:3)(cid:87)(cid:76)(cid:86)(cid:86)(cid:88)(cid:72)(cid:29)(cid:3)(cid:76)(cid:81)(cid:87)(cid:68)(cid:70)(cid:87)(cid:3)(cid:40)(cid:23)(cid:3)(cid:75)(cid:72)(cid:68)(cid:85)(cid:87)(cid:86) (cid:26)(cid:3)(cid:81)(cid:49) (cid:42)(cid:41)(cid:51)(cid:16)(cid:46)(cid:56)(cid:27)(cid:19)(cid:80)(cid:38)(cid:75)(cid:72)(cid:85)(cid:85)(cid:92)(cid:16)(cid:70)(cid:42)(cid:36)(cid:54) (cid:42) (cid:41) (cid:51) (cid:16) (cid:46) (cid:56) (cid:27)(cid:19) (cid:80) (cid:38) (cid:75)(cid:72) (cid:85)(cid:85) (cid:92) (cid:16) (cid:70) (cid:42) (cid:36)(cid:54) (cid:37)(cid:72)(cid:73)(cid:82)(cid:85)(cid:72) (cid:39)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74) (cid:36)(cid:73)(cid:87)(cid:72)(cid:85)(cid:3)(cid:11)(cid:24)(cid:80)(cid:76)(cid:81)(cid:12) 53BP1 RPA2 DNA Cytoplasmic 0 20 40 60 80 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 034 D (cid:76)(cid:86)(cid:87)(cid:68)(cid:81)(cid:70)(cid:72) ( μ (cid:80) ) R (cid:72) l (cid:17) (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) B 0 2 4 0 20 40 60 24 + (cid:44)(cid:80)(cid:83)(cid:16)(cid:76) (cid:81)(cid:17)(cid:86)(cid:17) T (cid:76)(cid:80)(cid:72) ( h ) (cid:8) (cid:87) r (cid:68)(cid:81) (cid:86) f (cid:72) (cid:70) (cid:87) (cid:72)(cid:71) (cid:70) (cid:72) ll (cid:86) (cid:90) / f r (cid:68)(cid:74) (cid:80) (cid:72)(cid:81) (cid:87) (cid:72)(cid:71) DN A 0 2 4 24 R (cid:72) l (cid:68) (cid:87) (cid:76) v (cid:72) (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) Cytopl . 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 0 B (cid:72) f (cid:82) r (cid:72) Af (cid:87)(cid:72) r 0 20 40 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 0 B (cid:72) f (cid:82) r (cid:72) Af (cid:87)(cid:72) r D (cid:76)(cid:86)(cid:87)(cid:68)(cid:81)(cid:70)(cid:72) ( μ (cid:80) ) C 0 2 4 6 8 10 0 (cid:17) 8 1 (cid:17) 0 1 (cid:17) 2 0 (cid:17) 8 1 (cid:17) 0 1 (cid:17) 2 T (cid:76)(cid:80)(cid:72) ( (cid:86)(cid:72)(cid:70) ) N (cid:82) r (cid:80) (cid:17) DN A (cid:80) (cid:72)(cid:68)(cid:81) (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y N (cid:88) (cid:70) l (cid:17) A r (cid:72)(cid:68) / A r (cid:72)(cid:68) r (cid:72) f NT (cid:86)(cid:76) C (cid:87) l (cid:86)(cid:76) LMNA (cid:86)(cid:76) LMNA 0 5000 10000 (cid:81)(cid:17)(cid:86)(cid:17) + Bl (cid:72) bb (cid:17) T (cid:82) (cid:87) (cid:68) l K U 80 (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) 0 (cid:17) 4 0 (cid:17) 6 0 (cid:17) 8 1 (cid:17) 0 1 (cid:17) 2 12 14 16 18 20 NT (cid:86)(cid:76) C (cid:87) l (cid:86)(cid:76) LMNA (cid:86)(cid:76) LMNA + Bl (cid:72) bb (cid:17) (cid:86)(cid:76) LMNA + OM R 2 = 0 (cid:17) 9145 r = (cid:16) 0 (cid:17) 9563 K (cid:88) 80 N (cid:88)(cid:70) l (cid:17) / Cy (cid:87)(cid:82)(cid:83) l (cid:17) γ H 2 A X f (cid:82) (cid:70) (cid:76) # ii i E (cid:47)(cid:48)(cid:49)(cid:36)(cid:3)(cid:46)(cid:39)(cid:3)(cid:82)(cid:85)(cid:3)(cid:36)(cid:41)(cid:48)(cid:3)(cid:83)(cid:85)(cid:82)(cid:69)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:3)(cid:81)(cid:88)(cid:70)(cid:79)(cid:72)(cid:76)(cid:3)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:3)(cid:80)(cid:76)(cid:86)(cid:16)(cid:79)(cid:82)(cid:70)(cid:68)(cid:79)(cid:76)(cid:93)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:80)(cid:88)(cid:79)(cid:87)(cid:76)(cid:83)(cid:79)(cid:72)(cid:3)(cid:85)(cid:72)(cid:83)(cid:68)(cid:76)(cid:85)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:15)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:83)(cid:72)(cid:85)(cid:86)(cid:76)(cid:86)(cid:87)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:97)(cid:75)(cid:82)(cid:88)(cid:85)(cid:86)(cid:3) i ii (cid:86)(cid:75)(cid:47)(cid:48)(cid:49)(cid:36)(cid:3)(cid:36)(cid:24)(cid:23)(cid:28)(cid:3)(cid:79)(cid:88)(cid:81)(cid:74)(cid:3)(cid:70)(cid:72)(cid:79)(cid:79)(cid:3)(cid:79)(cid:76)(cid:81)(cid:72) (cid:75)(cid:76)(cid:51)(cid:54)(cid:16)(cid:38)(cid:48)(cid:86) (cid:75)(cid:76)(cid:51)(cid:54)(cid:16)(cid:38)(cid:48)(cid:86) (cid:56)(cid:21)(cid:50)(cid:54)(cid:3)(cid:82)(cid:86)(cid:87)(cid:72)(cid:82) (cid:56) (cid:21) (cid:50) (cid:54) (cid:3) (cid:82) (cid:86) (cid:87) (cid:72)(cid:82) D M S O B l (cid:72) bb (cid:17) W (cid:68) (cid:86) h (cid:17) W (cid:68) (cid:86) h (cid:17) + (cid:44) (cid:80) (cid:83) (cid:16) (cid:76) W (cid:68) (cid:86) h (cid:17) + M (cid:76) f (cid:72)(cid:83) r (cid:17) W (cid:68) (cid:86) h (cid:17) + (cid:40) (cid:91) (cid:83) (cid:16) (cid:76) 0 10 20 * * * (cid:81)(cid:17)(cid:86)(cid:17) ( (cid:81)(cid:82)(cid:81) (cid:16) K U 80 N L S ) (cid:8) (cid:70) (cid:72) ll (cid:86) (cid:90) / K U 80 (cid:80) (cid:76) (cid:86) (cid:16) l (cid:82) (cid:70) (cid:68) l (cid:76) (cid:93) (cid:68) (cid:87) (cid:76) (cid:82)(cid:81) G (cid:75)(cid:76)(cid:51)(cid:54)(cid:16)(cid:38)(cid:48)(cid:3)(cid:82)(cid:85)(cid:74)(cid:68)(cid:81)(cid:82)(cid:76)(cid:71) (cid:47)(cid:72)(cid:81)(cid:74) (cid:87) (cid:75) (cid:3) (cid:11) (cid:97) (cid:20) (cid:80)(cid:80) (cid:12) (cid:97)(cid:20)(cid:19)(cid:3)(cid:86)(cid:72)(cid:70) (cid:14)(cid:40)(cid:87)(cid:82)(cid:83)(cid:82)(cid:86)(cid:76)(cid:71)(cid:72) (cid:58)(cid:68)(cid:86)(cid:75)(cid:82)(cid:88)(cid:87) 0 (cid:21)(cid:17)(cid:24) 24 (cid:55)(cid:76)(cid:80)(cid:72)(cid:3)(cid:11)(cid:75)(cid:12) (cid:46)(cid:92)(cid:80)(cid:82)(cid:74)(cid:85)(cid:68)(cid:83)(cid:75) Figure S3 0 5000 10000 15000 20000 0 20 40 60 80 (cid:86)(cid:76) C (cid:87) l (cid:86)(cid:76) K (cid:88) 80 KU80 (cid:81)(cid:88)(cid:70) l (cid:17) (cid:76)(cid:81)(cid:87)(cid:72)(cid:81)(cid:86)(cid:76)(cid:87) y ( A (cid:17) U (cid:17) ) γ H 2 AX f (cid:82) (cid:70) (cid:76) # 0 50 (cid:86)(cid:76) C (cid:87) l 2N = 92 (cid:8) 4N = 8 (cid:8) 0 50 (cid:86)(cid:76) LMNA 2N = 84 (cid:8) 4N = 16 (cid:8) 0 50 (cid:86)(cid:76) KU80 2N = 85 (cid:8) 4N = 15 (cid:8) 0 50 (cid:86)(cid:76) BRCA1 2N = 78 (cid:8) 4N = 22 (cid:8) 0 50 (cid:86)(cid:76) RPA1 2N = 81 (cid:8) 4N = 19 (cid:8) 1 2 4 0 50 (cid:86)(cid:76) C (cid:82)(cid:80) b (cid:82) 2N = 59 (cid:8) 4N = 41 (cid:8) N (cid:82) r (cid:80)(cid:17) (cid:87)(cid:82)(cid:87)(cid:68) l DNA (cid:70)(cid:82)(cid:81)(cid:87)(cid:72)(cid:81)(cid:87) ( A (cid:17) U (cid:17) ) (cid:8) (cid:82) f (cid:83)(cid:82)(cid:83)(cid:88) l (cid:68) (cid:87) (cid:76) (cid:82)(cid:81) (cid:86)(cid:76) C (cid:87) l (cid:86)(cid:76) LMNA (cid:86)(cid:76) KU80 (cid:86)(cid:76) BRCA1 (cid:86)(cid:76) RPA1 (cid:86)(cid:76) C (cid:82)(cid:80) b (cid:82) (cid:86)(cid:76) C (cid:87) l (cid:86)(cid:76) LMNA * * * * (cid:86)(cid:76) KU80 * * * * * * * * (cid:86)(cid:76) BRCA1 * * * * * * * * (cid:81)(cid:17)(cid:86)(cid:17) (cid:86)(cid:76) RPA1 * * * * * * * * * * * (cid:86)(cid:76) C (cid:82)(cid:80) b (cid:82) * * * * (cid:81)(cid:17)(cid:86)(cid:17) * * * * * * * * * * (cid:46)(cid:82)(cid:79)(cid:80)(cid:82)(cid:74)(cid:82)(cid:85)(cid:82)(cid:89)(cid:177)(cid:54)(cid:80)(cid:76)(cid:85)(cid:81)(cid:82)(cid:89)(cid:3)(cid:87)(cid:72)(cid:86)(cid:87)(cid:15)(cid:3)(cid:302)(cid:3)(cid:32)(cid:3)(cid:19)(cid:17)(cid:19)(cid:24)(cid:3) A D i ii (cid:302) GFP : GFP (cid:16) KU70 (cid:302)(cid:44)(cid:74) G LMNALMNB2KU80RPA1 …TMPO 253 193 88 E i ii iii (cid:46)(cid:39)(cid:3)(cid:82)(cid:73)(cid:3)(cid:47)(cid:48)(cid:49)(cid:36)(cid:3)(cid:82)(cid:85)(cid:3)(cid:85)(cid:72)(cid:83)(cid:68)(cid:76)(cid:85)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:70)(cid:85)(cid:72)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:39)(cid:49)(cid:36)(cid:3)(cid:71)(cid:68)(cid:80)(cid:68)(cid:74)(cid:72)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:68)(cid:70)(cid:70)(cid:88)(cid:80)(cid:88)(cid:79)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:81)(cid:3)(cid:79)(cid:68)(cid:87)(cid:72)(cid:3)(cid:70)(cid:72)(cid:79)(cid:79)(cid:3)(cid:70)(cid:92)(cid:70)(cid:79)(cid:72)(cid:30)(cid:3)(cid:85)(cid:72)(cid:86)(cid:70)(cid:88)(cid:72)(cid:3)(cid:69)(cid:92)(cid:3)(cid:69)(cid:79)(cid:72)(cid:69)(cid:69)(cid:76)(cid:86)(cid:87)(cid:68)(cid:87)(cid:76)(cid:81) (cid:39)(cid:49)(cid:36)(cid:3)(cid:85)(cid:72)(cid:83)(cid:68)(cid:76)(cid:85)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:11)(cid:46)(cid:56)(cid:26)(cid:19)(cid:18)(cid:27)(cid:19)(cid:15)(cid:3)(cid:53)(cid:36)(cid:51)(cid:20)(cid:12)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:68)(cid:70)(cid:87)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:47)(cid:48)(cid:49)(cid:36)(cid:15)(cid:46)(cid:56)(cid:27)(cid:19)(cid:3)(cid:83)(cid:85)(cid:72)(cid:73)(cid:72)(cid:85)(cid:72)(cid:81)(cid:87)(cid:76)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:68)(cid:70)(cid:87)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:81)(cid:82)(cid:81)(cid:16)(cid:83)(cid:75)(cid:82)(cid:86)(cid:83)(cid:75)(cid:82)(cid:85)(cid:92)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:47)(cid:48)(cid:49)(cid:36)(cid:3)(cid:89)(cid:86)(cid:3)(cid:83)(cid:75)(cid:82)(cid:86)(cid:83)(cid:75)(cid:82)(cid:16)(cid:86)(cid:82)(cid:79)(cid:88)(cid:69)(cid:76)(cid:79)(cid:76)(cid:93)(cid:72)(cid:71)(cid:3)(cid:47)(cid:48)(cid:49)(cid:36)(cid:3)(cid:3) B 0 1 2 3 4 1 10 100 1000 10000 T (cid:82)(cid:87)(cid:68) l DNA ( A (cid:17) U (cid:17) ) (cid:40) (cid:71) U (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) G2 G1 S G1 S G2 0 20 40 60 80 WT (cid:86)(cid:76) LMNA (cid:86)(cid:76) LMNA + Bl (cid:72) bb * * * * (cid:8) (cid:82) f (cid:83)(cid:82)(cid:83)(cid:88) l (cid:68) (cid:87) (cid:76) (cid:82)(cid:81) i ii P (cid:88) l l (cid:16) (cid:71)(cid:82) (cid:90) (cid:81) (cid:87) (cid:82) (cid:87) (cid:68) l G F P (cid:87) (cid:82) (cid:87) (cid:68) l (cid:44) (cid:74) G P (cid:88) l l (cid:16) (cid:71)(cid:82) (cid:90) (cid:81) (cid:87) (cid:82) (cid:87) (cid:68) l G F P (cid:87) (cid:82) (cid:87) (cid:68) l (cid:44) (cid:74) G P (cid:88) l l (cid:16) (cid:71)(cid:82) (cid:90) (cid:81) (cid:87) (cid:82) (cid:87) (cid:68) l G F P (cid:87) (cid:82) (cid:87) (cid:68) l (cid:44) (cid:74) G 10 7 10 8 10 9 10 10 GFP (cid:83)(cid:71) (cid:44)(cid:74) G (cid:83)(cid:71) KU70 (cid:81)(cid:17)(cid:86)(cid:17) KU80 LMNA 52 (cid:8) 2 (cid:8) 7 (cid:8) (cid:81)(cid:17)(cid:86)(cid:17) (cid:81)(cid:17)(cid:86)(cid:17) M S (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) (cid:86)(cid:76) C (cid:87)(cid:85)(cid:79) (cid:86)(cid:76) C (cid:82)(cid:80) b (cid:82) 0 5 10 15 20 DMSO Bl (cid:72) bb (cid:76)(cid:86)(cid:87)(cid:68)(cid:87)(cid:76)(cid:81) γ H 2 AX f (cid:82) (cid:70) (cid:76) (cid:86)(cid:76) C (cid:87) rl (cid:86)(cid:76) LMNA 0 1 2 2N4N * * * * * γ H 2 AX f (cid:82) (cid:70) (cid:76) (cid:81)(cid:82) r (cid:80) (cid:17) (cid:87) (cid:82) DN A ( A (cid:17) U (cid:17) ) (cid:81)(cid:86) (cid:81)(cid:86) C Figure S4 C 1 10 10 8 10 9 R 2 = 0 . 9963 Lamin - A ~ E t0 . 750 (cid:40) 4 (cid:40) 6 (cid:40) 10 (cid:40) 18 * T (cid:76)(cid:86)(cid:86)(cid:88)(cid:72) (cid:86)(cid:87)(cid:76) ff (cid:81)(cid:72)(cid:86)(cid:86)(cid:15) E (cid:87) ( kP (cid:68) ) L (cid:68) (cid:80) (cid:76) (cid:81) (cid:16) A M (cid:68) (cid:86)(cid:86) S (cid:83)(cid:72) (cid:70) (cid:17) L F Q (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y 10 6 10 7 10 8 10 9 1 10 E t ~ < Collagen - I > 0 . 52 R 2 = 0 . 9975 (cid:40) 4 (cid:40) 6 (cid:40) 10 (cid:40) 18 * 0 (cid:17) 4 (cid:31) α (cid:31) 0 (cid:17) 65 f (cid:82) r R 2 > 0 (cid:17) 95 C (cid:82) ll (cid:68)(cid:74)(cid:72)(cid:81)(cid:16)(cid:44) M (cid:68)(cid:86)(cid:86) (cid:86)(cid:83)(cid:72)(cid:70)(cid:17) LFQ (cid:76)(cid:81)(cid:87)(cid:72)(cid:81)(cid:86)(cid:76)(cid:87) y T (cid:76) (cid:86)(cid:86) (cid:88)(cid:72) (cid:86) (cid:87) (cid:76) ff (cid:81)(cid:72) (cid:86)(cid:86) (cid:15) E (cid:87) ( k P (cid:68) ) 10 7 10 8 10 9 10 10 10 11 (cid:40) 4 (cid:40) 6 (cid:40) 18 * 10 R 2 = 0 . 9687 1 Lamin - B1 ~ Const . Lamin - B2 ~ E 0 . 25 < Lamin - B > (cid:40) 10 T (cid:76)(cid:86)(cid:86)(cid:88)(cid:72) (cid:86)(cid:87)(cid:76) ff (cid:81)(cid:72)(cid:86)(cid:86)(cid:15) E (cid:87) ( kP (cid:68) ) L (cid:68) (cid:80) (cid:76) (cid:81) (cid:16) B M (cid:68) (cid:86)(cid:86) S (cid:83)(cid:72) (cid:70) (cid:17) L F Q (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y E F A B Lamin - A HSP90 (cid:47)(cid:68)(cid:80)(cid:76)(cid:81)(cid:16)(cid:37) (cid:47)(cid:76)(cid:89)(cid:72)(cid:85) (cid:43)(cid:72)(cid:68)(cid:85)(cid:87) (cid:37)(cid:85)(cid:68)(cid:76)(cid:81) (cid:40)(cid:20)(cid:19)(cid:3)(cid:87)(cid:76)(cid:86)(cid:86)(cid:88)(cid:72) 84 73 68 (cid:78)(cid:39)(cid:68) D 0 100 200 300 0 1 (cid:17) 0 × 10 10 2 (cid:17) 0 × 10 10 3 (cid:17) 0 × 10 10 4 (cid:17) 0 × 10 10 R (cid:68)(cid:87) (cid:87)(cid:68)(cid:76) l C (cid:82) l1 (cid:68) 1 R (cid:68)(cid:87) (cid:87)(cid:68)(cid:76) l C (cid:82) l1 (cid:68) 2 R 2 = 0 (cid:17) 9995 (cid:31) C (cid:82) ll (cid:68)(cid:74)(cid:72)(cid:81)(cid:16)(cid:44) > C (cid:82) ll (cid:68)(cid:74)(cid:72)(cid:81) (cid:86)(cid:83)(cid:76) k (cid:72)(cid:16)(cid:76)(cid:81) ( μ (cid:74) ) M (cid:68) (cid:86)(cid:86) S (cid:86) (cid:83)(cid:72) (cid:70) (cid:17) M S (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) Br (cid:68)(cid:76)(cid:81) H (cid:72)(cid:68) r (cid:87) L (cid:76) v (cid:72) r 0 2 4 6 * (cid:81)(cid:17)(cid:86)(cid:17) (cid:40) 10 (cid:87) (cid:76) (cid:86)(cid:86) (cid:88)(cid:72) (cid:86) (cid:87) (cid:76) ff (cid:81)(cid:72) (cid:86)(cid:86) E (cid:87) ( k P (cid:68) ) (cid:40)(cid:23) (cid:40)(cid:25) (cid:40)(cid:20)(cid:19) (cid:41)(cid:82)(cid:79)(cid:71) (cid:70) h (cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:85)(cid:72)(cid:79)(cid:17)(cid:3)(cid:87)(cid:82)(cid:3)(cid:85)(cid:82)(cid:90)(cid:3)(cid:80)(cid:72)(cid:68)(cid:81)(cid:3) 125 (cid:17) 81 51 (cid:17) 65 132 (cid:17) 32 137 (cid:17) 5 38 (cid:17) 642 96 (cid:17) 081 78 (cid:17) 137 324 (cid:17) 63 273 (cid:17) 25 168 (cid:17) 51 51 (cid:17) 969 63 (cid:17) 696 339 (cid:17) 59 (cid:48)(cid:58)(cid:3)(cid:11)(cid:78)(cid:39)(cid:68)(cid:12) (cid:40) (cid:38) (cid:48) COL1A2 VTN FBLN2 COL1A1 LUM POSTN FBLN1 FBN2 / 3 FN1 LAMB1 MFAP1 (cid:40) LN COL6A3 (cid:54) (cid:68) (cid:85) (cid:70) (cid:82) (cid:80) (cid:72) (cid:85) (cid:72) (cid:18) (cid:36) (cid:70) (cid:87) (cid:82) (cid:80) (cid:92) (cid:82) (cid:86) (cid:76) (cid:81) 41 (cid:17) 792 42 (cid:17) 019 226 (cid:17) 5 221 (cid:17) 82 83 (cid:17) 305 223 (cid:17) 6 229 (cid:17) 04 182 (cid:17) 15 140 (cid:17) 79 102 (cid:17) 83 101 (cid:17) 49 231 (cid:17) 99 64 (cid:17) 091 85 (cid:17) 113 222 (cid:17) 81 104 (cid:17) 21 (cid:36) (cid:71)(cid:75)(cid:72) (cid:86) (cid:76) (cid:82)(cid:81) 61 117 272 68 272 59 PXN VCL TLN1 RDX TLN2 ZYX ACTB ACTC1 MYH9 MYH7 ABL (cid:44) M1 MYH15 MYH10 MYOM1 MYBPC1 ACTN2 ACTN1 MYO18A PDL (cid:44) M5 L (cid:44) MA1 MYH3 ACTN4 0 (cid:17) 1 (cid:91) 10 (cid:91) (cid:47)(cid:68) (cid:80) (cid:76) (cid:81)(cid:68) LMNA LMNB1 LMNB2 73 67 68 (cid:47)(cid:48)(cid:49)(cid:36)(cid:3)(cid:11)(cid:69)(cid:88)(cid:87)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:47)(cid:48)(cid:49)(cid:37)(cid:12)(cid:3)(cid:76)(cid:81)(cid:70)(cid:85)(cid:72)(cid:68)(cid:86)(cid:72)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:38)(cid:82)(cid:79)(cid:20)(cid:3)(cid:9)(cid:3)(cid:87)(cid:76)(cid:86)(cid:86)(cid:88)(cid:72)(cid:3)(cid:86)(cid:87)(cid:76)(cid:73)(cid:73)(cid:81)(cid:72)(cid:86)(cid:86)(cid:15)(cid:3)(cid:73)(cid:82)(cid:79)(cid:79)(cid:82)(cid:90)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:3)(cid:181)(cid:79)(cid:82)(cid:86)(cid:72)(cid:3)(cid:76)(cid:87)(cid:3)(cid:82)(cid:85)(cid:3)(cid:88)(cid:86)(cid:72)(cid:3)(cid:76)(cid:87)(cid:182)(cid:3)(cid:80)(cid:82)(cid:71)(cid:72)(cid:79)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:72)(cid:81)(cid:86)(cid:76)(cid:82)(cid:81)(cid:16)(cid:86)(cid:88)(cid:83)(cid:83)(cid:85)(cid:72)(cid:86)(cid:86)(cid:72)(cid:71)(cid:3)(cid:87)(cid:88)(cid:85)(cid:81)(cid:82)(cid:89)(cid:72)(cid:85) G 0 2 4 6 8 10 12 14 0 2 3 4 1 * LMNA LMNB (cid:40)(cid:80) bry (cid:82)(cid:81)(cid:76)(cid:70) (cid:68)(cid:74)(cid:72) ( (cid:71)(cid:68) y (cid:86) ) (cid:44) (cid:80)(cid:80) (cid:88) (cid:81)(cid:82) b l (cid:82) (cid:87) (cid:81)(cid:82) r (cid:80) (cid:17) (cid:87) (cid:82) (cid:40) 4 ( A (cid:17) U (cid:17) ) ii i (cid:40) 4 (cid:40) 6 0 1 2 L (cid:68) (cid:80) (cid:76) (cid:81) (cid:16) A : B r (cid:68) (cid:87) (cid:76) (cid:82) b y (cid:44) F ( A (cid:17) U (cid:17) ) Figure S5 B (cid:51)(cid:85)(cid:82)(cid:16)(cid:48)(cid:48)(cid:51)(cid:21) (cid:38)(cid:79)(cid:72)(cid:68)(cid:89)(cid:72)(cid:71) MMP2 (cid:533)(cid:16)(cid:68)(cid:70)(cid:87)(cid:76)(cid:81) DMSO Bl (cid:72) bb (cid:17) C (cid:82) l ' (cid:68)(cid:86)(cid:72) (cid:55)(cid:85)(cid:91)(cid:16)(cid:76) (cid:48)(cid:48)(cid:51)(cid:16)(cid:76) (cid:38)(cid:39)(cid:46)(cid:16)(cid:76) + Bl (cid:72) bb (cid:76)(cid:86)(cid:87)(cid:68)(cid:87)(cid:76)(cid:81) 6875 42 (cid:78)(cid:39)(cid:68) DMSO Bl (cid:72) bb (cid:17) C (cid:82) l ' (cid:68)(cid:86)(cid:72) Tr (cid:91)(cid:16)(cid:76) MMP (cid:16)(cid:76) CDK (cid:16)(cid:76) 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 0 1 (cid:17) 5 + Bl (cid:72) bb (cid:76)(cid:86)(cid:87)(cid:68)(cid:87)(cid:76)(cid:81) (cid:81)(cid:17)(cid:86)(cid:17) C l (cid:72)(cid:68) v (cid:72)(cid:71) / P r (cid:82) (cid:16) MM P 2 b y (cid:76) (cid:80)(cid:80) (cid:88)(cid:81)(cid:82) b l (cid:82) (cid:87) ( A (cid:17) U (cid:17) ) 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 0 1 (cid:17) 5 (cid:81)(cid:17)(cid:86)(cid:17) R PA 1 M S (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) DMSO Bl (cid:72) bb (cid:17) C (cid:82) l ' (cid:68)(cid:86)(cid:72) Tr (cid:91)(cid:16)(cid:76) MMP (cid:16)(cid:76) CDK (cid:16)(cid:76) 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 0 1 (cid:17) 5 2 (cid:17) 0 (cid:81)(cid:17)(cid:86)(cid:17) + Bl (cid:72) bb (cid:76)(cid:86)(cid:87)(cid:68)(cid:87)(cid:76)(cid:81) P r (cid:82) (cid:16) MM P 2 M S (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) LMNA (cid:76)(cid:81)(cid:87)(cid:68)(cid:70)(cid:87) (cid:83) LMNA (cid:76)(cid:81)(cid:87)(cid:68)(cid:70)(cid:87) (cid:83) LMNA fr (cid:68)(cid:74)(cid:80)(cid:17) (cid:14)(cid:3)(cid:37)(cid:79)(cid:72)(cid:69)(cid:69)(cid:76)(cid:86)(cid:87)(cid:68)(cid:87)(cid:76)(cid:81) (cid:41)(cid:88)(cid:85)(cid:87)(cid:75)(cid:72)(cid:85)(cid:73)(cid:85)(cid:68)(cid:74)(cid:80)(cid:17) T (cid:76)(cid:80)(cid:72) (cid:41) (cid:85) (cid:68) (cid:70) (cid:87) (cid:76) (cid:82)(cid:81)(cid:68) (cid:79) (cid:3) (cid:68)(cid:69)(cid:88)(cid:81)(cid:71)(cid:68)(cid:81) (cid:70) (cid:72) A LMNA (cid:83)(cid:54)(cid:72)(cid:85)(cid:21)(cid:21) HSP90 73 73 84 (cid:38)(cid:82)(cid:79)(cid:182)(cid:68)(cid:86)(cid:72) (cid:55)(cid:85)(cid:91)(cid:16)(cid:76) (cid:48)(cid:48)(cid:51)(cid:16)(cid:76) (cid:38)(cid:39)(cid:46)(cid:16)(cid:76) (cid:78)(cid:39)(cid:68) (cid:37)(cid:79)(cid:72)(cid:69)(cid:69)(cid:76)(cid:86)(cid:87)(cid:68)(cid:87)(cid:76)(cid:81)(cid:29) (cid:83)(cid:54)(cid:72)(cid:85)(cid:22)(cid:28)(cid:19) 73 - - + + + + + 1 * * * * * * (cid:81)(cid:86) (cid:81)(cid:86) 0 (cid:17) 5 L M N A ( A (cid:17) U (cid:17) ) (cid:38)(cid:82)(cid:79)(cid:182)(cid:68)(cid:86)(cid:72) (cid:55)(cid:85)(cid:91)(cid:16)(cid:76) (cid:48)(cid:48)(cid:51)(cid:16)(cid:76) (cid:38)(cid:39)(cid:46)(cid:16)(cid:76) (cid:37)(cid:79)(cid:72)(cid:69)(cid:69)(cid:76)(cid:86)(cid:87)(cid:68)(cid:87)(cid:76)(cid:81)(cid:29) - - + + + + + (cid:83) S (cid:72) r22 / LMNA 1 * * * * * * * 3 (cid:83) S (cid:72) r390 / LMNA 0 (cid:17) 5 * * * * (cid:81)(cid:86) P h (cid:82) (cid:86) (cid:83) h (cid:82) r y l (cid:68) (cid:87) (cid:72)(cid:71) L M N A ( A (cid:17) U (cid:17) ) C i ii iii (cid:53)(cid:72)(cid:71)(cid:88)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:86)(cid:87)(cid:85)(cid:72)(cid:86)(cid:86)(cid:3)(cid:76)(cid:81)(cid:70)(cid:85)(cid:72)(cid:68)(cid:86)(cid:72)(cid:86)(cid:3)(cid:83)(cid:75)(cid:82)(cid:86)(cid:83)(cid:75)(cid:82)(cid:85)(cid:17)(cid:3)(cid:82)(cid:73)(cid:3)(cid:47)(cid:48)(cid:49)(cid:36)(cid:3)(cid:68)(cid:87)(cid:3)(cid:80)(cid:88)(cid:79)(cid:87)(cid:76)(cid:83)(cid:79)(cid:72)(cid:3)(cid:86)(cid:76)(cid:87)(cid:72)(cid:86) (cid:39)(cid:85)(cid:88)(cid:74)(cid:3)(cid:83)(cid:72)(cid:85)(cid:87)(cid:88)(cid:85)(cid:69)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:71)(cid:82)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:3)(cid:85)(cid:72)(cid:83)(cid:68)(cid:76)(cid:85)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:3)(cid:53)(cid:51)(cid:36)(cid:20)(cid:82)(cid:85)(cid:3)(cid:48)(cid:48)(cid:51)(cid:21)(cid:3)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:86)(cid:18)(cid:68)(cid:70)(cid:87)(cid:76)(cid:89)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81) (cid:40)(cid:23) (cid:40)(cid:20)(cid:20) (cid:54)(cid:82)(cid:73)(cid:87) (cid:54)(cid:87)(cid:76)(cid:73)(cid:73) (cid:40)(cid:23)(cid:3)(cid:38)(cid:48)(cid:86)(cid:3)(cid:82)(cid:81)(cid:3)(cid:74)(cid:72)(cid:79)(cid:86)(cid:29)(cid:76)(cid:81)(cid:3)(cid:89)(cid:76)(cid:89)(cid:82)(cid:29) (cid:54)(cid:83)(cid:85)(cid:72)(cid:68)(cid:71)(cid:76)(cid:81)(cid:74)(cid:51)(cid:82)(cid:79)(cid:68)(cid:85)(cid:76)(cid:93)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:40)(cid:79)(cid:82)(cid:81)(cid:74)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81) (cid:36)(cid:91)(cid:76)(cid:68)(cid:79)(cid:3)(cid:68)(cid:79)(cid:76)(cid:74)(cid:81)(cid:80)(cid:72)(cid:81)(cid:87) (cid:48)(cid:92)(cid:82)(cid:73)(cid:76)(cid:69)(cid:85)(cid:76)(cid:79)(cid:3)(cid:68)(cid:86)(cid:86)(cid:72)(cid:80)(cid:69)(cid:79)(cid:92) (cid:47)(cid:68)(cid:80)(cid:76)(cid:81)(cid:16)(cid:36) A B D 0 (cid:17) 1 1 10 100 1 2 3 4 5 10 6 10 7 Rigidplastic * * * * * * (cid:40) 4 (cid:40) 6 (cid:40) 10 in vivo ( (cid:40) 4 (cid:16) (cid:40) 10 ) in vitro (cid:15) (cid:40) 4 CM (cid:86) G (cid:72) l S (cid:87)(cid:76) ff (cid:81)(cid:72)(cid:86)(cid:86)(cid:15) E (cid:74)(cid:72) l ( kP (cid:68) ) C (cid:72) ll A R ( (cid:70) (cid:88) l (cid:87) (cid:88) r (cid:72) ) C (cid:38) (cid:72) (cid:79)(cid:79) (cid:16) (cid:70) (cid:72) (cid:79)(cid:79) (cid:3) (cid:68) (cid:79)(cid:76) (cid:74)(cid:81) (cid:80) (cid:72)(cid:81) (cid:87) i ii F G H i ii 0 (cid:17) 1 1 10 100 0 (cid:17) 00 0 (cid:17) 01 10 6 10 7 0 (cid:17) 15 0 (cid:17) 20 0 (cid:17) 25 0 (cid:17) 30 0 (cid:17) 35 Rigidplastic * * * * * * (cid:40) 4 (cid:40) 6 (cid:40) 10 (cid:81)(cid:17)(cid:86)(cid:17) Bl (cid:72) bb (cid:76)(cid:86)(cid:87)(cid:68)(cid:87)(cid:76)(cid:81) DMSO C (cid:87) rl Bl (cid:72) bb (cid:17) + GM Bl (cid:72) bb (cid:17) + ARP in vivo ( (cid:40) 4 (cid:16) (cid:40) 10 ) in vitro (cid:40) 4 CM (cid:86) G (cid:72) l S (cid:87)(cid:76) ff (cid:81)(cid:72)(cid:86)(cid:86)(cid:15) E (cid:74)(cid:72) l ( kP (cid:68) ) N (cid:88) (cid:70) l (cid:17) / C y (cid:87) (cid:82) (cid:17) (cid:68) r (cid:72)(cid:68) f r (cid:68) (cid:70) (cid:87) (cid:76) (cid:82)(cid:81) 0 5 10 15 0 100 200 250 300 350 * (cid:97) 25 (cid:8) (cid:40)(cid:80) bry (cid:82)(cid:81)(cid:76)(cid:70) (cid:68)(cid:74)(cid:72) ( (cid:71)(cid:68) y (cid:86) ) N (cid:88) (cid:70) l (cid:72)(cid:68) r v (cid:82) l (cid:88) (cid:80) (cid:72) ( μ (cid:80) 3 ) E 0 5 10 15 0 2 4 6 * (cid:40)(cid:80) bry (cid:82)(cid:81)(cid:76)(cid:70) (cid:68)(cid:74)(cid:72) ( (cid:71)(cid:68) y (cid:86) ) N (cid:88) (cid:70) l (cid:72)(cid:88) (cid:86) (cid:80) (cid:68) j (cid:82) r (cid:68) (cid:91) (cid:76) (cid:86) (cid:68)(cid:81)(cid:74) l (cid:72) 1 / (cid:70) (cid:82)(cid:72) ff (cid:17) (cid:82) f v (cid:68) r (cid:76) (cid:68) (cid:87) (cid:76) (cid:82)(cid:81) ( C O V ) 0 30 60 90 120 150 180 210 240 270 300 330 0 (cid:19)(cid:17)(cid:20) (cid:19)(cid:17)(cid:21) (cid:19)(cid:17)(cid:22) (cid:19)(cid:17)(cid:23) (cid:19)(cid:17)(cid:24) (cid:40)(cid:20)(cid:20)(cid:40)(cid:23) (cid:48)(cid:68)(cid:77)(cid:82)(cid:85)(cid:3)(cid:68)(cid:91)(cid:76)(cid:86)(cid:3)(cid:68)(cid:81)(cid:74)(cid:79)(cid:72)(cid:3)(cid:71)(cid:76)(cid:86)(cid:87)(cid:85)(cid:17) Embryonic heart stiffness 0 (cid:17) 1 1 10 100 0 5 10 15 20 25 * + Bl (cid:72) bb (cid:17) (cid:81)(cid:17)(cid:86)(cid:17) G (cid:72) l (cid:86)(cid:87)(cid:76) ff (cid:81)(cid:72)(cid:86)(cid:86)(cid:15) E (cid:74)(cid:72) l ( kP (cid:68) ) (cid:8) b (cid:72)(cid:68) (cid:87) (cid:76) (cid:81)(cid:74) (cid:70) (cid:72) ll (cid:86) 0 (cid:17) 1 1 10 100 0 (cid:17) 00 0 (cid:17) 05 0 (cid:17) 10 0 (cid:17) 15 * * * * C (cid:72) ll N (cid:88)(cid:70) l (cid:72)(cid:88)(cid:86) + Bl (cid:72) bb (cid:17) N (cid:82) r (cid:80) (cid:17) b (cid:72)(cid:68) (cid:87) (cid:76) (cid:81)(cid:74) (cid:86) (cid:87) r (cid:68) (cid:76) (cid:81) Δ A R / A R r (cid:72) f 0 (cid:17) 1 1 10 100 0 (cid:17) 00 0 (cid:17) 02 0 (cid:17) 04 0 (cid:17) 06 * + Bl (cid:72) bb (cid:17) C (cid:72) ll Δ A r (cid:72)(cid:68) / A r (cid:72)(cid:68) r (cid:72) f i ii iii 5 10 15 10 8 TUBA1C ( 45 (cid:17) 9 kD (cid:68) ) TUBB7 ( 49 (cid:17) 67 kD (cid:68) ) TTLL12 ( 72 (cid:17) 81 kD (cid:68) ) 1 . 7x 0 . 5x 1 . 7x (cid:40)(cid:80) bry (cid:82)(cid:81)(cid:76)(cid:70) (cid:68)(cid:74)(cid:72) ( (cid:71)(cid:68) y (cid:86) ) T (cid:88) b (cid:88) l (cid:76) (cid:81) (cid:86) (cid:9) TT L M S (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) Figure S6 DMSO OM MYK 0 1 2 * (cid:81)(cid:17)(cid:86)(cid:17) Rigid plastic L (cid:68) (cid:80) (cid:76) (cid:81) (cid:16) A : B r (cid:68) (cid:87) (cid:76) (cid:82) ( A (cid:17) U (cid:17) ) 0 (cid:17) 00 0 (cid:17) 05 0 (cid:17) 10 0 (cid:17) 15 0 (cid:17) 00 0 (cid:17) 04 0 (cid:17) 08 0 (cid:17) 12 0 (cid:17) 3 kP (cid:68) 1 kP (cid:68) 10 kP (cid:68) 34 kP (cid:68) r = 0 (cid:17) 9097 R 2 = 0 (cid:17) 8276 Sl (cid:82)(cid:83)(cid:72) (cid:97) 0 (cid:17) 7 C (cid:72) ll Δ AR / AR r (cid:72) f N (cid:88) (cid:70) l (cid:72)(cid:88) (cid:86) Δ A R / A R r (cid:72) f 0 (cid:17) 00 0 (cid:17) 05 0 (cid:17) 10 0 (cid:17) 15 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 0 1 (cid:17) 5 0 (cid:17) 3 kP (cid:68) 1 kP (cid:68) 10 kP (cid:68) 34 kP (cid:68) r = 0 (cid:17) 2199 R 2 = 0 (cid:17) 04837 C (cid:72) ll Δ AR / AR r (cid:72) f L (cid:68) (cid:80) (cid:76) (cid:81) (cid:16) A : B r (cid:68) (cid:87) (cid:76) (cid:82) ( A (cid:17) U (cid:17) ) (cid:38)(cid:48)(cid:86)(cid:3)(cid:70)(cid:88)(cid:79)(cid:87)(cid:88)(cid:85)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:86)(cid:82)(cid:73)(cid:87)(cid:18)(cid:86)(cid:87)(cid:76)(cid:73)(cid:73)(cid:3)(cid:38)(cid:82)(cid:79)(cid:16)(cid:44)(cid:16)(cid:79)(cid:76)(cid:74)(cid:68)(cid:81)(cid:71)(cid:3)(cid:74)(cid:72)(cid:79)(cid:86)(cid:3)(cid:80)(cid:76)(cid:80)(cid:76)(cid:70)(cid:3)(cid:69)(cid:68)(cid:86)(cid:76)(cid:70)(cid:3)(cid:80)(cid:82)(cid:85)(cid:83)(cid:75)(cid:82)(cid:71)(cid:92)(cid:81)(cid:68)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3) in vivo (cid:3)(cid:71)(cid:72)(cid:89)(cid:72)(cid:79)(cid:82)(cid:83)(cid:80)(cid:72)(cid:81)(cid:87) (cid:47)(cid:48)(cid:49)(cid:36)(cid:3)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:86)(cid:3)(cid:71)(cid:82)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:70)(cid:82)(cid:85)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:71)(cid:92)(cid:81)(cid:68)(cid:80)(cid:76)(cid:70)(cid:3)(cid:69)(cid:72)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:30)(cid:3)(cid:76)(cid:81)(cid:86)(cid:87)(cid:72)(cid:68)(cid:71)(cid:3)(cid:76)(cid:81)(cid:70)(cid:85)(cid:72)(cid:68)(cid:86)(cid:72)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:69)(cid:68)(cid:86)(cid:68)(cid:79)(cid:3)(cid:76)(cid:86)(cid:82)(cid:80)(cid:72)(cid:87)(cid:85)(cid:76)(cid:70)(cid:3)(cid:87)(cid:72)(cid:81)(cid:86)(cid:76)(cid:82)(cid:81) anti - GFP Chicken E18 embryo (cid:97)(cid:19)(cid:17)(cid:22)(cid:21) E18 Hearts E F (cid:55)(cid:76)(cid:86)(cid:86)(cid:88)(cid:72)(cid:3)(cid:86)(cid:87)(cid:76)(cid:73)(cid:73)(cid:81)(cid:72)(cid:86)(cid:86) 4 4 5 C (cid:82) l1 (cid:68) 2 L (cid:80)(cid:81)(cid:68) L (cid:82)(cid:91) (cid:31) L (cid:80)(cid:81) b1 (cid:15) L (cid:80)(cid:81) b2 > M (cid:82)(cid:88)(cid:86)(cid:72) h (cid:72)(cid:68) r (cid:87) (cid:71)(cid:72) v (cid:72) l (cid:82)(cid:83)(cid:80)(cid:72)(cid:81)(cid:87) L (cid:76) (cid:72)(cid:87) (cid:68) l (cid:17)(cid:15) Physiol Genomics 2014 (cid:40) 18 (cid:17) 5 (cid:40) 7 (cid:17) 5 (cid:72)(cid:80) bry (cid:82) l (cid:82)(cid:74) 2 ( Col1a1 ) l (cid:82)(cid:74) 2 ( m RN A ) C o l 1a2 Lo x Lo x l 1Lo x l 2Lo x l 3Lo x l 4 T g m 2 M m p1 M m p8 M m p13 M m p2 M m p9 A c t a2 M y h9 T uba1 c T t l S un1 S un2 E m dL m naL m nb1L m nb2 X r cc 6 R a r a R a r b R a r g Y ap1 G a t a4 N kx 2 . 5 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 0 mRNA ~ Col1 α mRNA C (cid:82) l (cid:9) X (cid:16) l (cid:76)(cid:81) k (cid:72) r (cid:86) MMP (cid:86) N (cid:40) L (cid:68)(cid:80)(cid:76)(cid:81)(cid:68) Tr (cid:68)(cid:81)(cid:86)(cid:70) r (cid:76)(cid:83)(cid:87)(cid:76)(cid:82)(cid:81) f (cid:68)(cid:70)(cid:87)(cid:82) r (cid:86) C (cid:82) rr (cid:72) l (cid:68) (cid:87) (cid:76) (cid:82)(cid:81) v (cid:86) (cid:86) (cid:87) (cid:76) ff (cid:81)(cid:72) (cid:86)(cid:86) * * * * * * * * * * * * * * * * * * * * (cid:81)(cid:17)(cid:86)(cid:17) Cy (cid:87)(cid:82)(cid:86) k (cid:72) l (cid:17) A v (cid:72) r (cid:68)(cid:74)(cid:72) (cid:86)(cid:70) (cid:68) l (cid:76) (cid:81)(cid:74) (cid:72) (cid:91) (cid:83)(cid:82)(cid:81)(cid:72)(cid:81) (cid:87) (cid:31) α m RN A > v (cid:86) C o l 1a1 (cid:16) 5 0 5 10 15 20 5 10 15 20 25 30 M (cid:72)(cid:86)(cid:72)(cid:81)(cid:70) hy (cid:80)(cid:72) L (cid:88)(cid:81)(cid:74) K (cid:76)(cid:71)(cid:81)(cid:72) y L (cid:76) v (cid:72) r Br (cid:68)(cid:76)(cid:81) R 2 = 0 . 8673 R (cid:82) b (cid:72) r (cid:72)(cid:87) (cid:68) l (cid:17)(cid:15) Development 1989 H (cid:72)(cid:68) r (cid:87) S (cid:82) l (cid:82) v (cid:72)(cid:76) (cid:72)(cid:87) (cid:68) l (cid:17)(cid:15) Cell 2013 CM (cid:86) A (cid:71)(cid:68)(cid:83)(cid:87)(cid:72)(cid:71) fr (cid:82)(cid:80) S (cid:90)(cid:76) f (cid:87) (cid:72)(cid:87) (cid:68) l (cid:17)(cid:15) Science 2013 T (cid:76)(cid:86)(cid:86)(cid:88)(cid:72) (cid:86)(cid:87)(cid:76) ff (cid:81)(cid:72)(cid:86)(cid:86)(cid:15) E (cid:87) ( kP (cid:68) ) D (cid:72) (cid:87) (cid:72) (cid:70) (cid:87) (cid:68) b l (cid:72) (cid:72) (cid:91) (cid:83) r (cid:72) (cid:86)(cid:86) (cid:76) (cid:82)(cid:81) (cid:82) f l (cid:68) (cid:80) (cid:76) (cid:81) (cid:16) A ( (cid:72) (cid:80) b r y (cid:82)(cid:81) (cid:76) (cid:70) (cid:71)(cid:68) y ) 10 8 10 9 10 8 10 9 Br (cid:68)(cid:76)(cid:81) B (cid:88) r (cid:86)(cid:68) f (cid:68) br (cid:76)(cid:70)(cid:76)(cid:76) H (cid:72)(cid:68) r (cid:87) K (cid:76)(cid:71)(cid:81)(cid:72) y L (cid:76) v (cid:72) r L (cid:88)(cid:81)(cid:74) Br (cid:72)(cid:68)(cid:86)(cid:87) (cid:80)(cid:88)(cid:86)(cid:70) l (cid:72) S (cid:83) l (cid:72)(cid:72)(cid:81) T (cid:72)(cid:86)(cid:87)(cid:76)(cid:86) Ov (cid:68) r (cid:76)(cid:72)(cid:86) C (cid:82) l1 (cid:68) 2 L (cid:80)(cid:81)(cid:68) Lamin - A not detected in brain U (cid:72) bb (cid:76)(cid:81)(cid:74) (cid:72)(cid:87) (cid:68) l (cid:17)(cid:15) Mol Biol Evol (cid:15) 2015 C (cid:82) l1 (cid:68) 1 MS LFQ (cid:76)(cid:81)(cid:87)(cid:72)(cid:81)(cid:86)(cid:76)(cid:87) y M S L F Q (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y 10 9 10 8 10 9 F1M2 F2 M3 F3 M4 M5 F5 R 2 = 0 (cid:17) 8547 R 2 = 0 (cid:17) 9967 C (cid:82) l1 (cid:68) 1 N (cid:82) r (cid:80) (cid:17) M S (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y + DMSO + (cid:55)(cid:85)(cid:91)(cid:16)(cid:76) G F (cid:51) (cid:16) (cid:54) (cid:21)(cid:21) (cid:36) G F (cid:51) (cid:16) (cid:54) (cid:21)(cid:21) (cid:40) B A i ii iii 0 5 10 15 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 0 1 (cid:17) 5 GFP (cid:16) S22A GFP (cid:16) S22A + Tr (cid:91)(cid:16)(cid:76) GFP (cid:16) S22 (cid:40) GFP (cid:16) S22 (cid:40) + Tr (cid:91)(cid:16)(cid:76) D (cid:76)(cid:86)(cid:87)(cid:68)(cid:81)(cid:70)(cid:72) ( μ (cid:80) ) N (cid:82) r (cid:80) (cid:17) G F P (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) G F P (cid:16) S 22 A G F P (cid:16) S 22 A + T r (cid:91) (cid:16) (cid:76) G F P (cid:16) S 22 (cid:40) G F P (cid:16) S 22 (cid:40) + T r (cid:91) (cid:16) (cid:76) 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 0 1 (cid:17) 5 (cid:81)(cid:17)(cid:86)(cid:17) (cid:81)(cid:17)(cid:86)(cid:17) * * * N (cid:88) (cid:70) l (cid:72)(cid:82)(cid:83) l (cid:68) (cid:86) (cid:80) / L (cid:68) (cid:80) (cid:76) (cid:81)(cid:68) r (cid:68) (cid:87) (cid:76) (cid:82) LMNC LMNA β (cid:16)(cid:68)(cid:70)(cid:87)(cid:76)(cid:81) (cid:42)(cid:41)(cid:51)(cid:16)(cid:47)(cid:48)(cid:49)(cid:36)(cid:18)(cid:38) i ii C (cid:42)(cid:41)(cid:51)(cid:16)(cid:54)(cid:21)(cid:21)(cid:40) (cid:42)(cid:41)(cid:51)(cid:16)(cid:54)(cid:21)(cid:21)(cid:40)(cid:3)(cid:14)(cid:3)(cid:48)(cid:48)(cid:51)(cid:21)(cid:16)(cid:76) (cid:68)(cid:81) (cid:87) (cid:76) (cid:16) (cid:47)(cid:68) (cid:80) (cid:76) (cid:81) (cid:16) (cid:36) (cid:18) (cid:38) GFP (cid:16) S22 (cid:40) GFP (cid:16) S22 (cid:40) 0 1000 2000 3000 4000 + MMP2 (cid:16)(cid:76) * L (cid:68) (cid:80) (cid:76) (cid:81) (cid:16) A / C R (cid:72) l (cid:17) (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) 0 2 4 0 (cid:17) 0 0 (cid:17) 5 1 (cid:17) 0 1 (cid:17) 5 2 (cid:17) 0 24 GFP (cid:16) S22A GFP (cid:16) S22A + Tr (cid:91)(cid:16)(cid:76) GFP (cid:16) S22 (cid:40) GFP (cid:16) S22 (cid:40) + Tr (cid:91)(cid:16)(cid:76) T (cid:76)(cid:80)(cid:72) ( h ) N (cid:82) r (cid:80) (cid:17) G F P (cid:76) (cid:81) (cid:87) (cid:72)(cid:81) (cid:86) (cid:76) (cid:87) y ( A (cid:17) U (cid:17) ) 80 60 50 40 30 20 110 160 15 G F P (cid:16) S 22 A G F P (cid:16) S 22 A + T r (cid:91) (cid:16) (cid:76) G F P (cid:16) S 22 (cid:40) G F P (cid:16) S 22 (cid:40) + T r (cid:91) (cid:16) (cid:76) LMNALMNC (cid:42)(cid:41)(cid:51)(cid:16) LMNA / C 0 (cid:17) 0 0 (cid:17) 2 0 (cid:17) 4 0 (cid:17) 6 0 (cid:17) 8 1 (cid:17) 0 1 (cid:17) 2 60 80 110 50 40 30 20 15 GFP (cid:16) S22A + Tr (cid:91)(cid:16)(cid:76) GFP (cid:16) S22A GFP (cid:16) S22 (cid:40) GFP (cid:16) S22 (cid:40) + Tr (cid:91)(cid:16)(cid:76) Fr (cid:68)(cid:74)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86) M (cid:82) l (cid:72)(cid:70)(cid:88) l (cid:68) r (cid:90)(cid:72)(cid:76)(cid:74) h (cid:87) ( kD (cid:68) ) (cid:68)(cid:81) (cid:87) (cid:76) (cid:16) L (cid:68) (cid:80) (cid:76) (cid:81) (cid:16) A / C (cid:71)(cid:72)(cid:81) (cid:86) (cid:76) (cid:87) (cid:82) (cid:80) (cid:72) (cid:87) r y (cid:81)(cid:82) r (cid:80) (cid:17) (cid:87) (cid:82) β (cid:16) (cid:68) (cid:70) (cid:87) (cid:76) (cid:81) ( A (cid:17) U (cid:17) ) D Figure S7 (cid:51)(cid:75)(cid:82)(cid:86)(cid:83)(cid:75)(cid:82)(cid:80)(cid:76)(cid:80)(cid:72)(cid:87)(cid:76)(cid:70)(cid:3)(cid:54)(cid:21)(cid:21)(cid:40)(cid:3)(cid:47)(cid:48)(cid:49)(cid:36)(cid:3)(cid:80)(cid:88)(cid:87)(cid:68)(cid:81)(cid:87)(cid:3)(cid:76)(cid:86)(cid:3)(cid:80)(cid:82)(cid:85)(cid:72)(cid:3)(cid:81)(cid:88)(cid:70)(cid:79)(cid:72)(cid:82)(cid:83)(cid:79)(cid:68)(cid:86)(cid:80)(cid:76)(cid:70)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:80)(cid:82)(cid:85)(cid:72)(cid:3)(cid:85)(cid:68)(cid:83)(cid:76)(cid:71)(cid:79)(cid:92)(cid:3)(cid:71)(cid:72)(cid:74)(cid:85)(cid:68)(cid:71)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:68)(cid:81)(cid:3)(cid:54)(cid:21)(cid:21)(cid:36) (cid:48)(cid:72)(cid:87)(cid:68)(cid:16)(cid:68)(cid:81)(cid:68)(cid:79)(cid:92)(cid:86)(cid:76)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:83)(cid:88)(cid:69)(cid:79)(cid:76)(cid:70)(cid:3)(cid:87)(cid:76)(cid:86)(cid:86)(cid:88)(cid:72)(cid:3)(cid:16)(cid:82)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:71)(cid:68)(cid:87)(cid:68)(cid:69)(cid:68)(cid:86)(cid:72)(cid:86)(cid:3)(cid:86)(cid:88)(cid:74)(cid:74)(cid:72)(cid:86)(cid:87)(cid:86)(cid:3)(cid:83)(cid:82)(cid:87)(cid:72)(cid:81)(cid:87)(cid:76)(cid:68)(cid:79)(cid:3)(cid:181)(cid:88)(cid:81)(cid:76)(cid:89)(cid:72)(cid:85)(cid:86)(cid:68)(cid:79)(cid:76)(cid:87)(cid:92)(cid:182)(cid:3)(cid:82)(cid:73)(cid:3)(cid:47)(cid:48)(cid:49)(cid:36)(cid:3)(cid:89)(cid:86)(cid:3)(cid:38)(cid:82)(cid:79)(cid:20)(cid:3)(cid:40)(cid:38)(cid:48)(cid:3)(cid:70)(cid:82)(cid:85)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86) Lamin - A Mechano - Protects the Heart Ioannis Xanthis 1 and Thomas Iskratsch 1 , * 1 Division of Bioengineering , School of Engineering and Materials Science , Queen Mary University of London * Correspondence : t . iskratsch @ qmul . ac . uk https : / / doi . org / 10 . 1016 / j . devcel . 2019 . 05 . 041 In this issue of Developmental Cell , Cho et al . ( 2019 ) ﬁnd that lamin - A levels in the nuclear envelope are regu - lated in response to mechanical stimuli to prevent the nucleus from rupture , keep DNA repair factors in the nucleus , and consequentially ‘‘mechano - protect the genome . ’’ The cardiac microenvironment constantly changes during development and dis - ease , and the associated mechanical properties affect cellular responses , such as proliferation or differentiation ( Ward and Iskratsch , 2019 ) . The stiffness of the microenvironment is sensed by the resident cells either through cell - sur - face receptors and attached adaptor proteins , such as talin , or directly by the nucleus ( Pandey et al . , 2018 ; Swift et al . , 2013 ) . Previous work from the Discher lab demonstrated that the nuclear enve - lope composition and especially the lamin - A ( LMNA ) : lamin - B ratio is not only regulated downstream of mechanical sig - nals , but can also modify differentiation pathways ( Swift et al . , 2013 ) . Moreover , recent work from migratory cells high - lighted how nuclear lamina composition ( and stiffness ) can affect nuclear defor - mation and lead to DNA damage , thus linking mechanical signaling to genomic instability ( Denais et al . , 2016 ; Raab et al . , 2016 ) . However , while previous studies suggested that DNA damage can be a factor leading to heart failure ( Higo et al . , 2017 ) , how stiffness , nuclear mechanics , and DNA integrity are all associated in the context of heart devel - opment or disease remained unresolved . In the current issue of Developmental Cell , Cho et al . ( 2019 ) use a wide range of techniques and experimental models to analyze the role of LMNA in cardiomyo - cyte mechanosensing . The authors initially set out to study the interference of cardiomyocyte contrac - tility and collagen matrix rigidity in embry - onic chick hearts , using pharmacological inhibitors , collagenase , or transglutami - nase . The authors detected signiﬁcant effects on LMNA levels and concurrent DNA damage , suggesting a link between mechanical forces and genome integrity in the heart . This hypothesis was sup - ported by LMNA knockdown , which led to nuclear rupture and increased DNA damage . To further explore the link be - tween extracellular matrix ( ECM ) stiffness , nuclear integrity , and DNA damage , the authors ﬁrst knocked down LMNA in embryonic hearts . This led to the mis - localization of ﬂuorescently tagged DNA repair factors outside of the nucleus . Further , when human induced pluripotent stem cell - derived cardiomyocytes ( hIPS - CM ) were cultured on either stiff or soft matrices , DNA repair factors were again mis - localized on stiff surfaces due to nuclear envelope rupture , which was aggravated by LMNA knockdown . Im - portantly , in both scenarios the effects were blocked by simultaneous blebbista - tin treatment , underlining the role of contractile forces in this process . Last , cyclic ( passive ) stretching of cardiomyo - cytes and U2OS cells also led to DNA damage and mis - localization of DNA repair factors especially after LMNA knockdown , conﬁrming the link between mechanical forces , LMNA levels , and nuclear damage . To study how LMNA levels were regulated downstream of mechanical signaling , a range of mass spectrometry ( MS ) analyses was performed . The au - thors ﬁrst conﬁrmed previous results showing that LMNA levels and collagen - I are tightly linked to the changing stiffness of the heart during development . Next , the authors proﬁled the proteome of embry - onic hearts after acute ( 1 h ) drug treat - ments . Levels of collagen - I , LMNA , and vinculin were decreased after blebbistatin treatment , but LMNA and collagen - I were rescued after simultaneously treating with a matrix metalloproteinase ( MMP ) inhibi - tor , suggesting that MMPs can degrade both collagen in the ECM and LMNA in the nucleus . Intriguingly , the simultaneous treatment of cells with a cyclin - dependent kinase ( CDK ) inhibitor and blebbistatin also resulted in a rescue of LMNA levels , implying a role for CDKs as regulators of LMNA turnover . CDKs were previously shown by the authors to phosphorylate LMNA , which regulated the targeting of LMNA from the nuclear lamina to the nucleoplasm and its subsequent proteo - lytic degradation ( Buxboim et al . , 2014 ) . Consistently , the authors detected an in - crease in phospho - LMNA fragments after blebbistatin treatment , but a reduction after simultaneous treatment with a pan - MMP or a MMP2 inhibitor . These experiments linked CDKs to proteolytic degradation of LMNA by MMP2 and also to the regulation of nu - clear stiffness and DNA integrity . Im - portantly , immunoprecipitation combined with MS additionally indicated that repair factors interacted preferentially with non - phosphorylated LMNA compared to its phospho - solubilized nucleoplasmic form , suggesting that LMNA in its unphos - phorylated nuclear lamina - associated form also acts as scaffold for the repair factors . This involvement of CDKs in stiffness - dependent phosphorylation of LMNA is intriguing in several regards . First , CDKs were previously shown to affect the localization of other nuclear envelope pro - teins , such as SUN , KASH5 , and lamin - C2 ; however , the mechanism remained elusive ( Viera et al . , 2015 ) . Could it be sec - ondary to the loss of LMNA or are these regulated in a similar manner ? Second , levels of certain endogenous CDK inhibi - tors ( especially p21 and p27 ) were previ - ously found to increase during heart development , but signiﬁcantly decreased in heart disease ( Burton et al . , 1999 ) . This could suggest that LMNA degradation due to its phosphorylation by CDKs con - tributes signiﬁcantly to disease progres - sion and heart failure . Finally , the ﬁndings Developmental Cell Previews Developmental Cell 49 , June 17 , 2019 ª 2019 Elsevier Inc . 821 by Cho et al . could also have implications for cancer therapy and explain the cardio - toxicity of doxorubicin and perhaps other chemotherapeutic agents , since CDK ac - tivity in the heart was increased due to doxorubicin chemotherapy ( Xia et al . , 2018 ) . According to Cho et al . , this would lead to increased phosphorylation and degradation of LMNA , hence a softer nu - cleus , more nuclear rupture , and DNA damage , possibly explaining the link to heart failure ( Xia et al . , 2018 ) . Indeed , treatment with CDK inhibitors preserved the heart function . In summary , Cho et al . provide strong evidence that LMNA expression and turn - over depends on ECM stiffness and is regulated by CDKs and MMP2 ( Figure 1 ) . If forces are low , LMNA becomes phos - phorylated by CDKs , then moves to the nucleoplasm and is degraded by MMP2 . In embryonic hearts , where the ECM is soft , LMNA is present at low levels in part due to changes in expression ( through self - regulation via the retinoic acid pathway [ Swift et al . , 2013 ] ) , but presumably also in part because of CDK activity , consecutive removal from the nu - clear envelope , and subsequent degrada - tion . On the contrary , in adult hearts , where the matrix is stiffer , LMNA is stabi - lized in the membrane in order to prevent nuclear rupture and DNA damage , in what the authors call a ‘‘lose it or use it’’ mech - anism . How CDKs or MMP2 are regulated through cytoskeletal contractility or stiff - ness , however , remains unresolved . The response to blebbistatin is fast , thus excluding transcriptional regulation and rather suggesting a more direct mechani - cal activation . Therefore , evidence points to cardiomyocytes sensing matrix rigidity through a network of mechanosensitive proteins , including talin at integrin adhe - sions and LMNA in the nuclear envelope . However , the intermediate molecules and interactions remain to be elucidated . REFERENCES Burton , P . B . , Yacoub , M . H . , and Barton , P . J . ( 1999 ) . Cyclin - dependent kinase inhibitor expres - sioninhumanheartfailure . Acomparison withfetal development . Eur . Heart J . 20 , 604 – 611 . Buxboim , A . , Swift , J . , Irianto , J . , Spinler , K . R . , Dingal , P . C . , Athirasala , A . , Kao , Y . R . , Cho , S . , Harada , T . , Shin , J . W . , and Discher , D . E . ( 2014 ) . Matrix elasticity regulates lamin - A , C phosphoryla - tion and turnover with feedback to actomyosin . Curr . Biol . 24 , 1909 – 1917 . Cho , S . , Vashisth , M . , Abbas , A . , Majkut , S . , Vogel , K . , Xia , Y . , Ivanovska , I . L . , Irianto , J . , Tewari , M . , Zhu , K . , et al . ( 2019 ) . Mechanosensing by the lamina protects against nuclear rupture , DNA damage , and cell - cycle arrest . Dev . Cell 49 , this issue , 920 – 935 . Denais , C . M . , Gilbert , R . M . , Isermann , P . , McGregor , A . L . , te Lindert , M . , Weigelin , B . , Davidson , P . M . , Friedl , P . , Wolf , K . , and Lammerding , J . ( 2016 ) . Nuclear envelope rupture and repair during cancer cell migration . Science 352 , 353 – 358 . Higo , T . , Naito , A . T . , Sumida , T . , Shibamoto , M . , Okada , K . , Nomura , S . , Nakagawa , A . , Yamaguchi , T . , Sakai , T . , Hashimoto , A . , et al . ( 2017 ) . DNA sin - gle - strand break - induced DNA damage response causes heart failure . Nat . commun . 8 , 15104 . Pandey , P . , Hawkes , W . , Hu , J . , Megone , W . V . , Gautrot , J . , Anilkumar , N . , Zhang , M . , Hirvonen , L . , Cox , S . , Ehler , E . , et al . ( 2018 ) . Cardiomyocytes sense matrix rigidity through a combination of muscle and non - muscle myosin contractions . Dev . Cell 44 , 326 – 336 . e3 . Raab , M . , Gentili , M . , de Belly , H . , Thiam , H . R . , Vargas , P . , Jimenez , A . J . , Lautenschlaeger , F . , Voituriez , R . , Lennon - Dume´nil , A . M . , Manel , N . , andPiel , M . ( 2016 ) . ESCRTIIIrepairsnuclearenve - lope ruptures during cell migration to limit DNA damage and cell death . Science 352 , 359 – 362 . Swift , J . , Ivanovska , I . L . , Buxboim , A . , Harada , T . , Dingal , P . C . , Pinter , J . , Pajerowski , J . D . , Spinler , K . R . , Shin , J . W . , Tewari , M . , et al . ( 2013 ) . Nuclear lamin - A scales with tissue stiffness and enhances matrix - directed differentiation . Science 341 , 1240104 . Viera , A . , Alsheimer , M . , Go´mez , R . , Berenguer , I . , Ortega , S . , Symonds , C . E . , Santamarı´a , D . , Benavente , R . , and Suja , J . A . ( 2015 ) . CDK2 regu - lates nuclear envelope protein dynamics and telo - mere attachment in mouse meiotic prophase . J . Cell Sci . 128 , 88 – 99 . Ward , M . , and Iskratsch , T . ( 2019 ) . Mix and ( mis - ) match - The mechanosensing machinery in the changing environment of the developing , healthy adult and diseased heart . Biochim . Biophys . Acta . Mol . Cell Res . Published online February 8 , 2019 . https : / / doi . org / 10 . 1016 / j . bbamcr . 2019 . 01 . 017 . Xia , P . , Liu , Y . , Chen , J . , Coates , S . , Liu , D . X . , and Cheng , Z . ( 2018 ) . Inhibition of cyclin - dependent ki - nase 2 protects against doxorubicin - induced cardiomyocyte apoptosis and cardiomyopathy . J . Biol . Chem . 293 , 19672 – 19685 . Embryonic Heart Healthy Adult Heart Integrins Talin Vinculin LMNA ECM ( Col1 etc . ) CDK CDKi Cyclin Diseased Adult Heart CDK Cyclin Stiff Nucleus No Rupture H i gh A c t o m y o s i n C on t r a c t ili t y H i gh A c t o m y o s i n C on t r a c t ili t y NUCLEARRUPTURE Soft Nucleus Lo w A c t o m y o s i n C on t r a c t ili t y P CDK Cyclin Soft Nucleus No Rupture P MMP2 P P P MMP2 P DNA Repair Factors DNA Repair Factors Sarcomeres Figure 1 . Nuclear Mechanosensing through LMNA and Potential Implications in Heart Disease ThestiffnessoftheECMchangesduringdevelopment . SimultaneousincreasesinLMNAinthenuclearlamina , duetochanges inexpressionandturnover , stiffen thenucleusandpreventnuclearrupture . EndogenousCDKinhibitorsarestronglyreducedinheartdisease , leadingtohigherCDKactivity , removalofLMNAfrom the nuclear lamina , and its degradation in the nucleoplasm by MMP2 . The softer nucleus is unable to resist the contractile forces , leading to nuclear rupture and loss of DNA repair factors , which are otherwise associated with LMNA . Developmental Cell Previews 822 Developmental Cell 49 , June 17 , 2019